
<html lang="en"     class="pb-page"  data-request-id="73c16ba6-a790-45a2-b9f9-bcfbe3830900"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm9012906;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2010.53.issue-6;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders" /></meta><meta name="dc.Creator" content="David M.  Goldstein" /></meta><meta name="dc.Creator" content="Andreas  Kuglstatter" /></meta><meta name="dc.Creator" content="Yan  Lou" /></meta><meta name="dc.Creator" content="Michael J.  Soth" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 1, 2009" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9012906" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9012906" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9012906" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9012906" /></link>
        
    
    

<title>Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9012906" /></meta><meta property="og:title" content="Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9012906"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9012906">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9012906&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9012906&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9012906&amp;href=/doi/10.1021/jm9012906" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2345-2353</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901090b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm901654x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+M.++Goldstein">David M. Goldstein</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Kuglstatter">Andreas Kuglstatter</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Lou">Yan Lou</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Soth">Michael J. Soth</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, California 94304</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +1 (973) 235-4008. Fax: +1 (973) 235-6263. E-mail: <a href="/cdn-cgi/l/email-protection#8eeaeff8e7eaa3e3a0e9e1e2eafdfaebe7e0cefce1ede6eba0ede1e3"><span class="__cf_email__" data-cfemail="9df9fcebf4f9b0f0b3faf2f1f9eee9f8f4f3ddeff2fef5f8b3fef2f0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9012906&amp;href=/doi/10.1021%2Fjm9012906" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2345–2353</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 1, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 August 2009</li><li><span class="item_label"><b>Published</b> online</span>1 December 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 March 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9012906" title="DOI URL">https://doi.org/10.1021/jm9012906</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2345%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDavid%2BM.%2BGoldstein%252C%2BAndreas%2BKuglstatter%252C%2BYan%2BLou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D6%26contentID%3Djm9012906%26title%3DSelective%2Bp38%25CE%25B1%2BInhibitors%2BClinically%2BEvaluated%2Bfor%2Bthe%2BTreatment%2Bof%2BChronic%2BInflammatory%2BDisorders%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2353%26publicationDate%3DMarch%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9012906"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4355</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">136</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9012906" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;M. Goldstein&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Kuglstatter&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Lou&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Soth&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;2345-2353&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9012906&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9012906&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9012906" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9012906&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9012906" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9012906&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9012906" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9012906&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9012906&amp;href=/doi/10.1021/jm9012906" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9012906" /></input><a href="/doi/pdf/10.1021/jm9012906" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9012906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9012906%26sid%3Dliteratum%253Aachs%26pmid%3D19950901%26genre%3Darticle%26aulast%3DGoldstein%26date%3D2010%26atitle%3DSelective%2Bp38%25CE%25B1%2BInhibitors%2BClinically%2BEvaluated%2Bfor%2Bthe%2BTreatment%2Bof%2BChronic%2BInflammatory%2BDisorders%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D6%26spage%3D2345%26epage%3D2353%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36341" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36341" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">p38α is a member of the well characterized mitogen activated protein (MAP<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: ACR, American College of Rheumatology improvement criteria; COPD, chronic obstructive pulmonary disease ; CNS, central nervous system; CRP, c-reactive protein; DAS, disease activity score in joints; DMARD, disease modifying anti-rheumatic drug; GI, gastrointestinal; MAP, mitogen activated protein; MM, multiple myeloma; RA, rheumatoid arthritis.</p></div> kinase family of serine/threonine protein kinases. p38α is widely expressed in endothelial, immune, and inflammatory cells and plays a central role in the regulation of proinflammatory cytokine production including TNF-α, IL-1β, and IL-6.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Selective blockade of any one of these cytokines with biologic agents has proven efficacious for inflammatory diseases including rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div><div class="NLM_p">The p38 subfamily of MAP kinases includes four isoforms (p38α, p38β, p38γ, and p38δ) that are encoded by separate genes. Analysis of differential tissue expression and activation of these isoforms in synovial tissue extracted from RA patients has suggested that the p38α isoform is overactivated within inflamed tissue and may be a preferred target for intervention in the disease.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> This expectation has prompted a huge investment by the pharmaceutical industry in the development of p38α inhibitors as potential oral disease modifying anti-rheumatic drugs (DMARDs).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><div class="NLM_p">This Perspective will summarize key learnings from over 15 years of industrial experience with p38α as a drug target, with a focus on the rational design of highly selective small molecule inhibitors, followed by a discussion of data for examples <b>1</b>−<b>11</b> that have entered into or are recruiting for phase 2 clinical studies (summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). To date, these results have been disappointing. We conclude that p38α inhibition alone is unlikely to be a successful strategy toward treating chronic inflammatory disorders. Others have also concluded that “the era of optimism surrounding the use of p38 MAPK inhibition for the treatment of RA is over”.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and Reported Status of the Reviewed p38α Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9012906/production/images/medium/jm-2009-012906_0002.gif" alt="" id="fx1" /></img></td></tr></tbody></table></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Kinome Selectivity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34456" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34456" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It is generally believed that, for the treatment of chronic diseases like rheumatoid arthritis, small molecule kinase inhibitors have to be highly selective in order to avoid unwanted effects caused by off-target kinase inhibition. Highly selective inhibitors are also required for unambiguous pharmacological evaluation of drug targets. This requirement for high kinase selectivity is a high hurdle, considering the fact that the human genome contains over 500 protein kinases sharing a high degree of sequence homology.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Nevertheless, selective kinase inhibition is possible and has been demonstrated for several targets, with exceptional examples including the CSF1R inhibitor 5-[[3-methoxy-4-[(4-methoxyphenyl) methoxy]phenyl]methyl]-2,4-pyrimidinediamine (GW2580)<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> and the dual EGFR/ERBB2 inhibitor 4-[[3-chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline (lapatinib).<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><div class="NLM_p">First and second generation p38α inhibitors like 4-[5-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1<i>H</i>-imidazol-4-yl]pyridine (SB203580)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and <b>4</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> were not highly selective against other human kinases, complicating the interpretation of their disclosed results.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Multiple reviews summarizing earlier work on p38 inhibitors have been published.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, more recent “third generation” inhibitors are much improved and clearly demonstrate that selective p38 inhibition is possible. In this section, we summarize the kinome selectivity profiles of three third generation compounds for which the chemical structures and phase 2 clinical trial data are publicly available: <b>2</b>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>5</b>,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and <b>1</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The selectivity profiles of these p38α inhibitors are then discussed in the context of their binding modes and protein−ligand interactions observed by protein crystallography. We also include recently disclosed data on the p38α inhibitor <b>9</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> which appears to be highly selective although it has not been tested against as many off-target kinases as the other three examples.</div><div class="NLM_p">All of these third generation inhibitors are highly kinase selective, with the Scios inhibitor <b>2</b> being an outstanding example (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In a panel of 321 human protein kinases, <b>2</b> binds strongly to only p38α (<i>K</i><sub>D</sub> = 0.48 nM) and its closely related isoform p38β (<i>K</i><sub>D</sub> = 15 nM). The Vertex inhibitor <b>5</b> binds to p38α (<i>K</i><sub>D</sub> = 3.7 nM) and p38β (<i>K</i><sub>D</sub> = 17 nM); in addition, <b>5</b> shows moderate binding to five other kinases. The Roche inhibitor <b>1</b> binds to p38α (<i>K</i><sub>D</sub> = 1.3 nM) and more weakly to JNK2/3 and p38β (<i>K</i><sub>D</sub> of 16/19 and 120 nM, respectively). Compound <b>1</b> additionally binds weakly to five other protein kinases. The Pfizer inhibitor <b>9</b> has been reported to inhibit p38α (<i>K</i><sub>i</sub> = 5.8 nM) and p38β (<i>K</i><sub>i</sub> = 40 nM) but no other targets out of two panels covering 58 kinases.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Selectivity Profiles of p38α Inhibitors in Phase 2 Clinical Trials</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"><b>2</b> (SCIO-469)</th><th align="center"><b>5</b> (VX-702)</th><th align="center"><b>1</b> (Pamapimod)</th></tr></thead><tbody><tr valign="top"><td class="colsep1" colspan="3" align="center"><b>p38α <i>K</i><sub>D</sub> <a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> in μM</b></td></tr><tr valign="top"><td align="left">0.00048</td><td align="left">0.0037</td><td align="left">0.0013</td></tr><tr valign="top"><td class="colsep1" colspan="3" align="center"><b>Off-Target Kinases (<i>K</i><sub>D</sub> in μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></b></td></tr><tr valign="top"><td align="left">P38β (0.015)</td><td align="left">P38β (0.017)</td><td align="left">JNK2 (0.016)</td></tr><tr valign="top"><td align="left"> </td><td align="left">ACVR2β (0.092)</td><td align="left">JNK3 (0.019)</td></tr><tr valign="top"><td align="left"> </td><td align="left">NLK (0.16)</td><td align="left">P38β (0.12)</td></tr><tr valign="top"><td align="left"> </td><td align="left">JNK3 (0.78)</td><td align="left">RSK4β (0.15)</td></tr><tr valign="top"><td align="left"> </td><td align="left">JNK2 (2.6)</td><td align="left">NLK (0.17)</td></tr><tr valign="top"><td align="left"> </td><td align="left">PIK4Cβ (3.3)</td><td align="left">JNK1 (0.19)</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">CSNK1ε (0.26)</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left">RSK3β (0.32)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Compounds with >50% inhibition at 10 μM in a 321 human kinase assay panel where followed up with <i>K</i><sub>D</sub> determination.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Off-target kinases with <i>K</i><sub>D</sub> < 1000-fold the p38α K<sub>D</sub> are listed in the order of their <i>K</i><sub>D</sub> values. Selectivity profiles for <b>6</b> and <b>4</b> have previously been published.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div></div></div><div class="NLM_p">The high degree of p38α selectivity that has been achieved with these hinge-binding, ATP-competitive inhibitors is remarkable. Notably, all four compounds share one common off-target kinase, p38β. Compound <b>1</b> has the largest window between the two p38 isoforms. Because of the high similarity between p38α and p38β (75% sequence identity), in particular at the ATP binding site, some degree of p38β off-target activity appears unavoidable.</div><div class="NLM_p">The p38α inhibitors <b>1</b>, <b>2</b>, <b>5</b>, and <b>9</b> achieve their high kinase selectivity by positioning ligand side chains in multiple “selectivity hotspots”. These hotspots are regions in or in proximity to the ATP binding site where the amino acid sequence of p38α is distinct from the majority of other human kinases. Therefore, engaging this region of the protein with the appropriate ligand interaction results in significant selectivity gain. Here, we will describe four p38α selectivity hotspots and discuss how they are addressed by the above-mentioned inhibitors. X-ray crystal structures of p38α complexed with <b>1</b> (manuscript in preparation) and <b>9</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> are available. Structures of <b>2</b> and <b>5</b> bound to p38α are not available, and structures of close analogues<a onclick="showRef(event, 'ref22 ref64'); return false;" href="javascript:void(0);" class="ref ref22 ref64">(22, 64)</a> will be used instead to analyze their binding modes (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9012906/production/images/medium/jm-2009-012906_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9012906/production/images/large/jm-2009-012906_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystal structures: ball-and-stick representations of p38α (gray) complexed with inhibitors (yellow). Hydrogen bonds are indicated by black dashes. Water molecules are not displayed. (a) Heterobicyclic analogue of <b>2</b> (PDB accession number <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QD9">2QD9</a>, 1.7 Å resolution).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (b) Heterobicyclic analogue of <b>5</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M7Q">1M7Q</a>, 2.4 Å).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (c) <b>1</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FLW">3FLW</a>, 2.1 Å, manuscript in preparation). (d) <b>9</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HLL">3HLL</a>, 1.95 Å).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9012906/production/images/large/jm-2009-012906_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012906&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Back Pocket (T106)</h3><div class="NLM_p">The back pocket is a lipophilic region that is separated from the ATP binding site by the side chain of the “gate keeper” residue. In p38α, this gate keeper is T106, which because of its small size and rotatability allows inhibitors to enter the back pocket directly from the ATP binding site.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> About 20% of all human protein kinases share threonine as the gate keeper residue (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Interestingly, all four inhibitors described in this section fill the p38α back pocket with similar fluorinated phenyl side chains, and in all structures the gate keeper T106 side chain adopts the same conformation, which allows back pocket access (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Presumably, occupying this hotspot is contributing to the high selectivity profiles observed for <b>1</b>, <b>2</b>, <b>5</b>, and <b>9</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Human Kinome Frequency of Amino Acids That Determine Selectivity Hotspots</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center" char=".">T106</th><th align="center" char=".">G110</th><th align="center" char=".">M109−D112, del</th><th align="center" char=".">A157</th></tr></thead><tbody><tr valign="top"><td align="left">no. kinases</td><td align="char" char=".">97</td><td align="char" char=".">41</td><td align="char" char=".">72</td><td align="char" char=".">6</td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Hinge (G110)</h3><div class="NLM_p last">The N- and C-terminal lobes of protein kinases are connected by the “hinge” sequence (T106−D112 in p38α). Typically, the backbone carbonyl of hinge residue X (H107 in p38α) and the backbone NH and carbonyl of residue X + 2 (M109) are directed toward the ATP binding site and therefore available for H-bonding interactions with inhibitors. P38α, however, is able to flip the peptide bond between M109 and G110, resulting in a structural replacement of the exposed M109 backbone carbonyl by the G110 backbone NH. This peptide flip is considered energetically feasible in p38α because of the small size of the G110 side chain.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> About 8% of all human protein kinases have glycine at the equivalent sequence position (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The inhibitor <b>9</b> binds to the p38α hinge in its peptide-flipped conformation (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>d). On the basis of the crystal structures of analogues of <b>2</b> and <b>5</b> bound to p38α (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a,b), we can assume that these inhibitors also bind to the peptide-flipped hinge conformation, which is not accessible to the majority of human kinases. Consequently, addressing this selectivity hotspot improves kinome selectivity.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Front Hinge (M109−D112, Deletion)</h3><div class="NLM_p last">Sequence and structure alignments reveal that in about 14% of all human kinases, including p38α, one amino acid, in most cases a glycine, is deleted from the front hinge region (M109−D112 in p38α, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). This results in additional space available for ligand binding in the deletion region of these kinases.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Analysis of the <b>1</b>, <b>2</b>, <b>5</b>, and <b>9</b> binding modes shows that all four ligands fill, at least partially, this front hinge selectivity hotspot (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Hydrophobic Pocket (A157)</h3><div class="NLM_p">Of all amino acids that present their side chain to the ATP binding site, the one most unique to p38α is A157 (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Alanine is found at that position in only five other human protein kinases: p38β, p38γ, p38δ, and τ tubulin kinases 1 and 2. This fact has recently been discussed as a selectivity driver for a series of highly potent phthalazinine p38α inhibitors.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> A157 forms the bottom of a hydrophobic subpocket at the C-terminal side of the ATP binding site. <b>1</b>, <b>2</b>, and <b>5</b> are all within 4 Å of the A157 methyl side chain, suggesting that kinases with larger residues at this position are likely to bind these ligands with lower affinity. Enzymatic experiments using site-directed mutant variants as performed with first generation p38α inhibitors<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> will be required to assess the contribution of the A157 selectivity hotspot toward the kinome profiles of <b>1</b>, <b>2</b>, and <b>5</b>.</div><div class="NLM_p last">It is remarkable that three independently discovered p38α inhibitor classes as distinct as <b>1</b>, <b>2</b>, and <b>5</b> all achieve kinome selectivity by interacting with the same three selectivity hotspots: back pocket, front hinge, and hydrophobic pocket. Compounds <b>2</b> and <b>5</b> have in common that they additionally trigger the Gly110 hinge flip and therefore address all four p38α selectivity hotspots described in this manuscript. The recently described <b>9</b> fills the back pocket, occupies the front hinge region, and binds to the peptide-flipped hinge conformation, but it does not take full advantage of the unique hydrophobic pocket. It is also noteworthy that the four inhibitors described in this paragraph are all DFG-in binders, and yet their kinome selectivity profiles are superior to the profile of the DFG-out binding p38α inhibitor <b>4</b>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This observation does not support the perception that higher selectivity can be more easily achieved with kinase inhibitors that bind to the DFG-out conformation. Finally, <b>1</b>, <b>2</b>, <b>5</b>, and <b>9</b> demonstrate that the design of highly kinase selective, druglike p38α inhibitors is possible.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Reported Phase 2 Clinical Trials</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51346" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51346" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Multiple p38α inhibitors have advanced into clinical trials. In this section, we summarize the results from p38α inhibitors for which phase 2 data have been disclosed along with phase 1 data for more recent examples reported to be clinically active in phase 2 studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> <b>1</b> (Pamapimod)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></h3><div class="NLM_p">Compound <b>1</b> is a potent and highly selective inhibitor of phosphorylated p38α (IC<sub>50</sub> = 14 nM). The preclinical pharmacology of <b>1</b> has recently been published in detail and is briefly summarized below.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Compound <b>1</b> inhibited the production of TNFα by human monocytic cells (THP-1, IC<sub>50</sub> = 25 nM) and inhibited production of IL-1β and TNFα in human whole blood (IC<sub>50</sub> = 100 nM IL-1β). In a variety of in vivo preclinical models, <b>1</b> inhibited TNFα, IL-1β, and IL-6 production. In acute PK/PD models in rodents, <b>1</b> inhibited LPS induced TNFα production in rodents (ED<sub>50</sub> = 0.3 mg/kg rats; ED<sub>50</sub> = 1.0 mg/kg mice) as well as TNFα-induced IL-6 production (ED<sub>50</sub> = 1.1 mg/kg) and LPS-induced IL-6 production (ED<sub>50</sub> = 0.5 mg/kg). In a chronic in vivo model of inflammation in rodents, <b>1</b> was efficacious at blocking murine collagen induced arthritis (ED<sub>50</sub> = 100 mg/kg), and in a rat model of hyperalgesia, <b>1</b> increased tolerance to pressure in a dose-dependent manner (ED<sub>50</sub> = 20 mg/kg), suggesting that p38α inhibition may also reduce the pain associated with inflammation.</div><div class="NLM_p">In the first of two phase 2 trials, <b>1</b> was evaluated for safety and efficacy in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis (204 patients). The primary efficacy end point was the proportion of patients reaching the American College of Rheumatology 20% improvement criteria (ACR20) at 12 weeks. Secondary end points of the trial included ACR50 and ACR70 response rates and changes from baseline in the Disease Activity Score in 28 joints (DAS28). After 12 weeks of dosing, fewer patients taking <b>1</b> had an ACR20 response (23%, 18%, and 31% in the 50, 150, and 300 mg q.d. groups, respectively) compared with patients taking methotrexate (45%). For each of the eight ACR core component criteria, the methotrexate group showed greater improvement from baseline compared with the three dose groups on compound <b>1</b>. Similar results were observed with the secondary end points of the trial with the conclusion that <b>1</b> was not as effective as methotrexate in the treatment of active RA. In the 300 mg dose group, a drop in C-reactive protein (CRP) levels from baseline was observed but was not sustained after 2 weeks of dosing, suggesting that compensatory inflammatory pathways may have been up-regulated in response to prolonged p38α inhibition.</div><div class="NLM_p">Compound <b>1</b> was generally well tolerated across the dose groups with the most common adverse events, characterized as mild, included infections, skin disorders, and dizziness. The incidence of these adverse events increased with dosage levels, and they occurred with greater frequency in <b>1</b>-treated patients than in methotrexate-treated patients.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">The efficacy and safety of <b>1</b> was also evaluated in a phase 2 trial in patients with active rheumatoid arthritis receiving stable methotrexate therapy (328 patients). The primary efficacy end point was the proportion of patients reaching ACR20 at 12 weeks. Secondary end points of the trial included ACR50 and ACR70 response rates and changes from baseline in DAS28. After 12 weeks of dosing, the percentage of patients taking <b>1</b> with ACR20 response (40%, 40%, 42%, 31%, and 43% in the 25 and 75 mg b.i.d. and the 50, 150, and 300 mg q.d. groups, respectively) was similar or slightly higher compared with placebo (34%); the differences were not statistically significant. Secondary efficacy end points showed similar results. CRP levels showed modest decreases after 1 week in all <b>1</b> dose groups, which were not sustained through the fourth week of the study. Compound <b>1</b> was generally well tolerated; the most common adverse events were characterized as mild and included infections, gastrointestinal (GI) disorders, dizziness, and skin disorders. More adverse events were observed at higher doses of <b>1</b> compared to placebo.</div><div class="NLM_p last">On the basis of the results of these phase 2 trials, Roche has discontinued development of <b>1</b> for RA.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <b>6</b> (VX-745)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></h3><div class="NLM_p">Vertex reported the first clinical “proof-of-principle” of p38α-targeting with <b>6</b>, a potent, selective inhibitor based on a pyridazinopyridone scaffold. Compound <b>6</b> is potent against p38α (IC<sub>50</sub> = 10 nM) and blocks TNFα production in LPS-stimulated HWB in vitro (IC<sub>50</sub> = 177 nM).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">In a phase 2 clinical trial involving 59 patients, administration of <b>6</b> at 250 mg b.i.d. resulted in ACR20 scores at 12 weeks for 43% of subjects, compared to only 8% of patients in a placebo control arm. The drug was generally well-tolerated, with the most significant adverse event being elevation in liver transaminases, which was reversible upon discontinuation of the drug. Other adverse events were GI-related.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p last">These initially disclosed results were encouraging and still appear to be the best reported for a p38α inhibitor with respect to efficacy; however, less information has been disclosed on <b>6</b> than for other late-stage p38α inhibitors, such as <b>1</b> and <b>5</b>. In September 2001, Vertex announced the discontinuation of <b>6</b> because of adverse effects noted in the central nervous system (CNS) for one of two animal species receiving high doses.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The blood levels associated with the neurological effects were approximately 10 times higher than those seen in their human clinical trials up to that point. Subsequent meeting reports detailed that CNS toxicity had been observed in dogs after 6 months of dosing.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The company further noted that <b>6</b> crosses the blood−brain barrier but that follow-up compounds such as <b>5</b> do not.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <b>5</b> (VX-702)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></h3><div class="NLM_p">Compound <b>5</b> is a ring-opened analogue of <b>6</b> that does not cross the blood−brain barrier and presumably has a decreased probability of causing CNS-related adverse events. Preclinical in vitro potencies for this compound have not been reported, but Vertex reported potency in ex vivo assays from phase 1 tolerability studies; <b>5</b> inhibited IL-6, IL-1β, and TNFα production in LPS-primed blood with IC<sub>50</sub> values of 59, 122, and 99 ng/mL, respectively.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">Vertex recently reported detailed results from two 12-week randomized, double-blind, placebo-controlled phase 2 RA studies. The first study, labeled VeRA, investigated 5 and 10 mg b.i.d. dosing for patients with previous inadequate responses to DMARDs (313 patients total). The drug was generally well-tolerated, and the number of adverse events was similar to placebo, the most serious being infections, which were overall more frequent for the arms treated with <b>5</b> than for those treated with placebo (three serious infections in the 10 mg group and two in the 5 mg group, compared to zero in the placebo group). However, the efficacy seen in this study was unimpressive, with few patients achieving ACR50 (11−13% vs 9% placebo) and ACR70 responses (2% for both doses vs 3% for placebo). DAS28 improvements were also modest.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">The second study, labeled Study 304, investigated 10 mg q.d. and 10 mg twice-weekly dosing for subjects also on methotrexate (117 patients total). The 10 mg q.d. arm showed similar drug levels to the 10 mg b.i.d. arm of the VeRA study, while the twice-weekly arm showed much lower trough levels of drug. The results for Study 304 were similar to those for VeRA, although with an overall lower level of adverse advents. There were two serious infections (one from each dosed arm) but also two serious infections in the placebo arm. There was one additional serious adverse event, a gastric ulcer perforation in the 10 mg q.d. group. There were very few ACR50 and 70 responses with no dose-response trends.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p last">Across both studies, there were no clinically significant elevations of liver enzymes and no dropouts due to elevations in liver enzymes. There were also no reported CNS effects. There were dose-dependent, reversible increases in QtcF intervals but no significant cardiac-related adverse events. For both studies, the authors observed a significant decrease in CRP and other biomarkers within the first week of dosing, but this decrease reversed during week 2 and levels were back to baseline by week 12. The study authors’ conclusion is unfortunately very similar to others presented in this review: “... opportunities to achieve meaningful, sustained suppression of the chronic inflammation seen in RA through inhibition of p38 MAPK may be limited.”<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <b>2</b> (SCIO-469)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></h3><div class="NLM_p">Scios has developed a series of small-molecule, orally available, p38α inhibitors, with <b>2</b> (SCIO-469) going furthest in clinical evaluation. Compound <b>2</b> is highly potent against p38α with a reported IC<sub>50</sub> of 9 nM. The compound inhibited LPS-induced TNFα release from human whole blood (IC<sub>50</sub> ≈ 0.3 μM) and inhibited LPS-induced IL-1β release from human PBMCs in a dose-dependent manner.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">A phase 1 study investigated the safety, pharmacodynamics, and pharmacokinetics of <b>2</b> in healthy volunteers.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> A phase II study to determine the analgesic efficacy of <b>2</b> in acute postsurgical dental pain has also been completed (263 subjects). Inflammatory mediators and cytokines such as TNFα and IL-1 are known to contribute to peripheral and central sensitization and to modulate acute, chronic, and neuropathic pain; therefore, inhibition of p38 could be beneficial in managing pain.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> All patients treated with <b>2</b> showed a significantly longer time to rescue medication compared with placebo.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> This study represents the first clinical demonstration of acute analgesic effects by inhibition of p38α.</div><div class="NLM_p">Scios is also the first company to disclose clinical exploration of p38α inhibitors in multiple myeloma (MM). The rationale to study p38 inhibitors in this disease is that blockade of p38 kinase will inhibit the production of tumor-promoting factors such as IL-6 and VEGF in the multiple myeloma bone marrow microenvironment and enhance the ability of proteasome inhibitors such as bortezomib to induce the apoptosis of MM cells.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In 2006, Scios released the results of a phase II trial of <b>2</b> as monotherapy (60 mg po t.i.d.) or in combination with bortezomib, which showed stable disease in 24% of the 28 patients receiving the drug in monotherapy for patients with replased refractory MM.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> To our knowledge, no follow-on studies have since been reported.</div><div class="NLM_p last">In October 2008, Scios reported the results for a randomized, double-blinded, placebo-controlled phase 2 study of <b>2</b> at different oral dosing regimens (100 mg extended release (ER) q.d., 30 mg immediate release (IR) t.i.d., or 60 mg immediate release t.i.d.). The study, performed in patients with active RA not receiving methotrexate, was for 12 weeks followed by a 12-week extension phase (302 subjects). ACR20 and ACR50 response rates between active groups vs placebo group at week 12 did not reach statistical significance: ACR20 and ACR50 rates were 24% and 9% for placebo, 23% and 8% for 100 mg ER, 26% and 8% for 30 mg IR, 33% and 16% for 60 mg IR. There was a trend of improvement in ACR20 and decrease in CRP levels observed at week 2 that did not persist at week 12. Reported notable adverse events included rash and ALT elevations. Scios made the following conclusions from the study: there were no significant differences in ACR20 responses at week 12 (primary end point) between <b>2</b> and placebo; declines in CRP during early treatment did not persist to week 12 and did not correlate with stable <b>2</b> plasma levels; the transient effect of <b>2</b> on CRP suggests a complex role of p38α MAPK in inflammation; the 60 mg immediate release t.i.d. regimen showed a dose-limiting toxicity of ALT elevations with 24-week dosing.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <b>4</b> (BIRB 796)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></h3><div class="NLM_p">Compound <b>4</b> was one of the first p38α molecules that progressed into late stage clinical trials. It has IC<sub>50</sub> values of 21 and 960 nM for the inhibition of TNFα from LPS stimulated human PBMC and human whole blood, respectively.</div><div class="NLM_p">Details of phase 1 trials for compound <b>4</b> have already been summarized.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Results for phase 2 trials of compound <b>4</b> at different doses (5, 10, 20, and 30 mg b.i.d.) in RA have not been disclosed to our knowledge.</div><div class="NLM_p last">In 2006, Boehringer Ingelheim reported the results for a randomized, double-blinded, placebo-controlled phase 2 study of <b>4</b> at different oral dosing regimens (10, 20, 30, and 60 mg b.i.d.) in 354 patients with active Crohn’s disease.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The primary end point of the study was clinical remission defined as CDAI (Crohn’s disease activity index) of <150 after 8 weeks. There was no statistically significant difference in remission rates between all treatment groups for non-Russian patients including placebo, ranging from 20.0% to 23.9%. There appeared to be inverse dose response for Russian patients for remission rates: 64.3% for placebo, 41.2% for 30 mg dose group, and 41.9% for 60 mg dose group. The difference in trial results between the Russian and non-Russian groups was described as a dramatic region effect with placebo remission rates in Russia being almost 3-fold higher than in non-Russian centers (64% vs 23%). During the study, CRP levels in Russian patients were monitored. Interestingly, similar to the observations in other trials with different p38α inhibitors, it was reported that there was a clear dose-related drop of CRP levels at week 1 (−9.0% for placebo, −25.8% for 10 mg, −36.3% for 20 mg, −37.5% for 30 mg, and −48.0% for 60 mg) but that the effect quickly disappeared at week 2. In general, <b>4</b> was well tolerated. The majority of adverse events were related to the gastrointestinal tract and most likely were related to the disease. Other potentially drug-related side effects included infections (mainly upper-respiratory tract infection), symptoms related to the musculoskeletal system, dizziness and headache, rash, and increases in liver function test.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <b>3</b> (BMS-582949, Structure Not Disclosed)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></h3><div class="NLM_p">In collaboration with Pharmacopeia Drug Discovery Inc. (now Ligand Pharmaceuticals Inc.), BMS is investigating <b>3</b>, a p38α inhibitor for RA, in clinical trials. The in vitro activity of this agent has not been disclosed. A phase 1 study investigated the safety, pharmacodynamics, and pharmacokinetics of single ascending oral doses from 10 to 600 mg of <b>3</b> in healthy volunteers.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Compound <b>3</b> was well tolerated with only mild side effects, such as dizziness and rash. The study demonstrated dose-dependent inhibition of ex vivo LPS-induced TNFα in the two parallel studies. The 600 mg q.d. dose consistently suppressed TNFα inhibition close to 100% on both day 7 and day 28. BMS reported a second phase 1 study in subjects with stable RA receiving concomitant methotrexate, with oral doses of <b>3</b> of 30, 100, and 300 mg q.d. The most common adverse events were mild to moderate dizziness, mild upper respiratory infection, and moderate skin rash. Although no details were given, it was hinted that trends toward improving DAS28 scores were noted for the 300 mg dose group compared to lower doses and placebo.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p last">In March 2008, BMS progressed into phase 2 studies in RA with <b>3</b> given orally at 300 mg q.d. with concurrent methotrexate treatment for 12 weeks to subjects with RA having an inadequate response to methotrexate.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The study is ongoing, according to pipeline information from Ligand and BMS.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> BMS has reportedly completed a phase II trial for <b>3</b> in patients with moderate to severe plaque psoriasis<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and initiated a phase II trial to treat patients with atherosclerosis.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <b>7</b> (ARRY-797, Structure Not Disclosed)<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></h3><div class="NLM_p">Array Biopharma has entered the clinic with <b>7</b>, a highly potent and selective p38α inhibitor (enzyme IC<sub>50</sub> = 4.5 nM) claimed to have low potential to cross the blood−brain barrier. The compound was reported to have been selective versus a panel of 220 kinases. In a phase 1 14-day safety study, the compound was generally well-tolerated, with no serious adverse events at the doses studied. The most frequently reported adverse events were dizziness, headache, and nausea. Ex vivo assays at day 14 measuring PGE-2, IL-1β, and TNFα showed dose dependent reductions in all three inflammation biomarkers.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p last">Array was until very recently recruiting patients for a phase 2 active ankylosing spondylitis study and have completed a phase 1 study assessing PK of this compound in RA patients. In a July 8, 2009, press release, Array announced that in a phase 1b 28-day RA study, they observed only a transient inhibition of CRP production, similar to other p38 inhibitors. Array has now discontinued testing of <b>7</b> in chronic inflammatory diseases.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Compound <b>7</b> appears headed for pain indications, with two phase 2 studies completed on analgesic efficacy in dental patients undergoing third molar extraction. The results of the first study have been reported and showed significant improvements in pain relief scores for a 400 mg postoperative dose vs placebo, especially in the first 6 h. A second leg of the study, in which patients received a 200 mg presurgery dose and a 200 mg postsurgery dose, also showed reduced pain in the hours following surgery. The amount of pain relief roughly correlated to the plasma concentrations of drug present. No serious adverse events were reported for any leg of the study (103 patients distributed roughly evenly among the two legs and placebo), and the majority of adverse events were mild, the most common again being dizziness, headache, and nausea. The nausea and headache reports were similar to placebo; the dizziness reports were clearly drug-related.<a onclick="showRef(event, 'ref54 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref56">(54, 56)</a> The second study, results yet to be reported, includes a comparison to celecoxib.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <b>8</b> (ARRY-614, Structure Not Disclosed)<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></h3><div class="NLM_p last">Compound <b>8</b> belongs to the N1-substituted 5-aryloxyindazole class.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> It is a potent inhibitor of p38α (enzyme IC<sub>50</sub> < 2 nM) with limited activity against a panel of 201 kinases, including TIE-2 (IC<sub>50</sub> = 30 nM against TIE2 activity in HUVEC cells). Thus far, the focus for this program appears to be on hematological malignancies, and patients with myelodysplastic disorders are currently recruited for a phase 1 clinical trial. In a phase 1 14 day MAD study, the compound was well tolerated, with no MTD reached after 14 d at 400 mg q.d. Ex vivo assays at day 14 measuring PGE-2, IL-1β, TNFα, and IL6 showed dose dependent reductions in all biomarkers.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <b>9</b> (PH-797804)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></h3><div class="NLM_p">Some preclinical data on <b>9</b>, including its structure, have recently been released. The compound is a sterically congested pyridone that can potentially exist as one of two separable atropisomers, of which the (aS) atropisomer is responsible for potency (p38α <i>K</i><sub>i</sub> = 5.8 nM). The atropisomer is reported to have suitable stability for formulation work.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">Compound <b>9</b> showed good cellular potency (IC<sub>50</sub> between 1 and 10 nM for inhibition of Hsp-27 phosphorylation in an LPS-stimulated human cell line) and cellular selectivity with respect to pathways involving JNK and ERK kinases<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and demonstrated activity in in vivo animal models of acute and chronic inflammation.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Pfizer has completed various phase 2 studies on <b>9</b>, investigating efficacy and safety in neuropathic pain and in RA, but have not yet released results.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <b>10</b> (Losmapimod, GW 856553)<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></h3><div class="NLM_p last">Compound <b>10</b><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> is an orally active p38 inhibitor in phase 2 development as a treatment for chronic obstructive pulmonary disease (COPD), cardiovascular disease, and depression. The compound belongs to the nicotinamide class of p38 inhibitors and has a p38α p<i>K</i><sub>i</sub> = 8.1 and a p38β p<i>K</i><sub>i</sub> = 7.6. The compound has a pIC<sub>50</sub> = 7.6 in blocking LPS-induced TNFα production in human whole blood. The molecule is reported to be 100-fold selective against a modest panel of 67 human kinases. To our knowledge, no clinical data have been published to date with this inhibitor.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <b>11</b> (Dilmapimod, SB 681323)<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></h3><div class="NLM_p last">Compound <b>11</b><a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> belongs to the pyridopyrimidinone class of p38 inhibitors. Minimal data have been released to date, and the compound is reported to be in development only for neuropathic pain.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions and Future Directions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The potential of p38α inhibitors to block the synthesis and release of proinflammatory cytokines formed the basis of a tremendous investment by the pharmaceutical industry into their development as therapeutics for rheumatoid arthritis, inflammatory bowel disease, psoriasis, systemic lupus erythematosis, and other indications characterized by chronic inflammation. As a result, an impressive variety of structurally diverse inhibitors have been developed with excellent druglike properties. Most impressive is the high degree of selectivity that has been achieved despite the fact that most are ATP competitive inhibitors. What this chemically diverse set of competitive inhibitors of p38α have in common is their positioning into distinct regions in or in proximity to the ATP binding site where the amino acid sequence of p38α is distinct from the majority of other human kinases. Identification of such selectivity hotspots is an essential process to enable the successful development of highly selective ATP competitive kinase inhibitors.</div><div class="NLM_p">Recently, it has become possible to begin a comparative analysis of results from published clinical trials with a small set of chemically distinct yet highly selective p38α inhibitors. Some clear trends have begun to emerge, and preliminary conclusions can be drawn regarding both their efficacy and safety. Unfortunately, the primary efficacy end points for four phase 2 clinical trials with p38α inhibitors in rheumatoid arthritis and for one phase 2 clinical trial in Crohn’s disease were not achieved. Similarly disappointing results were reported for secondary end points from these same trials. All five trials reported a significant decrease in inflammatory biomarkers including CRP within the first weeks of dosing, but the effect was not sustained through the duration of the 12-week studies. These results suggest that a compensatory inflammatory pathway may be up-regulated in response to prolonged p38α inhibition in both RA and Crohn’s patients.</div><div class="NLM_p">While p38α inhibitors have been reported to be well tolerated with adverse events described as mild, a number of side effects are commonly reported. The dominant side effects include increase in infections, skin lesions, GI related adverse events, transaminase elevations, and dizziness (although the last was not reported with <b>5</b>, which apparently does not penetrate the CNS) and may be mechanism related.</div><div class="NLM_p last">While the combined results reported to date are disappointing, a number of studies are ongoing in RA as well as in other indications including respiratory, oncologic, and neuropathic pain. Results from these trials may yet identify therapeutic utility for p38α inhibitors. An open question remains whether selective inhibition of p38α is preferable versus agents that combine inhibition of p38α with other targets in parallel inflammatory signaling pathways to achieve the desired efficacy in chronic inflammatory diseases.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm9012906" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David M. Goldstein</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, California 94304</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2f4b4e59464b0242014840434b5c5b4a46416f5d404c474a014c4042"><span class="__cf_email__" data-cfemail="2c484d5a45480141024b4340485f584945426c5e434f4449024f4341">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Kuglstatter</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, California 94304</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Lou</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, California 94304</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Soth</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, California 94304</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13544" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13544" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012906&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>David M. Goldstein</b> received his Ph.D. in Organic Chemistry from the Department of Chemistry at the University of Virginia in 1992. From 1992 to 1994, he completed postdoctoral studies in Organic Chemistry at the University of Pittsburgh, PA, under the direction of Prof. Peter Wipf. In 1994, he joined Syntex in Palo Alto, CA, and continued on with Roche in 1995. Currently, he is a Senior Director and the Head of Inflammation Chemistry at Roche. David’s research is focused on the discovery of small molecule inhibitors in the areas of inflammatory, respiratory, and autoimmune diseases.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012906&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Andreas Kuglstatter</b> received his M.S. degree from the University of Frankfurt, Germany, in 1999 for the characterization of photosynthetic reaction centers under the supervision of Prof. Hartmut Michel, and a Ph.D. from the University of Cambridge, U.K., in 2003 for structural analysis of RNA−protein complexes under the supervision of Dr. Kiyoshi Nagai. After 2 years as a Postdoctoral Fellow at F. Hoffmann-La Roche in Basel, Switzerland, he joined Roche Palo Alto, CA, where he has been head of protein crystallography since 2007.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012906&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yan Lou</b> graduated from the University of Science and Technology of China in 1998. After receiving his Ph.D. in 2002 from Dartmouth College, NH, under the supervision of Prof. David M. Lemal, he joined Prof. E. J. Corey’s group at Harvard University, MA, and studied a novel class of chiral Rh(II) catalysts for enantioselective reactions of diazo compounds. In 2005, he joined Roche Palo Alto as a medicinal chemist and worked on different projects in the inflammation therapeutic area, including p38α projects. He is currently the lead chemist of an anti-inflammation project in the lead optimization stage at Roche Palo Alto.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012906&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Michael J. Soth</b> received his Ph.D. in Organic Chemistry in 1999 from University of California—Irvine under the direction of Prof. James Nowick and completed postdoctoral studies with Prof. Peter Wipf at the University of Pittsburgh, PA, in 2001. Since 2001, he has worked as a medicinal chemist at Roche Palo Alto and is currently a chemistry team leader.</p></figure></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank John Caulfield and Eric Sjogren for critical review of the manuscript.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This paper was published on December 1, 2009 with an incorrect definition for DMARD.  The revised version was published on December 8, 2009.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Schett, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwerina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G.</span><span> </span><span class="NLM_article-title">The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1136%2Fard.2007.074278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=17827184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2008&pages=909-916&author=G.+Schettauthor=J.+Zwerinaauthor=G.+Firestein&title=The+p38+mitogen-activated+protein+kinase+%28MAPK%29+pathway+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis</span></div><div class="casAuthors">Schett, G.; Zwerina, J.; Firestein, G.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">909-916</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chronic inflammatory processes are based on a sustained and tightly regulated communication network among different cells types.  This network comprises extracellular mediators such as cytokines, chemokines and matrix-degrading proteases, which orchestrate the participation of cells in the chronic inflammatory process.  The mirrors of this outside communication world are intracellular transcription factor pathways, which shuttle information about inflammatory stimuli to the cell nucleus.  This review examines the function of one key signal transduction pathway of inflammation-the p38 mitogen-activated protein kinases (p38MAPK).  The signalling pathway is considered as crucial for the induction and maintenance of chronic inflammation, and its components thus emerge as interesting mol. targets of small mol. inhibitors for controlling inflammation.  This review not only summarizes the current knowledge of activation, regulation and function of the p38MAPK pathway but also examines the role of this pathway in clin. disease.  It gives an overview of current evidence of p38MAPK activation in inflammatory arthritis and elaborates the key mol. determinants which contribute to p38MAPK activation in joint disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVrSODN-vBCrVg90H21EOLACvtfcHk0lhOP5y4qBFkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslChsL4%253D&md5=eafcfc4d371a539ef290edc39792ce33</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fard.2007.074278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2007.074278%26sid%3Dliteratum%253Aachs%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DZwerina%26aufirst%3DJ.%26aulast%3DFirestein%26aufirst%3DG.%26atitle%3DThe%2520p38%2520mitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520pathway%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2008%26volume%3D67%26spage%3D909%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Westra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limburg, P. C.</span><span> </span><span class="NLM_article-title">p38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=867-874&author=J.+Westraauthor=P.+C.+Limburg&title=p38+mitogen-activated+protein+kinase+%28MAPK%29+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestra%26aufirst%3DJ.%26aulast%3DLimburg%26aufirst%3DP.%2BC.%26atitle%3Dp38%2520mitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520in%2520rheumatoid%2520arthritis%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D867%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schett, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwerina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manger, B.</span><span> </span><span class="NLM_article-title">How antirheumatic drugs protect joints from damage in rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2936</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2Fart.23951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=18821703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12rur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=2936-2948&author=G.+Schettauthor=C.+Stachauthor=J.+Zwerinaauthor=R.+Vollauthor=B.+Manger&title=How+antirheumatic+drugs+protect+joints+from+damage+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">How antirheumatic drugs protect joints from damage in rheumatoid arthritis</span></div><div class="casAuthors">Schett, Georg; Stach, Christian; Zwerina, Jochen; Voll, Reinhard; Manger, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2936-2948</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  A review on the mechanisms of bone and cartilage destruction, conventional disease-modifying antirheumatic drugs (DMARDs), TNF, IL-1, IL-6, and costimulation blockade, and B cell-depleting therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0_h1WhG8_wLVg90H21EOLACvtfcHk0lhOP5y4qBFkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12rur%252FI&md5=9e56cdb792defe7c69298c6c1f98445a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fart.23951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23951%26sid%3Dliteratum%253Aachs%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DStach%26aufirst%3DC.%26aulast%3DZwerina%26aufirst%3DJ.%26aulast%3DVoll%26aufirst%3DR.%26aulast%3DManger%26aufirst%3DB.%26atitle%3DHow%2520antirheumatic%2520drugs%2520protect%2520joints%2520from%2520damage%2520in%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D2936%26epage%3D2948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Strand, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J. A.</span><span> </span><span class="NLM_article-title">Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials</span> <span class="citation_source-journal">Am. J. Manag. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=18415967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A280%3ADC%252BD1c3lsVOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=234-254&author=V.+Strandauthor=J.+A.+Singh&title=Improved+health-related+quality+of+life+with+effective+disease-modifying+antirheumatic+drugs%3A+evidence+from+randomized+controlled+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials</span></div><div class="casAuthors">Strand Vibeke; Singh Jasvinder A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of managed care</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">234-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the articular synovium, resulting in bony erosions, deformity, and, ultimately, joint destruction.  With associated comorbid conditions,especially cardiovascular, it can result in significant morbidity as well as early mortality.  Patients with RA report impairments in health-related quality of life (HRQOL) in comparison with age- and sex-matched populations without arthritis.  These decreases in HRQOL are attributed to the pain, impairment in physical function, and fatigue associated with this disease.  The introduction of new disease-modifying antirheumatic drugs has revolutionized the treatment of RA, particularly the biologic agents: etanercept, infliximab,adalimumab, abatacept, and rituximab.Importantly, administration of these agents has resulted in statistically significant and clinically meaningful improvements in physical function and HRQOL.  Many clinical studies confirm that with these therapies, RA patients report improvements in HRQOL, reflected by improved physical function, less fatigue, and better emotional and mental function.  Maintenance of physical function is no longer the only treatment goal for RA but also to improve, restore, and preserve HRQOL.  Results from pivotal clinical trials are analyzed in this article and the relevance of the data derived from the clinical studies to day-to-day clinical practice are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuq2tSJWA2IDUE-swuRqsHfW6udTcc2ebk6NJdIMoKjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3lsVOhtg%253D%253D&md5=107275f9d15e8ec78e60eb462f08a1ed</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrand%26aufirst%3DV.%26aulast%3DSingh%26aufirst%3DJ.%2BA.%26atitle%3DImproved%2520health-related%2520quality%2520of%2520life%2520with%2520effective%2520disease-modifying%2520antirheumatic%2520drugs%253A%2520evidence%2520from%2520randomized%2520controlled%2520trials%26jtitle%3DAm.%2520J.%2520Manag.%2520Care%26date%3D2008%26volume%3D14%26spage%3D234%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hale, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trollinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rihanek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthey, C. L.</span><span> </span><span class="NLM_article-title">Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">4246</span><span class="NLM_x">–</span> <span class="NLM_lpage">4252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=4246-4252&author=K.+K.+Haleauthor=D.+Trollingerauthor=M.+Rihanekauthor=C.+L.+Manthey&title=Differential+expression+and+activation+of+p38+mitogen-activated+protein+kinase+alpha%2C+beta%2C+gamma%2C+and+delta+in+inflammatory+cell+lineages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DK.%2BK.%26aulast%3DTrollinger%26aufirst%3DD.%26aulast%3DRihanek%26aufirst%3DM.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26atitle%3DDifferential%2520expression%2520and%2520activation%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%2520alpha%252C%2520beta%252C%2520gamma%252C%2520and%2520delta%2520in%2520inflammatory%2520cell%2520lineages%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D162%26spage%3D4246%26epage%3D4252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Korb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tohidast-Akrad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cetin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smolen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schett, G.</span><span> </span><span class="NLM_article-title">Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2745</span><span class="NLM_x">–</span> <span class="NLM_lpage">2756</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2Fart.22080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=16947383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWksLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=2745-2756&author=A.+Korbauthor=M.+Tohidast-Akradauthor=E.+Cetinauthor=R.+Axmannauthor=J.+Smolenauthor=G.+Schett&title=Differential+tissue+expression+and+activation+of+p38+MAPK+alpha%2C+beta%2C+gamma%2C+and+delta+isoforms+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Differential tissue expression and activation of p38 MAPK α, β, γ, and δ isoforms in rheumatoid arthritis</span></div><div class="casAuthors">Korb, Adelheid; Tohidast-Akrad, Makiyeh; Cetin, Erdal; Axmann, Roland; Smolen, Josef; Schett, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2745-2756</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. Activation of p38 MAPK is a key signaling step in chronic inflammation.  Inhibition of p38 MAPK is considered to be a promising future strategy to control inflammatory diseases, but studies of compds. to inhibit this kinase have so far been limited to investigation of their side effects.  We undertook the present study to investigate which specific mol., among 4 different isoforms of p38 MAPK (α, β, γ, and δ), is predominantly expressed and activated in inflammation.  Such knowledge could allow more specific targeting of p38 MAPK in inflammatory disease.  Methods. Studies were performed on inflamed tissue from patients with rheumatoid arthritis, as a prototype of inflammatory disease.  The expression and activation of the α, β, γ, and δ isoforms of p38 MAPK were examd. by immunoblotting, immunopptn., and immunohistochem.  Results. Immunoblot anal. revealed that α and γ were the predominantly expressed p38 MAPK isoforms, whereas the other 2 isoforms were less frequently present.  By immunohistochem., the expression of all p38 MAPK isoforms was localized to the synovial lining layer as well as to blood vessels.  Colabeling with cell-specific markers revealed that macrophages expressed the α and γ isoforms, synovial fibroblasts the β and γ isoforms, and granulocytes the δ isoform, whereas T lymphocytes were rarely pos. for any p38 MAPK isoform.  Double-labeling with isoform-specific antibody and pan-p38 antibody against the phosphorylated form of p38 MAPK showed activation of the α and γ isoforms.  Occasional activation of the β isoform was also noted in the synovial lining and the endothelium, whereas the δ isoform, although expressed in pericytes around blood vessels, was not phosphorylated.  This phosphorylation pattern was confirmed in immunopptn. studies in which activated p38 MAPK from synovial tissue exts. was identified as p38 MAPKα and -γ but not p38 MAPKβ or -δ.  Conclusion. These data show that the α and γ isoforms of p38 MAPK dominate in chronic inflammation.  Effective strategies to inhibit p38 MAPK should therefore aim to specifically target either or both of these isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcWrhAqc63DbVg90H21EOLACvtfcHk0lht6n4-I8YlxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWksLjN&md5=33803193f35ab7b1ee652d4005e968a0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fart.22080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.22080%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DA.%26aulast%3DTohidast-Akrad%26aufirst%3DM.%26aulast%3DCetin%26aufirst%3DE.%26aulast%3DAxmann%26aufirst%3DR.%26aulast%3DSmolen%26aufirst%3DJ.%26aulast%3DSchett%26aufirst%3DG.%26atitle%3DDifferential%2520tissue%2520expression%2520and%2520activation%2520of%2520p38%2520MAPK%2520alpha%252C%2520beta%252C%2520gamma%252C%2520and%2520delta%2520isoforms%2520in%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2006%26volume%3D54%26spage%3D2745%26epage%3D2756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Schett, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tohidast-Akrad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smolen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitzan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redlich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, G.</span><span> </span><span class="NLM_article-title">Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2501</span><span class="NLM_x">–</span> <span class="NLM_lpage">2512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2F1529-0131%28200011%2943%3A11%3C2501%3A%3AAID-ANR18%3E3.0.CO%3B2-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=11083274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosFyntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2501-2512&author=G.+Schettauthor=M.+Tohidast-Akradauthor=J.+S.+Smolenauthor=B.+J.+Schmidauthor=C.+W.+Steinerauthor=P.+Bitzanauthor=P.+Zenzauthor=K.+Redlichauthor=Q.+Xuauthor=G.+Steiner&title=Activation%2C+differential+localization%2C+and+regulation+of+the+stress-activated+protein+kinases%2C+extracellular+signal-regulated+kinase%2C+c-JUN+N-terminal+kinase%2C+and+p38+mitogen-activated+protein+kinase%2C+in+synovial+tissue+and+cells+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis</span></div><div class="casAuthors">Schett, Georg; Tohidast-Akrad, Makiyeh; Smolen, Josef S.; Schmid, Beatrice Jahn; Steiner, Carl-Walter; Bitzan, Peter; Zenz, Peter; Redlich, Kurt; Xu, Qingbo; Steiner, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2501-2512</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">It was investigated whether stress- and mitogen-activated protein kinases (SAPK/MAPK), such as extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK, are significantly activated in rheumatoid arthritis (RA) synovial tissue compared with their activation in degenerative joint disease.  The localization of SAPK/MAPK activation in rheumatoid synovial tissue was assessed.  The factors leading to stress kinase activation in human synovial cells were studied.  Immunoblotting and immunohistol. by antibodies specific for the activated forms of SAPK/MAPK were performed on synovial tissue samples from patients with RA and osteoarthritis (OA).  In addn., untreated and cytokine-treated human synovial cells were assessed for SAPK/MAPK activation and down-stream signaling by various techniques.  ERK, JNK, and p38 MAPK activation were almost exclusively found in synovial tissue from RA, but not OA, patients.  ERK activation was localized around synovial microvessels, JNK activation was localized around and within mononuclear cell infiltrates, and p38 MAPK activation was obsd. in the synovial lining layer and in synovial endothelial cells.  Tumor necrosis factor α, interleukin-1 (IL-1), and IL-6 were the major inducers of ERK, JNK, and p38 MAPK activation in cultured human synovial cells.  Signaling through SAPK/MAPK pathways is a typical feature of chronic synovitis in RA, but not in degenerative joint disease.  SAPK/MAPK signaling is found at distinct sites in the synovial tissue, is induced by proinflammatory cytokines, and could lead to the design of highly targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow29LR5uTJLLVg90H21EOLACvtfcHk0lgWcYJNMyqkuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosFyntbk%253D&md5=ea27cc31ad37eaadb5391f3fc7e791b7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F1529-0131%28200011%2943%3A11%3C2501%3A%3AAID-ANR18%3E3.0.CO%3B2-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1529-0131%2528200011%252943%253A11%253C2501%253A%253AAID-ANR18%253E3.0.CO%253B2-K%26sid%3Dliteratum%253Aachs%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DTohidast-Akrad%26aufirst%3DM.%26aulast%3DSmolen%26aufirst%3DJ.%2BS.%26aulast%3DSchmid%26aufirst%3DB.%2BJ.%26aulast%3DSteiner%26aufirst%3DC.%2BW.%26aulast%3DBitzan%26aufirst%3DP.%26aulast%3DZenz%26aufirst%3DP.%26aulast%3DRedlich%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DSteiner%26aufirst%3DG.%26atitle%3DActivation%252C%2520differential%2520localization%252C%2520and%2520regulation%2520of%2520the%2520stress-activated%2520protein%2520kinases%252C%2520extracellular%2520signal-regulated%2520kinase%252C%2520c-JUN%2520N-terminal%2520kinase%252C%2520and%2520p38%2520mitogen-activated%2520protein%2520kinase%252C%2520in%2520synovial%2520tissue%2520and%2520cells%2520in%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2000%26volume%3D43%26spage%3D2501%26epage%3D2512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, T.</span><span> </span><span class="NLM_article-title">Pathway to the clinic: inhibition of P38 MAP kinase. A review of ten chemotypes selected for development</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.2174%2F1568026054985939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=16178744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1017-1029&author=D.+M.+Goldsteinauthor=T.+Gabriel&title=Pathway+to+the+clinic%3A+inhibition+of+P38+MAP+kinase.+A+review+of+ten+chemotypes+selected+for+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pathway to the clinic: Inhibition of P38 MAP kinase. A review of ten chemotypes selected for development</span></div><div class="casAuthors">Goldstein, David M.; Gabriel, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  P38 mitogen activated protein (MAP) kinase remains the most compelling therapeutic target for oral drug intervention for a wide range of autoimmune disorders based on the central role this enzyme plays in inflammatory cell signaling.  Efforts to discover inhibitors of p38 suitable for clin. investigation have continued to escalate in part due to the incredible diversity of unique chemotypes reported to inhibit the enzyme.  Since 1993, at least seventeen p38 inhibitors have been reported to have entered into clin. trials.  Next generation inhibitors have been disclosed with improved potency for p38 and enhanced selectivity vs. other protein kinases.  Over the last three years, there have been multiple reports of cytokine suppression in humans following oral administration of p38 inhibitors.  These results, in addn. to proof of concept studies in rheumatoid patients, have established p38 inhibition as an avenue for the future management of pro-inflammatory cytokine based diseases.  This review describes the discovery at Roche of novel p38 inhibitors which have advanced into clin. trials.  The pharmacol. of the Roche compds. is then compared with eight chem. distinct p38 inhibitors known to have entered clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrve3HIFcxtSrVg90H21EOLACvtfcHk0lgWcYJNMyqkuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK&md5=a4acd0c62b42c1f2eb4dafd8f8b60306</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1568026054985939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985939%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGabriel%26aufirst%3DT.%26atitle%3DPathway%2520to%2520the%2520clinic%253A%2520inhibition%2520of%2520P38%2520MAP%2520kinase.%2520A%2520review%2520of%2520ten%2520chemotypes%2520selected%2520for%2520development%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1017%26epage%3D1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pettus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span> </span><span class="NLM_article-title">Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006−2008</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.2174%2F156802608786264245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=18991731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWgtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1452-1467&author=L.+H.+Pettusauthor=R.+P.+Wurz&title=Small+molecule+p38+MAP+kinase+inhibitors+for+the+treatment+of+inflammatory+diseases%3A+novel+structures+and+developments+during+2006%E2%88%922008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006-2008</span></div><div class="casAuthors">Pettus, Liping H.; Wurz, Ryan P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1452-1467</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The p38 mitogen-activated protein (MAP) kinase plays a central role in inflammation.  It has been the subject of extensive efforts in both basic research and drug discovery for the treatment of inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, where aberrant cytokine signaling is the driver of the disease.  This article reviews the patent and journal publication activities during 2006-2008 describing novel small mol. p38α inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKQu_KXhrvHrVg90H21EOLACvtfcHk0lgWcYJNMyqkuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWgtrfJ&md5=65fa3e72c52323dcd378421dd577a1b4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F156802608786264245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608786264245%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26atitle%3DSmall%2520molecule%2520p38%2520MAP%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%253A%2520novel%2520structures%2520and%2520developments%2520during%25202006%25E2%2588%25922008%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1452%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Genovese, M. C.</span><span> </span><span class="NLM_article-title">Inhibition of p38: has the fat lady sung?</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2Fart.24264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=19180514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A280%3ADC%252BD1M7isFyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=317-320&author=M.+C.+Genovese&title=Inhibition+of+p38%3A+has+the+fat+lady+sung%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38: has the fat lady sung?</span></div><div class="casAuthors">Genovese Mark C</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-20</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnT0jWinaMx0PI-fCgwosgfW6udTcc2ebdu3kZWwHaQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7isFyjtQ%253D%253D&md5=b8aaf19800021f9f8fb00f4220c8194a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fart.24264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24264%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26atitle%3DInhibition%2520of%2520p38%253A%2520has%2520the%2520fat%2520lady%2520sung%253F%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D317%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0ljbCnki2GD2fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Conway, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadepalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kull, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, J. T.</span><span> </span><span class="NLM_article-title">Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16078</span><span class="NLM_x">–</span> <span class="NLM_lpage">16083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1073%2Fpnas.0502000102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=16249345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WqsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16078-16083&author=J.+G.+Conwayauthor=B.+McDonaldauthor=J.+Parhamauthor=B.+Keithauthor=D.+W.+Rusnakauthor=E.+Shawauthor=M.+Jansenauthor=P.+Linauthor=A.+Payneauthor=R.+M.+Crosbyauthor=J.+H.+Johnsonauthor=L.+Frickauthor=M.+H.+Linauthor=S.+Depeeauthor=S.+Tadepalliauthor=B.+Vottaauthor=I.+Jamesauthor=K.+Fullerauthor=T.+J.+Chambersauthor=F.+C.+Kullauthor=S.+D.+Chamberlainauthor=J.+T.+Hutchins&title=Inhibition+of+colony-stimulating-factor-1+signaling+in+vivo+with+the+orally+bioavailable+cFMS+kinase+inhibitor+GW2580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580</span></div><div class="casAuthors">Conway, James G.; McDonald, Brad; Parham, Janet; Keith, Barry; Rusnak, David W.; Shaw, Eva; Jansen, Marilyn; Lin, Peiyuan; Payne, Alan; Crosby, Renae M.; Johnson, Jennifer H.; Frick, Lloyd; Lin, Min-Hwa Jasmine; Depee, Scott; Tadepalli, Sarva; Votta, Bart; James, Ian; Fuller, Karen; Chambers, Timothy J.; Kull, Frederick C.; Chamberlain, Stanley D.; Hutchins, Jeff T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">16078-16083</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Colony-stimulating-factor-1 (CSF-1) signaling through cFMS receptor kinase is increased in several diseases.  To help investigate the role of cFMS kinase in disease, the authors identified GW2580, an orally bioavailable inhibitor of cFMS kinase.  GW2580 completely inhibited human cFMS kinase in vitro at 0.06 μM and was inactive against 26 other kinases.  GW2580 at 1 μM completely inhibited CSF-1-induced growth of mouse M-NFS-60 myeloid cells and human monocytes and completely inhibited bone degrdn. in cultures of human osteoclasts, rat calvaria, and rat fetal long bone.  In contrast, GW2580 did not affect the growth of mouse NS0 lymphoblastoid cells, human endothelial cells, human fibroblasts, or five human tumor cell lines.  GW2580 also did not affect lipopolysaccharide (LPS)-induced TNF, IL-6, and prostaglandin E2 prodn. in freshly isolated human monocytes and mouse macrophages.  After oral administration, GW2580 blocked the ability of exogenous CSF-1 to increase LPS-induced IL-6 prodn. in mice, inhibited the growth of CSF-1-dependent M-NFS-60 tumor cells in the peritoneal cavity, and diminished the accumulation of macrophages in the peritoneal cavity after thioglycolate injection.  Unexpectedly, GW2580 inhibited LPS-induced TNF prodn. in mice, in contrast to effects on monocytes and macrophages in vitro.  In conclusion, GW2580's selective inhibition of monocyte growth and bone degrdn. is consistent with cFMS kinase inhibition.  The ability of GW2580 to chronically inhibit CSF-1 signaling through cFMS kinase in normal and tumor cells in vivo makes GW2580 a useful tool in assessing the role of cFMS kinase in normal and disease processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR5EGN2P59OrVg90H21EOLACvtfcHk0ljbCnki2GD2fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WqsrzM&md5=6a5afc80faa9acec528fdbf766ad05bd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0502000102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0502000102%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DJ.%2BG.%26aulast%3DMcDonald%26aufirst%3DB.%26aulast%3DParham%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DShaw%26aufirst%3DE.%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DPayne%26aufirst%3DA.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DJohnson%26aufirst%3DJ.%2BH.%26aulast%3DFrick%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DM.%2BH.%26aulast%3DDepee%26aufirst%3DS.%26aulast%3DTadepalli%26aufirst%3DS.%26aulast%3DVotta%26aufirst%3DB.%26aulast%3DJames%26aufirst%3DI.%26aulast%3DFuller%26aufirst%3DK.%26aulast%3DChambers%26aufirst%3DT.%2BJ.%26aulast%3DKull%26aufirst%3DF.%2BC.%26aulast%3DChamberlain%26aufirst%3DS.%2BD.%26aulast%3DHutchins%26aufirst%3DJ.%2BT.%26atitle%3DInhibition%2520of%2520colony-stimulating-factor-1%2520signaling%2520in%2520vivo%2520with%2520the%2520orally%2520bioavailable%2520cFMS%2520kinase%2520inhibitor%2520GW2580%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D16078%26epage%3D16083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lh1XHMK0X9gxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, N. L.</span><span> </span><span class="NLM_article-title">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6255</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1038%2Fsj.onc.1205794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=12214266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=6255-6263&author=W.+Xiaauthor=R.+J.+Mullinauthor=B.+R.+Keithauthor=L.+H.+Liuauthor=H.+Maauthor=D.+W.+Rusnakauthor=G.+Owensauthor=K.+J.+Alligoodauthor=N.+L.+Spector&title=Anti-tumor+activity+of+GW572016%3A+a+dual+tyrosine+kinase+inhibitor+blocks+EGF+activation+of+EGFR%2FerbB2+and+downstream+Erk1%2F2+and+AKT+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span></div><div class="casAuthors">Xia, Wenle; Mullin, Robert J.; Keith, Barry R.; Liu, Lei-Hua; Ma, Hong; Rusnak, David W.; Owens, Gary; Alligood, Krystal J.; Spector, Neil L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6255-6263</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dual EGFR/erbB2 inhibition is an attractive therapeutic strategy for epithelial tumors, as ligand-induced erbB2/EGFR heterodimerization triggers potent proliferative and survival signals.  Here we show that a small mol., GW572016, potently inhibits both EGFR and erbB2 tyrosine kinases leading to growth arrest and/or apoptosis in EGFR and erbB2-dependent tumor cell lines.  GW572016 markedly reduced tyrosine phosphorylation of EGFR and erbB2, and inhibited activation of Erk1/2 and AKT, downstream effectors of proliferation and cell survival, resp.  Complete inhibition of activated AKT in erbB2 overexpressing cells correlated with a 23-fold increase in apoptosis compared with vehicle controls.  EGF, often elevated in cancer patients, did not reverse the inhibitory effects of GW572016.  These observations were reproduced in vivo, where GW572016 treatment inhibited activation of EGFR, erbB2, Erk1/2 and AKT in human tumor xenografts.  Erk1/2 and AKT represent potential biomarkers to assess the clin. activity of GW572016.  Inhibition of activated AKT in EGFR or erbB2-dependent tumors by GW572016 may lead to tumor regressions when used as a monotherapy, or may enhance the anti-tumor activity of chemotherapeutics, since constitutive activation of AKT has been linked to chemo-resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYPkZ4sa88irVg90H21EOLACvtfcHk0lh1XHMK0X9gxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D&md5=38d6e25a7cfa1fdfe77fa2fea2c0aa0c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1205794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1205794%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DL.%2BH.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DOwens%26aufirst%3DG.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DSpector%26aufirst%3DN.%2BL.%26atitle%3DAnti-tumor%2520activity%2520of%2520GW572016%253A%2520a%2520dual%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520EGF%2520activation%2520of%2520EGFR%252FerbB2%2520and%2520downstream%2520Erk1%252F2%2520and%2520AKT%2520pathways%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D6255%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cuenda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doza, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=1995&pages=229-233&author=A.+Cuendaauthor=J.+Rouseauthor=Y.+N.+Dozaauthor=R.+Meierauthor=P.+Cohenauthor=T.+F.+Gallagherauthor=P.+R.+Youngauthor=J.+C.+Lee&title=SB+203580+is+a+specific+inhibitor+of+a+MAP+kinase+homologue+which+is+stimulated+by+cellular+stresses+and+interleukin-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuenda%26aufirst%3DA.%26aulast%3DRouse%26aufirst%3DJ.%26aulast%3DDoza%26aufirst%3DY.%2BN.%26aulast%3DMeier%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DGallagher%26aufirst%3DT.%2BF.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DSB%2520203580%2520is%2520a%2520specific%2520inhibitor%2520of%2520a%2520MAP%2520kinase%2520homologue%2520which%2520is%2520stimulated%2520by%2520cellular%2520stresses%2520and%2520interleukin-1%26jtitle%3DFEBS%2520Lett.%26date%3D1995%26volume%3D364%26spage%3D229%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=11896401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0lh1XHMK0X9gxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Hot topic: p38 kinase inhibitor</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.2174%2F1568026054985885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=919&author=K.+Leftheris&title=Hot+topic%3A+p38+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Editorial</span></div><div class="casAuthors">Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">919</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojP3_8LZLWfLVg90H21EOLACvtfcHk0ljPi3k8RFaxMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrnE&md5=162c76b306ecbf349b881bc27dc9a356</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F1568026054985885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985885%26sid%3Dliteratum%253Aachs%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DHot%2520topic%253A%2520p38%2520kinase%2520inhibitor%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Mavunkel, B. J.; Chakravarty, S.; Perumattam, J.; Dugar, S.; Lu, Q.; Liang, X.</span><span> </span><span class="NLM_article-title">Preparation of 5-[4-Benzylpiperidinyl(piperazinyl)]-indolecarboxamides as Inhibitors of p38 Kinase</span>. WO2000071535,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=B.+J.+Mavunkel&author=S.+Chakravarty&author=J.+Perumattam&author=S.+Dugar&author=Q.+Lu&author=X.+Liang&title=Preparation+of+5-%5B4-Benzylpiperidinyl%28piperazinyl%29%5D-indolecarboxamides+as+Inhibitors+of+p38+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMavunkel%26aufirst%3DB.%2BJ.%26atitle%3DPreparation%2520of%25205-%255B4-Benzylpiperidinyl%2528piperazinyl%2529%255D-indolecarboxamides%2520as%2520Inhibitors%2520of%2520p38%2520Kinase%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Oliver-Shaffer, P.-A.; Snoonian, J. R.</span><span> </span><span class="NLM_article-title">Processes for the Preparation of <i>N</i>-Heteroaryl-<i>N</i>-aryl-amines by Reacting an <i>N</i>-Aryl Carbamic Acid Ester with a Halo-Heteroaryl and Analogous Processes</span>. WO2004072038,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=P.-A.+Oliver-Shaffer&author=J.+R.+Snoonian&title=Processes+for+the+Preparation+of+N-Heteroaryl-N-aryl-amines+by+Reacting+an+N-Aryl+Carbamic+Acid+Ester+with+a+Halo-Heteroaryl+and+Analogous+Processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOliver-Shaffer%26aufirst%3DP.-A.%26atitle%3DProcesses%2520for%2520the%2520Preparation%2520of%2520N-Heteroaryl-N-aryl-amines%2520by%2520Reacting%2520an%2520N-Aryl%2520Carbamic%2520Acid%2520Ester%2520with%2520a%2520Halo-Heteroaryl%2520and%2520Analogous%2520Processes%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabbagh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phippard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suttmann, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. R.</span><span> </span><span class="NLM_article-title">Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1124%2Fjpet.108.139006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=18776065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=610-619&author=R.+J.+Hillauthor=K.+Dabbaghauthor=D.+Phippardauthor=C.+Liauthor=R.+T.+Suttmannauthor=M.+Welchauthor=E.+Pappauthor=K.+W.+Songauthor=K.+C.+Changauthor=D.+Leafferauthor=Y.+N.+Kimauthor=R.+T.+Robertsauthor=T.+S.+Zabkaauthor=D.+Audauthor=P.+J.+Dalauthor=A.+M.+Manningauthor=S.+L.+Pengauthor=D.+M.+Goldsteinauthor=B.+R.+Wong&title=Pamapimod%2C+a+novel+p38+mitogen-activated+protein+kinase+inhibitor%3A+preclinical+analysis+of+efficacy+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity</span></div><div class="casAuthors">Hill, Ronald J.; Dabbagh, Karim; Phippard, Deborah; Li, Ching; Suttmann, Rebecca T.; Welch, Mary; Papp, Eva; Song, Kyung W.; Chang, Kung-ching; Leaffer, David; Kim, Yong-Nam; Roberts, Richard T.; Zabka, Tanja S.; Aud, Dee; Dal Porto, Joseph; Manning, Anthony M.; Peng, Stanford L.; Goldstein, David M.; Wong, Brian R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">610-619</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P38α is a protein kinase that regulates the expression of inflammatory cytokines, suggesting a role in the pathogenesis of diseases such as rheumatoid arthritis (RA) or systemic lupus erythematosus.  Here, we describe the preclin. pharmacol. of pamapimod, a novel p38 mitogen-activated protein kinase inhibitor.  Pamapimod inhibited p38α and p38β enzymic activity, with IC50 values of 0.014±0.002 and 0.48±0.04 μM, resp.  There was no activity against p38δ or p38γ isoforms.  When profiled across 350 kinases, pamapimod bound only to four kinases in addn. to p38.  Cellular potency was assessed using phosphorylation of heat shock protein-27 and c-Jun as selective readouts for p38 and c-Jun NH2-terminal kinase (JNK), resp.  Pamapimod inhibited p38 (IC50, 0.06 μM), but inhibition of JNK was not detected.  Pamapimod also inhibited lipopolysaccharide (LPS)-stimulated tumor necrosis factor (TNF) α prodn. by monocytes, interleukin (IL)-1β prodn. in human whole blood, and spontaneous TNFα prodn. by synovial explants from RA patients.  LPS- and TNFα-stimulated prodn. of TNFα and IL-6 in rodents also was inhibited by pamapimod.  In murine collagen-induced arthritis, pamapimod reduced clin. signs of inflammation and bone loss at 50 mg/kg or greater.  In a rat model of hyperalgesia, pamapimod increased tolerance to pressure in a dose-dependent manner, suggesting an important role of p38 in pain assocd. with inflammation.  Finally, an analog of pamapimod that has equiv. potency and selectivity inhibited renal disease in lupus-prone MRL/lpr mice.  Our study demonstrates that pamapimod is a potent, selective inhibitor of p38α with the ability to inhibit the signs and symptoms of RA and other autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoImm011NnzW7Vg90H21EOLACvtfcHk0ljPi3k8RFaxMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtL3F&md5=9311aa6b1a51544ac755d1cc77cdd92f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.139006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.139006%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DDabbagh%26aufirst%3DK.%26aulast%3DPhippard%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSuttmann%26aufirst%3DR.%2BT.%26aulast%3DWelch%26aufirst%3DM.%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DSong%26aufirst%3DK.%2BW.%26aulast%3DChang%26aufirst%3DK.%2BC.%26aulast%3DLeaffer%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DY.%2BN.%26aulast%3DRoberts%26aufirst%3DR.%2BT.%26aulast%3DZabka%26aufirst%3DT.%2BS.%26aulast%3DAud%26aufirst%3DD.%26aulast%3DDal%26aufirst%3DP.%2BJ.%26aulast%3DManning%26aufirst%3DA.%2BM.%26aulast%3DPeng%26aufirst%3DS.%2BL.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DWong%26aufirst%3DB.%2BR.%26atitle%3DPamapimod%252C%2520a%2520novel%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibitor%253A%2520preclinical%2520analysis%2520of%2520efficacy%2520and%2520selectivity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D610%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadus, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span> </span><span class="NLM_article-title">Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6402</span><span class="NLM_x">–</span> <span class="NLM_lpage">6411</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi900655f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6402-6411&author=L.+Xingauthor=H.+S.+Shiehauthor=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+K.+Walkerauthor=B.+Devadasauthor=H.+R.+Hopeauthor=R.+P.+Comptonauthor=J.+F.+Schindlerauthor=J.+L.+Hirschauthor=A.+G.+Bensonauthor=R.+G.+Kurumbailauthor=R.+A.+Stegemanauthor=J.+M.+Williamsauthor=R.+M.+Broadusauthor=Z.+Waldenauthor=J.+B.+Monahan&title=Structural+bioinformatics-based+prediction+of+exceptional+selectivity+of+p38+MAP+kinase+inhibitor+PH-797804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fbi900655f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900655f%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DCompton%26aufirst%3DR.%2BP.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DBroadus%26aufirst%3DR.%2BM.%26aulast%3DWalden%26aufirst%3DZ.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DStructural%2520bioinformatics-based%2520prediction%2520of%2520exceptional%2520selectivity%2520of%2520p38%2520MAP%2520kinase%2520inhibitor%2520PH-797804%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D6402%26epage%3D6411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Murali Dhar, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todderud, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffolds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5019</span><span class="NLM_x">–</span> <span class="NLM_lpage">5024</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5019-5024&author=T.+G.+Murali+Dharauthor=S.+T.+Wrobleskiauthor=S.+Linauthor=J.+A.+Furchauthor=D.+S.+Nirschlauthor=Y.+Fanauthor=G.+Todderudauthor=S.+Pittauthor=A.+M.+Doweykoauthor=J.+S.+Sackauthor=A.+Mathurauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Synthesis+and+SAR+of+p38alpha+MAP+kinase+inhibitors+based+on+heterobicyclic+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurali%2BDhar%26aufirst%3DT.%2BG.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DFurch%26aufirst%3DJ.%2BA.%26aulast%3DNirschl%26aufirst%3DD.%2BS.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DTodderud%26aufirst%3DG.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520p38alpha%2520MAP%2520kinase%2520inhibitors%2520based%2520on%2520heterobicyclic%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5019%26epage%3D5024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canagarajah, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassisa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">abdel-Meguid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, E. J.</span><span> </span><span class="NLM_article-title">Structural basis of inhibitor selectivity in MAP kinases</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1016%2FS0969-2126%2898%2900113-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=9753691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVKjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=1117-1128&author=Z.+Wangauthor=B.+J.+Canagarajahauthor=J.+C.+Boehmauthor=S.+Kassisaauthor=M.+H.+Cobbauthor=P.+R.+Youngauthor=S.+abdel-Meguidauthor=J.+L.+Adamsauthor=E.+J.+Goldsmith&title=Structural+basis+of+inhibitor+selectivity+in+MAP+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of inhibitor selectivity in MAP kinases</span></div><div class="casAuthors">Wang, Zhulun; Canagarajah, Bertram J.; Boehm, Jeffrey C.; Kassisa, Skouki; Cobb, Melanie H.; Young, Peter R.; Abdel-Meguid, Sherin; Adams, Jerry L.; Goldsmith, Elizabeth J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1117-1128</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">The mitogen-activated protein (MAP) kinases are important signaling mols. that participate in diverse cellular events and are potential targets for intervention in inflammation, cancer, and other diseases.  The MAP kinase p38 is responsive to environmental stresses and is involved in the prodn. of cytokines during inflammation.  In contrast, the activation of the MAP kinase ERK2 (extracellular-signal-regulated kinase 2) leads to cellular differentiation or proliferation.  The anti-inflammatory agent pyridinylimidazole and its analogs (SB [SmithKline Beecham] compds.) are highly potent and selective inhibitors of p38, but not of the closely related ERK2, or other serine/threonine kinases.  Although these compds. are known to bind to the ATP-binding site, the origin of the inhibitory specificity toward p38 is not clear.  We report the structural basis for the exceptional selectivity of these SB compds. for p38 over ERK2, as detd. by comparative crystallog.  In addn., structural data on the origin of olomoucine (a better inhibitor of ERK2) selectivity are presented.  The crystal structures of four SB compds. in complex with p38 and of one SB compd. and olomoucine in complex with ERK2 are presented here.  The SB inhibitors bind in an extended pocket in the active site and are complementary to the open domain structure of the low-activity form of p38.  The relatively closed domain structure of ERK2 is able to accommodate the smaller olomoucine.  The unique kinase-inhibitor interactions obsd. in these complexes originate from amino-acid replacements in the active site and replacements distant from the active site that affect the size of the domain interface.  This structural information should facilitate the design of better MAP-kinase inhibitors for the treatment of inflammation and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrARvGug2CDHbVg90H21EOLACvtfcHk0ljfKknDWdJsdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVKjt7s%253D&md5=089de6c205e51ab37ba9cbce998cda5f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900113-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900113-0%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DCanagarajah%26aufirst%3DB.%2BJ.%26aulast%3DBoehm%26aufirst%3DJ.%2BC.%26aulast%3DKassisa%26aufirst%3DS.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3Dabdel-Meguid%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DGoldsmith%26aufirst%3DE.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520inhibitor%2520selectivity%2520in%2520MAP%2520kinases%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D1117%26epage%3D1128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Fitzgerald, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikounis, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span> </span><span class="NLM_article-title">Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=764-769&author=C.+E.+Fitzgeraldauthor=S.+B.+Patelauthor=J.+W.+Beckerauthor=P.+M.+Cameronauthor=D.+Zallerauthor=V.+B.+Pikounisauthor=S.+J.+O%27Keefeauthor=G.+Scapin&title=Structural+basis+for+p38alpha+MAP+kinase+quinazolinone+and+pyridol-pyrimidine+inhibitor+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DCameron%26aufirst%3DP.%2BM.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DPikounis%26aufirst%3DV.%2BB.%26aulast%3DO%2527Keefe%26aufirst%3DS.%2BJ.%26aulast%3DScapin%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520p38alpha%2520MAP%2520kinase%2520quinazolinone%2520and%2520pyridol-pyrimidine%2520inhibitor%2520specificity%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D764%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Herberich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosfeld, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span> </span><span class="NLM_article-title">Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6271</span><span class="NLM_x">–</span> <span class="NLM_lpage">6279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8005417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6271-6279&author=B.+Herberichauthor=G.+Q.+Caoauthor=P.+P.+Chakrabartiauthor=J.+R.+Falseyauthor=L.+Pettusauthor=R.+M.+Rzasaauthor=A.+B.+Reedauthor=A.+Reicheltauthor=K.+Shamauthor=M.+Thamanauthor=R.+P.+Wurzauthor=S.+Xuauthor=D.+Zhangauthor=F.+Hsiehauthor=M.+R.+Leeauthor=R.+Syedauthor=V.+Liauthor=D.+Grosfeldauthor=M.+H.+Plantauthor=B.+Henkleauthor=L.+Shermanauthor=S.+Middletonauthor=L.+M.+Wongauthor=A.+S.+Tasker&title=Discovery+of+highly+selective+and+potent+p38+inhibitors+based+on+a+phthalazine+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm8005417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8005417%26sid%3Dliteratum%253Aachs%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DG.%2BQ.%26aulast%3DChakrabarti%26aufirst%3DP.%2BP.%26aulast%3DFalsey%26aufirst%3DJ.%2BR.%26aulast%3DPettus%26aufirst%3DL.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DSham%26aufirst%3DK.%26aulast%3DThaman%26aufirst%3DM.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DSyed%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DGrosfeld%26aufirst%3DD.%26aulast%3DPlant%26aufirst%3DM.%2BH.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DSherman%26aufirst%3DL.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DL.%2BM.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26atitle%3DDiscovery%2520of%2520highly%2520selective%2520and%2520potent%2520p38%2520inhibitors%2520based%2520on%2520a%2520phthalazine%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6271%26epage%3D6279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lisnock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frantz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Laszlo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libby, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P.</span><span> </span><span class="NLM_article-title">Molecular basis for p38 protein kinase inhibitor specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">16573</span><span class="NLM_x">–</span> <span class="NLM_lpage">16581</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi981591x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=16573-16581&author=J.+Lisnockauthor=A.+Tebbenauthor=B.+Frantzauthor=E.+A.+O%27Neillauthor=G.+Croftauthor=S.+J.+O%27Keefeauthor=B.+Liauthor=C.+Hackerauthor=S.+de+Laszloauthor=A.+Smithauthor=B.+Libbyauthor=N.+Livertonauthor=J.+Hermesauthor=P.+LoGrasso&title=Molecular+basis+for+p38+protein+kinase+inhibitor+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fbi981591x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981591x%26sid%3Dliteratum%253Aachs%26aulast%3DLisnock%26aufirst%3DJ.%26aulast%3DTebben%26aufirst%3DA.%26aulast%3DFrantz%26aufirst%3DB.%26aulast%3DO%2527Neill%26aufirst%3DE.%2BA.%26aulast%3DCroft%26aufirst%3DG.%26aulast%3DO%2527Keefe%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DHacker%26aufirst%3DC.%26aulast%3Dde%2BLaszlo%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DLibby%26aufirst%3DB.%26aulast%3DLiverton%26aufirst%3DN.%26aulast%3DHermes%26aufirst%3DJ.%26aulast%3DLoGrasso%26aufirst%3DP.%26atitle%3DMolecular%2520basis%2520for%2520p38%2520protein%2520kinase%2520inhibitor%2520specificity%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D16573%26epage%3D16581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Cohen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chindalore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damjanov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delora, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimany, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulfield, J. P.</span><span> </span><span class="NLM_article-title">Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2Fart.24266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=19180516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1CgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=335-344&author=S.+B.+Cohenauthor=T.+T.+Chengauthor=V.+Chindaloreauthor=N.+Damjanovauthor=R.+Burgos-Vargasauthor=P.+Deloraauthor=K.+Zimanyauthor=H.+Traversauthor=J.+P.+Caulfield&title=Evaluation+of+the+efficacy+and+safety+of+pamapimod%2C+a+p38+MAP+kinase+inhibitor%2C+in+a+double-blind%2C+methotrexate-controlled+study+of+patients+with+active+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active Rheumatoid arthritis</span></div><div class="casAuthors">Cohen, Stanley B.; Cheng, Tien-Tsai; Chindalore, Vishala; Damjanov, Nemanja; Burgos-Vargas, Ruben; DeLora, Patricia; Zimany, Kathleen; Travers, Helen; Caulfield, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">335-344</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To det. the efficacy and safety of pamapimod (a selective inhibitor of the α-isoform of p38 MAP kinase) as monotherapy in comparison with methotrexate (MTX) treatment in adult patients with active rheumatoid arthritis (RA).  Methods: Patients were randomly assigned to 1 of 4 treatment groups and received 12 wk of double-blind treatment.  One group received MTX (7.5 mg/wk with planned escalation to 20 mg/wk), and 3 groups received pamapimod (50, 150, or 300 mg) once daily.  The primary efficacy end point was the proportion of patients meeting the American College of Rheumatol. 20% improvement criteria (achieving an ACR20 response) at 12 wk.  Secondary end points included ACR50 and ACR70 responses, change from baseline in the Disease Activity Score in 28 joints (DAS28), categorical analyses of DAS28/European League Against Rheumatism response, and change from baseline in each parameter of the ACR core set of measures.  Safety monitoring included recording of adverse events (AEs), lab. testing, immunol. assessments, administration of electrocardiograms, and assessment of vital signs.  Results: Patients assigned to receive MTX and pamapimod had similar demographics and baseline characteristics.  At week 12, fewer patients taking pamapimod had an ACR20 response (23%, 18%, and 31% in the 50-, 150-, and 300-mg groups, resp.) compared with patients taking MTX (45%).  Secondary efficacy end points showed a similar pattern.  AEs were typically characterized as mild and included infections, skin disorders, and dizziness.  Pamapimod was generally well tolerated, but the 300-mg dose appeared to be more toxic than either the 2 lower doses or MTX.  Conclusion: The present results showed that pamapimod was not as effective as MTX in the treatment of active RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp98GB6seTS2rVg90H21EOLACvtfcHk0ljzdME9R3nong"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1CgtL4%253D&md5=d76a0ea256ab02b1c16d388be13c2f3e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fart.24266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24266%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BB.%26aulast%3DCheng%26aufirst%3DT.%2BT.%26aulast%3DChindalore%26aufirst%3DV.%26aulast%3DDamjanov%26aufirst%3DN.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DDelora%26aufirst%3DP.%26aulast%3DZimany%26aufirst%3DK.%26aulast%3DTravers%26aufirst%3DH.%26aulast%3DCaulfield%26aufirst%3DJ.%2BP.%26atitle%3DEvaluation%2520of%2520the%2520efficacy%2520and%2520safety%2520of%2520pamapimod%252C%2520a%2520p38%2520MAP%2520kinase%2520inhibitor%252C%2520in%2520a%2520double-blind%252C%2520methotrexate-controlled%2520study%2520of%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D335%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Alten, R. E.; Zerbini, C.; Jeka, S.; Irazoque, F.; Khatib, F.; Emery, P.; Bertasso, A.; Rabbia, M.; Caulfield, J. P.</span><span> </span><span class="NLM_article-title">Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy</span>.  <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1136/ard.2008.104802</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1136%2Fard.2008.104802" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=R.+E.+Alten&author=C.+Zerbini&author=S.+Jeka&author=F.+Irazoque&author=F.+Khatib&author=P.+Emery&author=A.+Bertasso&author=M.+Rabbia&author=J.+P.+Caulfield&title=Efficacy+and+safety+of+pamapimod+in+patients+with+active+rheumatoid+arthritis+receiving+stable+methotrexate+therapy&doi=10.1136%2Fard.2008.104802"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1136%2Fard.2008.104802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2008.104802%26sid%3Dliteratum%253Aachs%26aulast%3DAlten%26aufirst%3DR.%2BE.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520pamapimod%2520in%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%2520receiving%2520stable%2520methotrexate%2520therapy%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2009%26doi%3D10.1136%2Fard.2008.104802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Haddad, J. J.</span><span> </span><span class="NLM_article-title">VX-745. Vertex Pharmaceuticals</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1070</span><span class="NLM_x">–</span> <span class="NLM_lpage">1076</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=1070-1076&author=J.+J.+Haddad&title=VX-745.+Vertex+Pharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaddad%26aufirst%3DJ.%2BJ.%26atitle%3DVX-745.%2520Vertex%2520Pharmaceuticals%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2001%26volume%3D2%26spage%3D1070%26epage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Weisman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merica, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Munley, S. A</span><span> </span><span class="NLM_article-title">Double-blind, placebo-controlled, trial of VX-745, an oral p38 mitogen activated protein kinase (MAPK) inhibitor, in patients with rheumatoid arthritis (RA)</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_elocation-id">FRI0018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&issue=Suppl.+1&author=M.+Weismanauthor=D.+Furstauthor=M.+Schiffauthor=R.+Kauffmanauthor=E.+Mericaauthor=S.+A+Martin-Munley&title=Double-blind%2C+placebo-controlled%2C+trial+of+VX-745%2C+an+oral+p38+mitogen+activated+protein+kinase+%28MAPK%29+inhibitor%2C+in+patients+with+rheumatoid+arthritis+%28RA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeisman%26aufirst%3DM.%26aulast%3DFurst%26aufirst%3DD.%26aulast%3DSchiff%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DR.%26aulast%3DMerica%26aufirst%3DE.%26aulast%3DMartin-Munley%26aufirst%3DS.%2BA%26atitle%3DDouble-blind%252C%2520placebo-controlled%252C%2520trial%2520of%2520VX-745%252C%2520an%2520oral%2520p38%2520mitogen%2520activated%2520protein%2520kinase%2520%2528MAPK%2529%2520inhibitor%252C%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%2520%2528RA%2529%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2002%26volume%3D61%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span>Vertex Homepage. <a href="http://www.vrtx.com/" class="extLink">http://www.vrtx.com/</a> (accessed Sep 24,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vertex+Homepage.+http%3A%2F%2Fwww.vrtx.com%2F+%28accessed+Sep+24%2C+2001%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Norman, P.</span><span> </span><span class="NLM_article-title">Advances in anti-arthritic agents. SMI's Third Annual Conference</span> <span class="citation_source-journal">IDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=530-538&author=P.+Norman&title=Advances+in+anti-arthritic+agents.+SMI%27s+Third+Annual+Conference"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DAdvances%2520in%2520anti-arthritic%2520agents.%2520SMI%2527s%2520Third%2520Annual%2520Conference%26jtitle%3DIDrugs%26date%3D2002%26volume%3D5%26spage%3D530%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ding, C.</span><span> </span><span class="NLM_article-title">Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1020</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1020-1025&author=C.+Ding&title=Drug+evaluation%3A+VX-702%2C+a+MAP+kinase+inhibitor+for+rheumatoid+arthritis+and+acute+coronary+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26atitle%3DDrug%2520evaluation%253A%2520VX-702%252C%2520a%2520MAP%2520kinase%2520inhibitor%2520for%2520rheumatoid%2520arthritis%2520and%2520acute%2520coronary%2520syndrome%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D7%26spage%3D1020%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Damjanov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer-Green, G. T.</span><span> </span><span class="NLM_article-title">Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1232</span><span class="NLM_x">–</span> <span class="NLM_lpage">1241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2Fart.24485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=19404957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A280%3ADC%252BD1MzkvFarsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=1232-1241&author=N.+Damjanovauthor=R.+S.+Kauffmanauthor=G.+T.+Spencer-Green&title=Efficacy%2C+pharmacodynamics%2C+and+safety+of+VX-702%2C+a+novel+p38+MAPK+inhibitor%2C+in+rheumatoid+arthritis%3A+results+of+two+randomized%2C+double-blind%2C+placebo-controlled+clinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies</span></div><div class="casAuthors">Damjanov Nemanja; Kauffman Robert S; Spencer-Green George T</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1232-41</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">OBJECTIVE:  To assess the efficacy and safety of VX-702, a p38 MAPK inhibitor, in patients with active, moderate-to-severe rheumatoid arthritis (RA).  METHODS:  Two 12-week, double-blind, placebo-controlled studies of VX-702 were conducted in patients with active, moderate-to-severe RA.  In the VeRA study, 313 patients received placebo or 2 daily doses of VX-702.  In Study 304, 117 patients received placebo, daily VX-702, or twice weekly VX-702 in addition to concomitant methotrexate (MTX).  Study end points included the proportion of patients meeting the American College of Rheumatology 20% improvement criteria (an ACR20 response), ACR50 and ACR70 responses, changes in the serum levels of biomarkers of inflammation, and safety assessments.  RESULTS:  The numerically superior ACR20 response rates among patients receiving VX-702 compared with those receiving placebo in both studies did not reach pairwise statistical significance at the highest doses in either study.  At week 12 in the VeRA study, ACR20 response rates were 40%, 36%, and 28% among patients receiving 10 mg of VX-702, 5 mg of VX-702, and placebo, respectively.  In Study 304, the response rates were 40%, 44%, and 22% for patients receiving 10 mg VX-702 daily plus MTX, 10 mg VX-702 twice weekly plus MTX, and placebo, respectively.  Reductions in the levels of C-reactive protein, soluble tumor necrosis factor receptor p55, and serum amyloid A were observed as early as week 1 in both studies, but these levels rapidly returned to baseline values by week 4.  The overall frequency of adverse events was similar between the VX-702 and placebo groups.  In the VeRA study, serious infections were more frequent in the VX-702 groups compared with the placebo group (2.4% versus 0%) but not in Study 304 (2.6% versus 4.9%).  CONCLUSION:  The modest clinical efficacy plus the transient suppression of biomarkers of inflammation observed in this study suggest that p38 MAPK inhibition may not provide meaningful, sustained suppression of the chronic inflammation seen in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuFLVCXOhEpYkFb3mqPUYDfW6udTcc2eYhmdgkL4ry57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzkvFarsQ%253D%253D&md5=f23f3b448939ed3cafd7d20410ff81f7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fart.24485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24485%26sid%3Dliteratum%253Aachs%26aulast%3DDamjanov%26aufirst%3DN.%26aulast%3DKauffman%26aufirst%3DR.%2BS.%26aulast%3DSpencer-Green%26aufirst%3DG.%2BT.%26atitle%3DEfficacy%252C%2520pharmacodynamics%252C%2520and%2520safety%2520of%2520VX-702%252C%2520a%2520novel%2520p38%2520MAPK%2520inhibitor%252C%2520in%2520rheumatoid%2520arthritis%253A%2520results%2520of%2520two%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520clinical%2520studies%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D1232%26epage%3D1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Nikas, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drosos, A. A.</span><span> </span><span class="NLM_article-title">SCIO-469 Scios Inc</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1205-1212&author=S.+N.+Nikasauthor=A.+A.+Drosos&title=SCIO-469+Scios+Inc"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNikas%26aufirst%3DS.%2BN.%26aulast%3DDrosos%26aufirst%3DA.%2BA.%26atitle%3DSCIO-469%2520Scios%2520Inc%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D1205%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Amakye, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beazley, W.</span><span> </span><span class="NLM_article-title">Pharmacokinetics (PK) and pharmacodynamics (PD) of SCIO-469, a p38 gamma MAP kinase inhibitor</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">P54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2004&pages=P54&author=D.+Amakyeauthor=S.+Tongauthor=C.+Wardauthor=W.+Beazley&title=Pharmacokinetics+%28PK%29+and+pharmacodynamics+%28PD%29+of+SCIO-469%2C+a+p38+gamma+MAP+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmakye%26aufirst%3DD.%26aulast%3DTong%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DC.%26aulast%3DBeazley%26aufirst%3DW.%26atitle%3DPharmacokinetics%2520%2528PK%2529%2520and%2520pharmacodynamics%2520%2528PD%2529%2520of%2520SCIO-469%252C%2520a%2520p38%2520gamma%2520MAP%2520kinase%2520inhibitor%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2004%26volume%3D75%26spage%3DP54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Schreiner, G.</span><span> </span><span class="NLM_article-title">Kinase Inhibitors: The Next Generation of Anti-Arthritic Agents. Scios: Case Study in Their p38 Kinase Inhibitor Program</span>. Presented at the Advances in Anti-Arthritic Agents SMI Conference,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=G.+Schreiner&title=Kinase+Inhibitors%3A+The+Next+Generation+of+Anti-Arthritic+Agents.+Scios%3A+Case+Study+in+Their+p38+Kinase+Inhibitor+Program"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiner%26aufirst%3DG.%26atitle%3DKinase%2520Inhibitors%253A%2520The%2520Next%2520Generation%2520of%2520Anti-Arthritic%2520Agents.%2520Scios%253A%2520Case%2520Study%2520in%2520Their%2520p38%2520Kinase%2520Inhibitor%2520Program%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Ji, R.-R.</span><span> </span><span class="NLM_article-title">Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases</span> <span class="citation_source-journal">Curr. Drug Targets: Inflammation Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.2174%2F1568010043343804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=15379598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=299-303&author=R.-R.+Ji&title=Peripheral+and+central+mechanisms+of+inflammatory+pain%2C+with+emphasis+on+MAP+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases</span></div><div class="casAuthors">Ji, Ru-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: Inflammation & Allergy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-303</span>CODEN:
                <span class="NLM_cas:coden">CDTICU</span>;
        ISSN:<span class="NLM_cas:issn">1568-010X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tissue injury is assocd. with inflammation and produces inflammatory pain.  In animal models, inflammatory pain is normally produced by injection of irritative chems. into the hindpaw or joint of animal.  Inflammatory pain manifests as an expression of neuronal plasticity, which consists of peripheral sensitization (increased sensitivity of primary sensory neurons in the peripheral nervous system, PNS) and central sensitization (increased sensitivity of spinal dorsal horn and other neurons in the central nervous system, CNS).  Activation of several protein kinases causes both forms of sensitization via posttranslational, translational, and transcriptional regulation.  In particular, mitogen-activated protein kinase (MAPK), such as ERK and p38, is activated by inflammatory mediators in primary sensory and secondary order dorsal horn neurons and participates in the generation and maintenance of inflammatory pain.  Development of specific MAPK inhibitors will open a new avenue to the pharmacol. intervention of inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLor-Z5BbQMrVg90H21EOLACvtfcHk0lhZJ3Maiu45jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVemur4%253D&md5=8fdb40d9143d70b148dfcb92d7186689</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F1568010043343804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568010043343804%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DR.-R.%26atitle%3DPeripheral%2520and%2520central%2520mechanisms%2520of%2520inflammatory%2520pain%252C%2520with%2520emphasis%2520on%2520MAP%2520kinases%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520Inflammation%2520Allergy%26date%3D2004%26volume%3D3%26spage%3D299%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. G.</span><span> </span><span class="NLM_article-title">p38 pathway kinases as anti-inflammatory drug targets</span> <span class="citation_source-journal">J. Dent. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1177%2F154405910708600902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=17720847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOqurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2007&pages=800-811&author=J.+F.+Schindlerauthor=J.+B.+Monahanauthor=W.+G.+Smith&title=p38+pathway+kinases+as+anti-inflammatory+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">p38 pathway kinases as anti-inflammatory drug targets</span></div><div class="casAuthors">Schindler, J. F.; Monahan, J. B.; Smith, W. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dental Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">800-811</span>CODEN:
                <span class="NLM_cas:coden">JDREAF</span>;
        ISSN:<span class="NLM_cas:issn">0022-0345</span>.
    
            (<span class="NLM_cas:orgname">International Association for Dental Research</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinases (MAPK) are intracellular signaling mols. involved in cytokine synthesis.  Several classes of mammalian MAPK have been identified, including extracellular signal-regulated kinase, c-jun N-terminal kinase, and p38 MAP kinase.  P38α is a key MAPK involved in tumor necrosis factor α and other cytokine prodn., as well as enzyme induction (cyclooxygenase-2, inducible nitric oxide synthase, and matrix metalloproteinases) and adhesion mol. expression.  An understanding of the broad biol. and pathophysiol. roles of p38 MAPK family members has grown significantly over the past decade, as has the complexity of the signaling network leading to their activation.  Downstream substrates of MAPK include other kinases (e.g., mitogen-activated protein-kinase-activated protein kinase 2) and factors that regulate transcription, nuclear export, and mRNA stability and translation.  The high-resoln. crystal structure of p38α has led to the design of selective inhibitors that have good pharmacol. activity.  Despite the strong rationale for MAPK inhibitors in human disease, direct proof of concept in the clinic has yet to be demonstrated, with most compds. demonstrating dose-limiting adverse effects.  The role of MAPK in inflammation makes them attractive targets for new therapies, and efforts are continuing to identify newer, more selective inhibitors for inflammatory diseases.  Abbreviations used: MAPK, mitogen-activated protein kinase; ERK, extracellular signaling kinase; JNK, c-jun N-terminal kinase; COX2, cyclo-oxygenase-2; iNOS, inducible nitric oxide synthase; MMP, matrix metalloproteinase; MAPKK, mitogen-activated protein kinase kinase; MK-2, mitogen-activated protein-kinase-activated protein kinase-2; MAPKAP, mitogen-activated protein kinase-activated protein; MAPKKK, mitogen-activated protein kinase kinase kinase; RANKL, receptor activator of NF-κB ligand; MNK, MAP kinase signal-integrating kinase; MSK, mitogen and stress-activated protein kinase; RSK, ribosomal S6 kinase; AP-1, activator protein-1; Tp1, tumor progression locus 2; IL, interleukin; ASK1, apoptosis signal-regulating kinase 1; TAO, thousand-and-one amino acids; MLK3, mixed-lineage kinase 3; TBK, transforming growth factor β activated protein kinase; TGFβ, transforming growth factor β; LPS, lipopolysaccharide; TRAF6, TNF receptor-assocd. factor 6; MKK, mitogen-activated protein kinase kinase; TAK-1, TGF-beta activated protein kinase; GRK2, G-protein coupled receptor kinase-2 MKPs, MAP kinase phosphatases; PRAK, p38 regulated/ activated protein kinase; IFNγ, interferon gamma; AREs, AU-rich elements; AUBPs, AU-rich binding proteins; TTP, tristetraprolin; hnRNP A0, heterogeneous nuclear ribonuclear protein A0; HUR, human R antigen; PGE2, prostaglandin E2; Hsp27, small heat-shock protein-27; TNF-α, tumor necrosis factor alpha.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp29bqrL8B2KrVg90H21EOLACvtfcHk0lhZJ3Maiu45jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOqurfN&md5=38486f3ec8603a4bf793b111441617b4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1177%2F154405910708600902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F154405910708600902%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DSmith%26aufirst%3DW.%2BG.%26atitle%3Dp38%2520pathway%2520kinases%2520as%2520anti-inflammatory%2520drug%2520targets%26jtitle%3DJ.%2520Dent.%2520Res.%26date%3D2007%26volume%3D86%26spage%3D800%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Tong, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desjardins, P.</span><span> </span><span class="NLM_article-title">SCIO-469, a novel p38 alpha MAPK inhibitor provides efficacy in acute post-surgical dental pain</span> <span class="citation_source-journal">Am. Soc. Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">PI-1</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2004&pages=PI-1&author=S.+E.+Tongauthor=S.+E.+Danielsauthor=T.+Montanoauthor=S.+Changauthor=P.+Desjardins&title=SCIO-469%2C+a+novel+p38+alpha+MAPK+inhibitor+provides+efficacy+in+acute+post-surgical+dental+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DS.%2BE.%26aulast%3DDaniels%26aufirst%3DS.%2BE.%26aulast%3DMontano%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DDesjardins%26aufirst%3DP.%26atitle%3DSCIO-469%252C%2520a%2520novel%2520p38%2520alpha%2520MAPK%2520inhibitor%2520provides%2520efficacy%2520in%2520acute%2520post-surgical%2520dental%2520pain%26jtitle%3DAm.%2520Soc.%2520Clin.%2520Pharmacol.%2520Ther.%26date%3D2004%26volume%3D75%26spage%3DPI-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Navas, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haghnazari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Young, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoun, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mavunkel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perumattam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medicherla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protter, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiner, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, L. S.</span><span> </span><span class="NLM_article-title">Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1017-1027&author=T.+A.+Navasauthor=A.+N.+Nguyenauthor=T.+Hideshimaauthor=M.+Reddyauthor=J.+Y.+Maauthor=E.+Haghnazariauthor=M.+Hensonauthor=E.+G.+Stebbinsauthor=I.+Kerrauthor=G.+O%27Youngauthor=A.+M.+Kapounauthor=S.+Chakravartyauthor=B.+Mavunkelauthor=J.+Perumattamauthor=G.+Luedtkeauthor=S.+Dugarauthor=S.+Medicherlaauthor=A.+A.+Protterauthor=G.+F.+Schreinerauthor=K.+C.+Andersonauthor=L.+S.+Higgins&title=Inhibition+of+p38alpha+MAPK+enhances+proteasome+inhibitor-induced+apoptosis+of+myeloma+cells+by+modulating+Hsp27%2C+Bcl-X%28L%29%2C+Mcl-1+and+p53+levels+in+vitro+and+inhibits+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNavas%26aufirst%3DT.%2BA.%26aulast%3DNguyen%26aufirst%3DA.%2BN.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DReddy%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DHaghnazari%26aufirst%3DE.%26aulast%3DHenson%26aufirst%3DM.%26aulast%3DStebbins%26aufirst%3DE.%2BG.%26aulast%3DKerr%26aufirst%3DI.%26aulast%3DO%2527Young%26aufirst%3DG.%26aulast%3DKapoun%26aufirst%3DA.%2BM.%26aulast%3DChakravarty%26aufirst%3DS.%26aulast%3DMavunkel%26aufirst%3DB.%26aulast%3DPerumattam%26aufirst%3DJ.%26aulast%3DLuedtke%26aufirst%3DG.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DMedicherla%26aufirst%3DS.%26aulast%3DProtter%26aufirst%3DA.%2BA.%26aulast%3DSchreiner%26aufirst%3DG.%2BF.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DHiggins%26aufirst%3DL.%2BS.%26atitle%3DInhibition%2520of%2520p38alpha%2520MAPK%2520enhances%2520proteasome%2520inhibitor-induced%2520apoptosis%2520of%2520myeloma%2520cells%2520by%2520modulating%2520Hsp27%252C%2520Bcl-X%2528L%2529%252C%2520Mcl-1%2520and%2520p53%2520levels%2520in%2520vitro%2520and%2520inhibits%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DLeukemia%26date%3D2006%26volume%3D20%26spage%3D1017%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Siegel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohl, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lust, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensinger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziarz, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetticaden, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span> </span><span class="NLM_article-title">Phase II trial of SCIO-469 as monotherapy (M) or in combination with bortezomib (MB) in relapsed refractory multiple myeloma (MM)</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_elocation-id">3580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&author=D.+S.+Siegelauthor=A.+Krishnanauthor=S.+Lonialauthor=G.+Chattaauthor=M.+Alsinaauthor=S.+Jagannathauthor=P.+Richardsonauthor=R.+J.+Hohlauthor=J.+A.+Lustauthor=W.+Bensingerauthor=G.+Carrumauthor=J.+Morebauthor=A.+Simicauthor=B.+Barlogieauthor=R.+T.+Maziarzauthor=K.+C.+Andersonauthor=J.+Linauthor=A.+Loweauthor=S.+Vetticadenauthor=J.+Zhu&title=Phase+II+trial+of+SCIO-469+as+monotherapy+%28M%29+or+in+combination+with+bortezomib+%28MB%29+in+relapsed+refractory+multiple+myeloma+%28MM%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DChatta%26aufirst%3DG.%26aulast%3DAlsina%26aufirst%3DM.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DHohl%26aufirst%3DR.%2BJ.%26aulast%3DLust%26aufirst%3DJ.%2BA.%26aulast%3DBensinger%26aufirst%3DW.%26aulast%3DCarrum%26aufirst%3DG.%26aulast%3DMoreb%26aufirst%3DJ.%26aulast%3DSimic%26aufirst%3DA.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DMaziarz%26aufirst%3DR.%2BT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLowe%26aufirst%3DA.%26aulast%3DVetticaden%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DPhase%2520II%2520trial%2520of%2520SCIO-469%2520as%2520monotherapy%2520%2528M%2529%2520or%2520in%2520combination%2520with%2520bortezomib%2520%2528MB%2529%2520in%2520relapsed%2520refractory%2520multiple%2520myeloma%2520%2528MM%2529%26jtitle%3DBlood%26date%3D2006%26volume%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Genovese, M. C.; Cohen, S. B.; Wofsy, D.; Weinblatt, M. E.; Firestein, G. S.; Brahn, E.; Strand, V.; Baker, D. G.; Tong, S. E.</span><span> </span><span class="NLM_article-title">A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of an Oral p38α MAPK Inhibitor, SCIO-469, in Patients with Active Rheumatoid Arthritis</span>. Presented at the American College of Rheumatology Scientifc Meeting, San Francisco, CA,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract 715.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+C.+Genovese&author=S.+B.+Cohen&author=D.+Wofsy&author=M.+E.+Weinblatt&author=G.+S.+Firestein&author=E.+Brahn&author=V.+Strand&author=D.+G.+Baker&author=S.+E.+Tong&title=A+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Phase+2+Study+of+an+Oral+p38%CE%B1+MAPK+Inhibitor%2C+SCIO-469%2C+in+Patients+with+Active+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26atitle%3DA%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Phase%25202%2520Study%2520of%2520an%2520Oral%2520p38%25CE%25B1%2520MAPK%2520Inhibitor%252C%2520SCIO-469%252C%2520in%2520Patients%2520with%2520Active%2520Rheumatoid%2520Arthritis%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitfelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span> </span><span class="NLM_article-title">Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2994</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020057r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2994-3008&author=J.+Reganauthor=S.+Breitfelderauthor=P.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=B.+Klausauthor=J.+Madwedauthor=M.+Moriakauthor=N.+Mossauthor=C.+Pargellisauthor=S.+Pavauthor=A.+Protoauthor=A.+Swinamerauthor=L.+Tongauthor=C.+Torcellini&title=Pyrazole+urea-based+inhibitors+of+p38+MAP+kinase%3A+from+lead+compound+to+clinical+candidate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate</span></div><div class="casAuthors">Regan, John; Breitfelder, Steffen; Cirillo, Pier; Gilmore, Thomas; Graham, Anne G.; Hickey, Eugene; Klaus, Bernhard; Madwed, Jeffrey; Moriak, Monica; Moss, Neil; Pargellis, Chris; Pav, Sue; Proto, Alfred; Swinamer, Alan; Tong, Liang; Torcellini, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2994-3008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase.  Importantly, a key binding domain that is distinct from the ATP (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.  We describe the correlation of the structure-activity relationships and crystallog. structures of these inhibitors with p38.  In addn., we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site.  This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of Compd. 45 (BIRB 796) as a clin. candidate for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotOOfLV3xRbVg90H21EOLACvtfcHk0lg9GNVAH_-VSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D&md5=e473f514179c8fe24ab3efccc292b6c6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm020057r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020057r%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DBreitfelder%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKlaus%26aufirst%3DB.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DTorcellini%26aufirst%3DC.%26atitle%3DPyrazole%2520urea-based%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%253A%2520from%2520lead%2520compound%2520to%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2994%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Haens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geboes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yurcov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golovenko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffgen, J.</span><span> </span><span class="NLM_article-title">Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Clin. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1016%2Fj.cgh.2005.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=16527696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFOqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=325-334&author=S.+Schreiberauthor=B.+Feaganauthor=G.+D%27Haensauthor=J.+F.+Colombelauthor=K.+Geboesauthor=M.+Yurcovauthor=V.+Isakovauthor=O.+Golovenkoauthor=C.+N.+Bernsteinauthor=D.+Ludwigauthor=T.+Winterauthor=U.+Meierauthor=C.+Yongauthor=J.+Steffgen&title=Oral+p38+mitogen-activated+protein+kinase+inhibition+with+BIRB+796+for+active+Crohn%27s+disease%3A+a+randomized%2C+double-blind%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double- blind, placebo- controlled trial</span></div><div class="casAuthors">Schreiber, Stefan; Feagan, Brian; D'Haens, Geert; Colombel, Jean-Frederic; Geboes, Karel; Yurcov, Mikhail; Isakov, Vasily; Golovenko, Oleg; Bernstein, Charles N.; Ludwig, Diether; Winter, Trevor; Meier, Ulrich; Yong, Chan; Steffgen, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-334</span>CODEN:
                <span class="NLM_cas:coden">CGHLAW</span>;
        ISSN:<span class="NLM_cas:issn">1542-3565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The p38 mitogen-activated protein kinase (MAPK) regulates the expression of proinflammatory cytokines, which play a crit. role in the pathophysiol. of Crohn's disease (CD).  This study investigated the efficacy and safety of BIRB 796, a highly potent inhibitor of p38 MAPK, in chronic active CD.  In a multicenter, multinational trial, 284 patients with moderate to severe CD were randomized to receive placebo, or 10, 20, 30, or 60 mg of BIRB 796 twice daily for 8 wk.  Clin. endpoints were based on std. safety assessments, CD Activity Index, C-reactive protein levels, and quality of life (Inflammatory Bowel Disease Questionnaire).  In a substudy, the Crohn's Disease Endoscopic Index of Severity and histol. results of biopsy specimens were assessed.  No clin. efficacy (primary end point, clin. remission; secondary end point, clin. response; Inflammatory Bowel Disease Questionnaire; Crohn's Disease Endoscopic Index of Severity) was seen for BIRB 796 in comparison with placebo.  A significant, dose-dependent decrease of C-reactive protein level was obsd. transiently after BIRB 796 after 1 wk with a return to baseline level over time.  The incidence of adverse events was comparable between all treatment groups, with the exception of a mild increase of transaminase levels that was seen more frequently in the BIRB 796 groups.  Geog. center effects were obsd. with Russian centers producing distinctly higher remission and response rates and lower adverse event rates than in other countries in both placebo and active treatment groups.  There was no evidence for clin. efficacy of BIRB 796 in CD.  A remarkable difference in the course of CD exists between Russia and non-Russian centers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPlk4HFJbHhrVg90H21EOLACvtfcHk0lg9GNVAH_-VSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFOqsrs%253D&md5=f99fbaeea2b16c7e5fa11069b99518f1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.cgh.2005.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cgh.2005.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DFeagan%26aufirst%3DB.%26aulast%3DD%2527Haens%26aufirst%3DG.%26aulast%3DColombel%26aufirst%3DJ.%2BF.%26aulast%3DGeboes%26aufirst%3DK.%26aulast%3DYurcov%26aufirst%3DM.%26aulast%3DIsakov%26aufirst%3DV.%26aulast%3DGolovenko%26aufirst%3DO.%26aulast%3DBernstein%26aufirst%3DC.%2BN.%26aulast%3DLudwig%26aufirst%3DD.%26aulast%3DWinter%26aufirst%3DT.%26aulast%3DMeier%26aufirst%3DU.%26aulast%3DYong%26aufirst%3DC.%26aulast%3DSteffgen%26aufirst%3DJ.%26atitle%3DOral%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibition%2520with%2520BIRB%2520796%2520for%2520active%2520Crohn%2527s%2520disease%253A%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DClin.%2520Gastroenterol.%2520Hepatol.%26date%3D2006%26volume%3D4%26spage%3D325%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Norman, P.</span><span> </span><span class="NLM_article-title">BMS-582949: crystalline form of a p38alpha inhibitor? WO2008079857</span> <span class="citation_source-journal">Expert. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">–</span> <span class="NLM_lpage">1168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1517%2F13543770902816160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=19505194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1165-1168&author=P.+Norman&title=BMS-582949%3A+crystalline+form+of+a+p38alpha+inhibitor%3F+WO2008079857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">BMS-582949: crystalline form of a p38α inhibitor? WO2008079857</span></div><div class="casAuthors">Norman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1165-1168</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The p38 kinases have long been recognized as potentially valuable targets in the development of novel anti-inflammatory therapies.  An application claiming a single cryst. form of N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)-5-methyl-1-(3-(trifluoromethyl)pyridin-2-yl)-1H-pyrazole-4-carboxamide and its therapeutic use for the treatment of inflammatory diseases including rheumatoid arthritis, psoriasis and atherosclerosis points to the claimed compd. being a development compd.  The available evidence suggests that the compd. could be BMS-582949, a compd. in Phase II studies for the treatment of rheumatoid arthritis, psoriasis and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxQkmddjt_jrVg90H21EOLACvtfcHk0lhymhRFShxp4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVKktL0%253D&md5=a075540dbc5f826ac8760432b901db74</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1517%2F13543770902816160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770902816160%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DBMS-582949%253A%2520crystalline%2520form%2520of%2520a%2520p38alpha%2520inhibitor%253F%2520WO2008079857%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D1165%26epage%3D1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Ji, P.; Gao, L.; Galbraith, S.; Kollia, G.; Xu, X.; Barrett, Y.; Kelsey, J.; Hawthorne, D.; Weiner, R.; Wang, J.; Luroe, S.; McKinnon, M.; Schieven, G.; Latek, R.; Thienel, U.; Kaul, S.</span><span> </span><span class="NLM_article-title">Multiple-Dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Potent P38 Inhibitor BMS-582949 in Healthy Subjects</span>. Presented at the American College of Rheumatology Scientific Meeting, San Francisco, CA,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Poster 335.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Ji&author=L.+Gao&author=S.+Galbraith&author=G.+Kollia&author=X.+Xu&author=Y.+Barrett&author=J.+Kelsey&author=D.+Hawthorne&author=R.+Weiner&author=J.+Wang&author=S.+Luroe&author=M.+McKinnon&author=G.+Schieven&author=R.+Latek&author=U.+Thienel&author=S.+Kaul&title=Multiple-Dose+Safety%2C+Tolerability%2C+Pharmacokinetics%2C+and+Pharmacodynamics+of+a+Potent+P38+Inhibitor+BMS-582949+in+Healthy+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DP.%26atitle%3DMultiple-Dose%2520Safety%252C%2520Tolerability%252C%2520Pharmacokinetics%252C%2520and%2520Pharmacodynamics%2520of%2520a%2520Potent%2520P38%2520Inhibitor%2520BMS-582949%2520in%2520Healthy%2520Subjects%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Wang, J.; Kaul, S.; Campanha, H.; Pikul, D.; Leftheris, K.; Xu, X.; Schieven, G.; Latek, R.; Kollia, G.; Ji, P.; Weiner, R.; McKinnon, M.; Galbraith, S.; Thienel, U.</span><span> </span><span class="NLM_article-title">Multiple Ascending Dose Study of a Potent p38 MAPK Inhibitor BMS-582949 in Subjects with Stable RA Receiving Concomitant Methotrexate</span>. Presented at the American College of Rheumatology Scientifc Meeting, San Francisco, CA,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract 356.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Wang&author=S.+Kaul&author=H.+Campanha&author=D.+Pikul&author=K.+Leftheris&author=X.+Xu&author=G.+Schieven&author=R.+Latek&author=G.+Kollia&author=P.+Ji&author=R.+Weiner&author=M.+McKinnon&author=S.+Galbraith&author=U.+Thienel&title=Multiple+Ascending+Dose+Study+of+a+Potent+p38+MAPK+Inhibitor+BMS-582949+in+Subjects+with+Stable+RA+Receiving+Concomitant+Methotrexate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DMultiple%2520Ascending%2520Dose%2520Study%2520of%2520a%2520Potent%2520p38%2520MAPK%2520Inhibitor%2520BMS-582949%2520in%2520Subjects%2520with%2520Stable%2520RA%2520Receiving%2520Concomitant%2520Methotrexate%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span>ClinicalTrials.gov Home Page. <a href="http://clinicaltrials.gov/show/NCT00605735" class="extLink">http://clinicaltrials.gov/show/NCT00605735</a> (accessed Jun 7,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Home+Page.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT00605735+%28accessed+Jun+7%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span>BMS Homepage. <a href="http://ctr.bms.com/OneBmsCtd/InitTrialDetailAction.do?pnum=IM119-015" class="extLink">http://ctr.bms.com/OneBmsCtd/InitTrialDetailAction.do?pnum=IM119-015</a> (accessed Jul 6,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BMS+Homepage.+http%3A%2F%2Fctr.bms.com%2FOneBmsCtd%2FInitTrialDetailAction.do%3Fpnum%3DIM119-015+%28accessed+Jul+6%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span>Ligand Homepage. <a href="http://www.pharmacopeia.com/collaborations.php#Bristol" class="extLink">http://www.pharmacopeia.com/collaborations.php#Bristol</a> (accessed Jul 6,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ligand+Homepage.+http%3A%2F%2Fwww.pharmacopeia.com%2Fcollaborations.php%23Bristol+%28accessed+Jul+6%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span>ClinicalTrials.gov Home Page. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00399906?term=BMS-582949&amp;rank=2" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT00399906?term=BMS-582949&rank=2</a> (accessed Jul 6,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Home+Page.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT00399906%3Fterm%3DBMS-582949%26rank%3D2+%28accessed+Jul+6%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span>ClinicalTrials.gov Home Page. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00570752?term=BMS-582949&amp;rank=4" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT00570752?term=BMS-582949&rank=4</a> (accessed Jul 6,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Home+Page.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT00570752%3Fterm%3DBMS-582949%26rank%3D4+%28accessed+Jul+6%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Remmers, A.</span><span> </span><span class="NLM_article-title">p38 Inhibitors as New Therapies for Inflammatory Pain: ARRY-797</span>. Presented at the Arrowhead Pain Therapeutic Summit, New Brunswick, NJ,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=A.+Remmers&title=p38+Inhibitors+as+New+Therapies+for+Inflammatory+Pain%3A+ARRY-797"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRemmers%26aufirst%3DA.%26atitle%3Dp38%2520Inhibitors%2520as%2520New%2520Therapies%2520for%2520Inflammatory%2520Pain%253A%2520ARRY-797%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span>Array Homepage. <a href="http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&amp;p=irol-newsArticle&amp;ID=1305781&amp;highlight=" class="extLink">http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=1305781&highlight=</a> (accessed Jul 8,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Array+Homepage.+http%3A%2F%2Finvestor.arraybiopharma.com%2Fphoenix.zhtml%3Fc%3D123810%26p%3Dirol-newsArticle%26ID%3D1305781%26highlight%3D+%28accessed+Jul+8%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Remmers, A.; Yates, J.; Daniels, S.; Martinez, C.</span><span> </span><span class="NLM_article-title">A Novel p38α Inhibitor, ARRY-797, Provides Significant Analgesic Benefit following Third Molar Extraction</span>. Presented at the American Pain Society's Annual Scientific Meeting, Tampa, FL,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=A.+Remmers&author=J.+Yates&author=S.+Daniels&author=C.+Martinez&title=A+Novel+p38%CE%B1+Inhibitor%2C+ARRY-797%2C+Provides+Significant+Analgesic+Benefit+following+Third+Molar+Extraction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRemmers%26aufirst%3DA.%26atitle%3DA%2520Novel%2520p38%25CE%25B1%2520Inhibitor%252C%2520ARRY-797%252C%2520Provides%2520Significant%2520Analgesic%2520Benefit%2520following%2520Third%2520Molar%2520Extraction%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Winski, S. L.; Humphries, M. J.; Yeh, T.; Gross, S. D.; Brown, S. A.; Anderson, D.; Wright, D.; Rodriguez, M.; Lee, P.; Munson, M.; Winkler, J.</span><span> </span><span class="NLM_article-title">Activity of ARRY-614, an Inhibitor of p38 MAP Kinase and Angiogenic Targets, In Hematological Malignancies</span>. Presented at the American Association for Cancer Research Annual Meeting, Denver, CO,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+L.+Winski&author=M.+J.+Humphries&author=T.+Yeh&author=S.+D.+Gross&author=S.+A.+Brown&author=D.+Anderson&author=D.+Wright&author=M.+Rodriguez&author=P.+Lee&author=M.+Munson&author=J.+Winkler&title=Activity+of+ARRY-614%2C+an+Inhibitor+of+p38+MAP+Kinase+and+Angiogenic+Targets%2C+In+Hematological+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWinski%26aufirst%3DS.%2BL.%26atitle%3DActivity%2520of%2520ARRY-614%252C%2520an%2520Inhibitor%2520of%2520p38%2520MAP%2520Kinase%2520and%2520Angiogenic%2520Targets%252C%2520In%2520Hematological%2520Malignancies%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Winski, S. L.; Freeman, B. B.; Remmers, A. E.; Carter, L. L.; Wright, A. D.; Munson, M. C.; Humphries, M. J.; Murphy, V. A.; Klopfenstein, N. S.; Wallace, R. D.; Baer, B. R.; Kemp, J. F.; Nugent, C. A.; Lee, P. A.; Winhler, J. D.</span><span> </span><span class="NLM_article-title">ARRY-614, an Inhibitor of p38 MAP Kinase and Angiogenic Targets, Is Active in Preclinical Models of Hematological Malignancies and Significantly Reduces ex-Vivo Cytokine Production in Normal Human Subjects</span>. Presented at the 7th International Symposium on Targeted Anti-Cancer Therapeutics, Amsterdam, The Netherlands,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+L.+Winski&author=B.+B.+Freeman&author=A.+E.+Remmers&author=L.+L.+Carter&author=A.+D.+Wright&author=M.+C.+Munson&author=M.+J.+Humphries&author=V.+A.+Murphy&author=N.+S.+Klopfenstein&author=R.+D.+Wallace&author=B.+R.+Baer&author=J.+F.+Kemp&author=C.+A.+Nugent&author=P.+A.+Lee&author=J.+D.+Winhler&title=ARRY-614%2C+an+Inhibitor+of+p38+MAP+Kinase+and+Angiogenic+Targets%2C+Is+Active+in+Preclinical+Models+of+Hematological+Malignancies+and+Significantly+Reduces+ex-Vivo+Cytokine+Production+in+Normal+Human+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWinski%26aufirst%3DS.%2BL.%26atitle%3DARRY-614%252C%2520an%2520Inhibitor%2520of%2520p38%2520MAP%2520Kinase%2520and%2520Angiogenic%2520Targets%252C%2520Is%2520Active%2520in%2520Preclinical%2520Models%2520of%2520Hematological%2520Malignancies%2520and%2520Significantly%2520Reduces%2520ex-Vivo%2520Cytokine%2520Production%2520in%2520Normal%2520Human%2520Subjects%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Monahan, J. B.; Hope, H.; Schindler, J.; Jungbluth, G.; Burnette, B.; Guzova, J.; Hirsch, J.; Saabye, M.; Compton, R.; Zhang, J.; Keith, R.; Anderson, G.; Stillwell, L.; Mbalaviele, G.; Webb, E.; Li, X.; Bonar, S.; Sommers, C.; Venkatraman, N.; Blorn, J.; Meyer, D.; Devraj, R.; Selness, S.</span><span> </span><span class="NLM_article-title">Anti-Inflammatory Properties of a Novel <i>N</i>-Phenyl Pyridinone Inhibitor of p38 MAP Kinase: Preclinical to Clinical Translation</span>. Presented at the Annual European Congress of Rheumatology, Copenhagen, Denmark,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Abstract FRI0001.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+B.+Monahan&author=H.+Hope&author=J.+Schindler&author=G.+Jungbluth&author=B.+Burnette&author=J.+Guzova&author=J.+Hirsch&author=M.+Saabye&author=R.+Compton&author=J.+Zhang&author=R.+Keith&author=G.+Anderson&author=L.+Stillwell&author=G.+Mbalaviele&author=E.+Webb&author=X.+Li&author=S.+Bonar&author=C.+Sommers&author=N.+Venkatraman&author=J.+Blorn&author=D.+Meyer&author=R.+Devraj&author=S.+Selness&title=Anti-Inflammatory+Properties+of+a+Novel+N-Phenyl+Pyridinone+Inhibitor+of+p38+MAP+Kinase%3A+Preclinical+to+Clinical+Translation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DAnti-Inflammatory%2520Properties%2520of%2520a%2520Novel%2520N-Phenyl%2520Pyridinone%2520Inhibitor%2520of%2520p38%2520MAP%2520Kinase%253A%2520Preclinical%2520to%2520Clinical%2520Translation%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Aston, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitulli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span> </span><span class="NLM_article-title">p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6257</span><span class="NLM_x">–</span> <span class="NLM_lpage">6269</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9004779" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6257-6269&author=N.+M.+Astonauthor=P.+Bamboroughauthor=J.+B.+Bucktonauthor=C.+D.+Edwardsauthor=D.+S.+Holmesauthor=K.+L.+Jonesauthor=V.+K.+Patelauthor=P.+A.+Smeeauthor=D.+O.+Somersauthor=G.+Vitulliauthor=A.+L.+Walker&title=p38alpha+mitogen-activated+protein+kinase+inhibitors%3A+optimization+of+a+series+of+biphenylamides+to+give+a+molecule+suitable+for+clinical+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm9004779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004779%26sid%3Dliteratum%253Aachs%26aulast%3DAston%26aufirst%3DN.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3Dp38alpha%2520mitogen-activated%2520protein%2520kinase%2520inhibitors%253A%2520optimization%2520of%2520a%2520series%2520of%2520biphenylamides%2520to%2520give%2520a%2520molecule%2520suitable%2520for%2520clinical%2520progression%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6257%26epage%3D6269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Adams, J. L.; Boehm, J. C.; Hall, R. J.; Jin, Q.; Kasparec, J.; Silva, D. J.; Taggart, J. J.</span><span> </span><span class="NLM_article-title">Preparation of 2,4,8-Trisubstituted-8<i>H</i>-pyrido[2,3-<i>d</i>]pyrimidin-7-ones as CSBP/RK/p38 Kinase Inhibitors</span>. WO2002059083,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+L.+Adams&author=J.+C.+Boehm&author=R.+J.+Hall&author=Q.+Jin&author=J.+Kasparec&author=D.+J.+Silva&author=J.+J.+Taggart&title=Preparation+of+2%2C4%2C8-Trisubstituted-8H-pyrido%5B2%2C3-d%5Dpyrimidin-7-ones+as+CSBP%2FRK%2Fp38+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3DPreparation%2520of%25202%252C4%252C8-Trisubstituted-8H-pyrido%255B2%252C3-d%255Dpyrimidin-7-ones%2520as%2520CSBP%252FRK%252Fp38%2520Kinase%2520Inhibitors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span>GlaxoSmithKline Homepage. <a href="http://www.gsk.com/investors/product_pipeline/pp.htm" class="extLink">http://www.gsk.com/investors/product_pipeline/pp.htm</a> (accessed Oct 29,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GlaxoSmithKline+Homepage.+http%3A%2F%2Fwww.gsk.com%2Finvestors%2Fproduct_pipeline%2Fpp.htm+%28accessed+Oct+29%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule−kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule%E2%88%92kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule%25E2%2588%2592kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Stelmach, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pivnichny, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmatz, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. B.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1016%2FS0960-894X%2802%2900752-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=12482439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=277-280&author=J.+E.+Stelmachauthor=L.+Liuauthor=S.+B.+Patelauthor=J.+V.+Pivnichnyauthor=G.+Scapinauthor=S.+Singhauthor=C.+E.+Hopauthor=Z.+Wangauthor=J.+R.+Straussauthor=P.+M.+Cameronauthor=E.+A.+Nicholsauthor=S.+J.+O%27Keefeauthor=E.+A.+O%27Neillauthor=D.+M.+Schmatzauthor=C.+D.+Schwartzauthor=C.+M.+Thompsonauthor=D.+M.+Zallerauthor=J.+B.+Doherty&title=Design+and+synthesis+of+potent%2C+orally+bioavailable+dihydroquinazolinone+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase</span></div><div class="casAuthors">Stelmach, John E.; Liu, Luping; Patel, Sangita B.; Pivnichny, James V.; Scapin, Giovanna; Singh, Suresh; Hop, Cornelis E. C. A.; Wang, Zhen; Strauss, John R.; Cameron, Patricia M.; Nichols, Elizabeth A.; O'Keefe, Stephen J.; O'Neill, Edward A.; Schmatz, Dennis M.; Schwartz, Cheryl D.; Thompson, Chris M.; Zaller, Dennis M.; Doherty, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-280</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The development of potent, orally bioavailable (in rat) and selective dihydroquinazolinone inhibitors I (R = CO2Me, R1 = H, Br, 2-FC6H4, etc.; R = OMe, R1 = 2-Cl-4-FC6H3, 2,4-F2C6H3, 2-ClC6H4), II (R1 = 2-Cl-4-FC6H3, 2,4-F2C6H3, 2-ClC6H4, X = none, O, NH, CH2, CO, Y = CH, N) and III (R2 = Me, Et, CHMe2, etc.) of p38α MAP kinase is described.  For example, III (R2 = CMe3) was prepd. via the Still coupling of I (R = OSO2CF3, R1 = 2-Cl-4-FC6H3) with 1-tert-butyl-4-(trimethylstannyl)-1,2,3,6-tetrahydropyridine.  These analogs are hybrids of a pyridinylimidazole p38α inhibitor reported by Merck Research Labs. and VX-745.  Optimization of the C-5 Ph and the C-7 piperidinyl substituents led to the identification of III (R2 = CMe3) which gave excellent suppression of TNF-α prodn. in LPS-stimulated whole blood (IC50=10 nM) and good oral exposure in rats (F=68%, AUCn PO=0.58 μM h).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeEsr0ksZsw7Vg90H21EOLACvtfcHk0lj49r0VfBoKjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVemu7c%253D&md5=489ab070411bc48e879737d57d98d745</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900752-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900752-7%26sid%3Dliteratum%253Aachs%26aulast%3DStelmach%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DPivnichny%26aufirst%3DJ.%2BV.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DHop%26aufirst%3DC.%2BE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DStrauss%26aufirst%3DJ.%2BR.%26aulast%3DCameron%26aufirst%3DP.%2BM.%26aulast%3DNichols%26aufirst%3DE.%2BA.%26aulast%3DO%2527Keefe%26aufirst%3DS.%2BJ.%26aulast%3DO%2527Neill%26aufirst%3DE.%2BA.%26aulast%3DSchmatz%26aufirst%3DD.%2BM.%26aulast%3DSchwartz%26aufirst%3DC.%2BD.%26aulast%3DThompson%26aufirst%3DC.%2BM.%26aulast%3DZaller%26aufirst%3DD.%2BM.%26aulast%3DDoherty%26aufirst%3DJ.%2BB.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520orally%2520bioavailable%2520dihydroquinazolinone%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D277%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 136 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sandra Röhm, Benedict-Tilman Berger, Martin Schröder, Apirat Chaikuad, Rob Winkel, Koen F. W. Hekking, Jorg J. C. Benningshof, Gerhard Müller, Roberta Tesch, Mark Kudolo, Michael Forster, Stefan Laufer, <span class="NLM_string-name hlFld-ContribAuthor">Stefan Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (23)
                                     , 10757-10782. <a href="https://doi.org/10.1021/acs.jmedchem.9b01227" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01227%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFast%252BIterative%252BSynthetic%252BApproach%252Btoward%252BIdentification%252Bof%252BNovel%252BHighly%252BSelective%252Bp38%252BMAP%252BKinase%252BInhibitors%26aulast%3DR%25C3%25B6hm%26aufirst%3DSandra%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29072019%26date%3D26112019%26date%3D08112019%26volume%3D62%26issue%3D23%26spage%3D10757%26epage%3D10782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunjian  Liu</span>, <span class="hlFld-ContribAuthor ">James  Lin</span>, <span class="hlFld-ContribAuthor ">John  Hynes</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>, <span class="hlFld-ContribAuthor ">Shuqun  Lin</span>, <span class="hlFld-ContribAuthor ">T. G. Murali  Dhar</span>, <span class="hlFld-ContribAuthor ">Vivekananda M.  Vrudhula</span>, <span class="hlFld-ContribAuthor ">Jung-Hui  Sun</span>, <span class="hlFld-ContribAuthor ">Sam  Chao</span>, <span class="hlFld-ContribAuthor ">Rulin  Zhao</span>, <span class="hlFld-ContribAuthor ">Bei  Wang</span>, <span class="hlFld-ContribAuthor ">Bang-Chi  Chen</span>, <span class="hlFld-ContribAuthor ">Gerry  Everlof</span>, <span class="hlFld-ContribAuthor ">Christoph  Gesenberg</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Taylor</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, and <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (19)
                                     , 7775-7784. <a href="https://doi.org/10.1021/acs.jmedchem.5b00839" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00839%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528%2525284-%2525285-%252528Cyclopropylcarbamoyl%252529-2-methylphenylamino%252529-5-methylpyrrolo%25255B1%25252C2-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine-6-carbonyl%252529%252528propyl%252529carbamoyloxy%252529methyl-2-%2525284-%252528phosphonooxy%252529phenyl%252529acetate%2525C2%2525A0%252528BMS-751324%252529%25252C%252Ba%252BClinical%252BProdrug%252Bof%252Bp38%2525CE%2525B1%252BMAP%252BKinase%252BInhibitor%26aulast%3DLiu%26aufirst%3DChunjian%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D01062015%26date%3D22092015%26date%3D08102015%26date%3D11092015%26volume%3D58%26issue%3D19%26spage%3D7775%26epage%3D7784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John G.  Cumming</span>, <span class="hlFld-ContribAuthor ">Judit É.  Debreczeni</span>, <span class="hlFld-ContribAuthor ">Fredrik  Edfeldt</span>, <span class="hlFld-ContribAuthor ">Emma  Evertsson</span>, <span class="hlFld-ContribAuthor ">Martin  Harrison</span>, <span class="hlFld-ContribAuthor ">Geoffrey A.  Holdgate</span>, <span class="hlFld-ContribAuthor ">Michael J.  James</span>, <span class="hlFld-ContribAuthor ">Scott G.  Lamont</span>, <span class="hlFld-ContribAuthor ">Keith  Oldham</span>, <span class="hlFld-ContribAuthor ">Jane E.  Sullivan</span>, and <span class="hlFld-ContribAuthor ">Stuart L.  Wells</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of MAPK-activated Protein Kinase-2 Prevention of Activation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 278-293. <a href="https://doi.org/10.1021/jm501038s" title="DOI URL">https://doi.org/10.1021/jm501038s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501038s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501038s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BMAPK-activated%252BProtein%252BKinase-2%252BPrevention%252Bof%252BActivation%252BInhibitors%26aulast%3DCumming%26aufirst%3DJohn%2BG.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D10072014%26date%3D09102014%26date%3D08012015%26date%3D25092014%26volume%3D58%26issue%3D1%26spage%3D278%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xitao  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Zuo</span>, <span class="hlFld-ContribAuthor ">Guanghui  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Mengying  Xia</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, and <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 2,5-Diaminopyrimidine Covalent Irreversible Inhibitors of Bruton’s Tyrosine Kinase with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5112-5128. <a href="https://doi.org/10.1021/jm4017762" title="DOI URL">https://doi.org/10.1021/jm4017762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4017762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4017762%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B2%25252C5-Diaminopyrimidine%252BCovalent%252BIrreversible%252BInhibitors%252Bof%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DLi%26aufirst%3DXitao%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16112013%26date%3D10062014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5112%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toru  Asano</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Chiyoshi  Kasahara</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Kubota</span>, <span class="hlFld-ContribAuthor ">Toru  Kontani</span>, <span class="hlFld-ContribAuthor ">Yu  Harayama</span>, <span class="hlFld-ContribAuthor ">Kazuki  Ohno</span>, <span class="hlFld-ContribAuthor ">Hidekazu  Mizuhara</span>, <span class="hlFld-ContribAuthor ">Masaharu  Yokomoto</span>, <span class="hlFld-ContribAuthor ">Keiji  Misumi</span>, <span class="hlFld-ContribAuthor ">Tomohiko  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Mitsuaki  Ohta</span>, and <span class="hlFld-ContribAuthor ">Makoto  Takeuchi.</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification, Synthesis, and Biological Evaluation of 6-[(6R)-2-(4-Fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a Potent p38 MAP Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7772-7785. <a href="https://doi.org/10.1021/jm3008008" title="DOI URL">https://doi.org/10.1021/jm3008008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3008008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3008008%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252B6-%25255B%2525286R%252529-2-%2525284-Fluorophenyl%252529-6-%252528hydroxymethyl%252529-4%25252C5%25252C6%25252C7-tetrahydropyrazolo%25255B1%25252C5-a%25255Dpyrimidin-3-yl%25255D-2-%2525282-methylphenyl%252529pyridazin-3%2525282H%252529-one%252B%252528AS1940477%252529%25252C%252Ba%252BPotent%252Bp38%252BMAP%252BKinase%252BInhibitor%26aulast%3DAsano%26aufirst%3DToru%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07062012%26date%3D31082012%26date%3D13092012%26date%3D20082012%26volume%3D55%26issue%3D17%26spage%3D7772%26epage%3D7785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Lou</span>, <span class="hlFld-ContribAuthor ">Timothy D.  Owens</span>, <span class="hlFld-ContribAuthor ">Andreas  Kuglstatter</span>, <span class="hlFld-ContribAuthor ">Rama K.  Kondru</span>, and <span class="hlFld-ContribAuthor ">David M.  Goldstein</span>  . </span><span class="cited-content_cbyCitation_article-title">Bruton’s Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (10)
                                     , 4539-4550. <a href="https://doi.org/10.1021/jm300035p" title="DOI URL">https://doi.org/10.1021/jm300035p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300035p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300035p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252BInhibitors%25253A%252BApproaches%252Bto%252BPotent%252Band%252BSelective%252BInhibition%25252C%252BPreclinical%252Band%252BClinical%252BEvaluation%252Bfor%252BInflammatory%252BDiseases%252Band%252BB%252BCell%252BMalignancies%26aulast%3DLou%26aufirst%3DYan%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D10012012%26date%3D21032012%26date%3D24052012%26date%3D06032012%26volume%3D55%26issue%3D10%26spage%3D4539%26epage%3D4550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Milletti</span> and <span class="hlFld-ContribAuthor ">Johannes C.  Hermann</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeted Kinase Selectivity from Kinase Profiling Data. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (5)
                                     , 383-386. <a href="https://doi.org/10.1021/ml300012r" title="DOI URL">https://doi.org/10.1021/ml300012r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300012r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300012r%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTargeted%252BKinase%252BSelectivity%252Bfrom%252BKinase%252BProfiling%252BData%26aulast%3DMilletti%26aufirst%3DFrancesca%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D10012012%26date%3D14032012%26date%3D19032012%26date%3D10052012%26date%3D14032012%26volume%3D3%26issue%3D5%26spage%3D383%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David S.  Millan</span>, <span class="hlFld-ContribAuthor ">Mark E.  Bunnage</span>, <span class="hlFld-ContribAuthor ">Jane L.  Burrows</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Butcher</span>, <span class="hlFld-ContribAuthor ">Peter G.  Dodd</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Evans</span>, <span class="hlFld-ContribAuthor ">David A.  Fairman</span>, <span class="hlFld-ContribAuthor ">Samantha J.  Hughes</span>, <span class="hlFld-ContribAuthor ">Iain C.  Kilty</span>, <span class="hlFld-ContribAuthor ">Arnaud  Lemaitre</span>, <span class="hlFld-ContribAuthor ">Russell A.  Lewthwaite</span>, <span class="hlFld-ContribAuthor ">Axel  Mahnke</span>, <span class="hlFld-ContribAuthor ">John P.  Mathias</span>, <span class="hlFld-ContribAuthor ">James  Philip</span>, <span class="hlFld-ContribAuthor ">Robert T.  Smith</span>, <span class="hlFld-ContribAuthor ">Mark H.  Stefaniak</span>, <span class="hlFld-ContribAuthor ">Michael  Yeadon</span>, and <span class="hlFld-ContribAuthor ">Christopher  Phillips</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (22)
                                     , 7797-7814. <a href="https://doi.org/10.1021/jm200677b" title="DOI URL">https://doi.org/10.1021/jm200677b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200677b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200677b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BInhaled%252Bp38%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BObstructive%252BPulmonary%252BDisease%26aulast%3DMillan%26aufirst%3DDavid%2BS.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D27052011%26date%3D28102011%26date%3D24112011%26date%3D05092011%26volume%3D54%26issue%3D22%26spage%3D7797%26epage%3D7814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenceslao  Lumeras</span>, <span class="hlFld-ContribAuthor ">Laura  Vidal</span>, <span class="hlFld-ContribAuthor ">Bernat  Vidal</span>, <span class="hlFld-ContribAuthor ">Cristina  Balagué</span>, <span class="hlFld-ContribAuthor ">Adelina  Orellana</span>, <span class="hlFld-ContribAuthor ">Mónica  Maldonado</span>, <span class="hlFld-ContribAuthor ">María  Domínguez</span>, <span class="hlFld-ContribAuthor ">Víctor  Segarra</span>, and <span class="hlFld-ContribAuthor ">Francisco  Caturla</span>  . </span><span class="cited-content_cbyCitation_article-title">1,7-Naphthyridine 1-Oxides as Novel Potent and Selective Inhibitors of p38 Mitogen Activated Protein Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (22)
                                     , 7899-7910. <a href="https://doi.org/10.1021/jm200975u" title="DOI URL">https://doi.org/10.1021/jm200975u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200975u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200975u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C7-Naphthyridine%252B1-Oxides%252Bas%252BNovel%252BPotent%252Band%252BSelective%252BInhibitors%252Bof%252Bp38%252BMitogen%252BActivated%252BProtein%252BKinase%26aulast%3DLumeras%26aufirst%3DWenceslao%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D21072011%26date%3D31102011%26date%3D24112011%26date%3D14102011%26volume%3D54%26issue%3D22%26spage%3D7899%26epage%3D7910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David M.  Goldstein</span>, <span class="hlFld-ContribAuthor ">Michael  Soth</span>, <span class="hlFld-ContribAuthor ">Tobias  Gabriel</span>, <span class="hlFld-ContribAuthor ">Nolan  Dewdney</span>, <span class="hlFld-ContribAuthor ">Andreas  Kuglstatter</span>, <span class="hlFld-ContribAuthor ">Humberto  Arzeno</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">William  Bingenheimer</span>, <span class="hlFld-ContribAuthor ">Stacie A.  Dalrymple</span>, <span class="hlFld-ContribAuthor ">James  Dunn</span>, <span class="hlFld-ContribAuthor ">Robert  Farrell</span>, <span class="hlFld-ContribAuthor ">Sandra  Frauchiger</span>, <span class="hlFld-ContribAuthor ">JoAnn  La Fargue</span>, <span class="hlFld-ContribAuthor ">Manjiri  Ghate</span>, <span class="hlFld-ContribAuthor ">Bradford  Graves</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Hill</span>, <span class="hlFld-ContribAuthor ">Fujun  Li</span>, <span class="hlFld-ContribAuthor ">Renee  Litman</span>, <span class="hlFld-ContribAuthor ">Brad  Loe</span>, <span class="hlFld-ContribAuthor ">Joel  McIntosh</span>, <span class="hlFld-ContribAuthor ">Daniel  McWeeney</span>, <span class="hlFld-ContribAuthor ">Eva  Papp</span>, <span class="hlFld-ContribAuthor ">Jaehyeon  Park</span>, <span class="hlFld-ContribAuthor ">Harlan F.  Reese</span>, <span class="hlFld-ContribAuthor ">Richard T.  Roberts</span>, <span class="hlFld-ContribAuthor ">David  Rotstein</span>, <span class="hlFld-ContribAuthor ">Bong  San Pablo</span>, <span class="hlFld-ContribAuthor ">Keshab  Sarma</span>, <span class="hlFld-ContribAuthor ">Martin  Stahl</span>, <span class="hlFld-ContribAuthor ">Man-Ling  Sung</span>, <span class="hlFld-ContribAuthor ">Rebecca T.  Suttman</span>, <span class="hlFld-ContribAuthor ">Eric B.  Sjogren</span>, <span class="hlFld-ContribAuthor ">Yunchou  Tan</span>, <span class="hlFld-ContribAuthor ">Alejandra  Trejo</span>, <span class="hlFld-ContribAuthor ">Mary  Welch</span>, <span class="hlFld-ContribAuthor ">Paul  Weller</span>, <span class="hlFld-ContribAuthor ">Brian R.  Wong</span>, and <span class="hlFld-ContribAuthor ">Hasim  Zecic</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 6-(2,4-Difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (Pamapimod) and 6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (R1487) as Orally Bioavailable and Highly Selective Inhibitors of p38α Mitogen-Activated Protein Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (7)
                                     , 2255-2265. <a href="https://doi.org/10.1021/jm101423y" title="DOI URL">https://doi.org/10.1021/jm101423y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101423y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101423y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B6-%2525282%25252C4-Difluorophenoxy%252529-2-%25255B3-hydroxy-1-%2525282-hydroxyethyl%252529propylamino%25255D-8-methyl-8H-pyrido%25255B2%25252C3-d%25255Dpyrimidin-7-one%252B%252528Pamapimod%252529%252Band%252B6-%2525282%25252C4-Difluorophenoxy%252529-8-methyl-2-%252528tetrahydro-2H-pyran-4-ylamino%252529pyrido%25255B2%25252C3-d%25255Dpyrimidin-7%2525288H%252529-one%252B%252528R1487%252529%252Bas%252BOrally%252BBioavailable%252Band%252BHighly%252BSelective%252BInhibitors%252Bof%252Bp38%2525CE%2525B1%252BMitogen-Activated%252BProtein%252BKinase%26aulast%3DGoldstein%26aufirst%3DDavid%2BM.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D04112010%26date%3D04032011%26date%3D14042011%26volume%3D54%26issue%3D7%26spage%3D2255%26epage%3D2265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunjian  Liu</span>, <span class="hlFld-ContribAuthor ">James  Lin</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>, <span class="hlFld-ContribAuthor ">Shuqun  Lin</span>, <span class="hlFld-ContribAuthor ">John  Hynes, Jr.</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, <span class="hlFld-ContribAuthor ">Tianle  Li</span>, <span class="hlFld-ContribAuthor ">John  Wityak</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Gillooly</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Rosemary F.  Zhang</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Punit H.  Marathe</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Kish</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, and <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (18)
                                     , 6629-6639. <a href="https://doi.org/10.1021/jm100540x" title="DOI URL">https://doi.org/10.1021/jm100540x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100540x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100540x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-%2525285-%252528Cyclopropylcarbamoyl%252529-2-methylphenylamino%252529-5-methyl-N-propylpyrrolo%25255B1%25252C2-f%25255D%25255B1%25252C2%25252C4%25255Dtriazine-6-carboxamide%252B%252528BMS-582949%252529%25252C%252Ba%252BClinical%252Bp38%2525CE%2525B1%252BMAP%252BKinase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammatory%252BDiseases%26aulast%3DLiu%26aufirst%3DChunjian%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D04052010%26date%3D30082010%26date%3D23092010%26volume%3D53%26issue%3D18%26spage%3D6629%26epage%3D6639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Liping  Pettus</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Doherty</span>, <span class="hlFld-ContribAuthor ">Bradley  Henkle</span>, <span class="hlFld-ContribAuthor ">Helen J.  McBride</span>, <span class="hlFld-ContribAuthor ">Christiaan J. M.  Saris</span>, <span class="hlFld-ContribAuthor ">Lu Min  Wong</span>, <span class="hlFld-ContribAuthor ">Matthew H.  Plant</span>, <span class="hlFld-ContribAuthor ">Lisa  Sherman</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Faye  Hsieh</span> and <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Pyridazinopyridinones as Potent and Selective p38 Mitogen-Activated Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (17)
                                     , 6398-6411. <a href="https://doi.org/10.1021/jm100567y" title="DOI URL">https://doi.org/10.1021/jm100567y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100567y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100567y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPyridazinopyridinones%252Bas%252BPotent%252Band%252BSelective%252Bp38%252BMitogen-Activated%252BProtein%252BKinase%252BInhibitors%26aulast%3DWu%26aufirst%3DBin%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D10052010%26date%3D16082010%26date%3D09092010%26volume%3D53%26issue%3D17%26spage%3D6398%26epage%3D6411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Niels D.  Prins</span>, <span class="hlFld-ContribAuthor ">John E.  Harrison</span>, <span class="hlFld-ContribAuthor ">Hui-May  Chu</span>, <span class="hlFld-ContribAuthor ">Kelly  Blackburn</span>, <span class="hlFld-ContribAuthor ">John J.  Alam</span>, <span class="hlFld-ContribAuthor ">Philip  Scheltens</span>. </span><span class="cited-content_cbyCitation_article-title">A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's Research & Therapy</span><span> <strong>2021,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13195-021-00843-2" title="DOI URL">https://doi.org/10.1186/s13195-021-00843-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13195-021-00843-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13195-021-00843-2%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520Research%2520%2526%2520Therapy%26atitle%3DA%252Bphase%252B2%252Bdouble-blind%252Bplacebo-controlled%252B24-week%252Btreatment%252Bclinical%252Bstudy%252Bof%252Bthe%252Bp38%252Balpha%252Bkinase%252Binhibitor%252Bneflamapimod%252Bin%252Bmild%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DPrins%26aufirst%3DNiels%2BD.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thamires R.  Machado</span>, <span class="hlFld-ContribAuthor ">Thayná R.  Machado</span>, <span class="hlFld-ContribAuthor ">Pedro G.  Pascutti</span>. </span><span class="cited-content_cbyCitation_article-title">The p38 MAPK Inhibitors and Their Role in Inflammatory Diseases. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (23)
                                     , 5729-5742. <a href="https://doi.org/10.1002/slct.202100406" title="DOI URL">https://doi.org/10.1002/slct.202100406</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100406%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DThe%252Bp38%252BMAPK%252BInhibitors%252Band%252BTheir%252BRole%252Bin%252BInflammatory%252BDiseases%26aulast%3DMachado%26aufirst%3DThamires%2BR.%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D23%26spage%3D5729%26epage%3D5742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrey  Skripchenko</span>, <span class="hlFld-ContribAuthor ">Monique P.  Gelderman</span>, <span class="hlFld-ContribAuthor ">Jaroslav G.  Vostal</span>, . </span><span class="cited-content_cbyCitation_article-title">P38 mitogen activated protein kinase inhibitor improves platelet in vitro parameters and in vivo survival in a SCID mouse model of transfusion for platelets stored at cold or temperature cycled conditions for 14 days. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , e0250120. <a href="https://doi.org/10.1371/journal.pone.0250120" title="DOI URL">https://doi.org/10.1371/journal.pone.0250120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0250120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0250120%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DP38%252Bmitogen%252Bactivated%252Bprotein%252Bkinase%252Binhibitor%252Bimproves%252Bplatelet%252Bin%252Bvitro%252Bparameters%252Band%252Bin%252Bvivo%252Bsurvival%252Bin%252Ba%252BSCID%252Bmouse%252Bmodel%252Bof%252Btransfusion%252Bfor%252Bplatelets%252Bstored%252Bat%252Bcold%252Bor%252Btemperature%252Bcycled%252Bconditions%252Bfor%252B14%252Bdays%26aulast%3DSkripchenko%26aufirst%3DAndrey%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D5%26spage%3De0250120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seth O.  Asiedu</span>, <span class="hlFld-ContribAuthor ">Samuel K.  Kwofie</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Broni</span>, <span class="hlFld-ContribAuthor ">Michael D.  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (5)
                                     , 653. <a href="https://doi.org/10.3390/biom11050653" title="DOI URL">https://doi.org/10.3390/biom11050653</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11050653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11050653%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DComputational%252BIdentification%252Bof%252BPotential%252BAnti-Inflammatory%252BNatural%252BCompounds%252BTargeting%252Bthe%252Bp38%252BMitogen-Activated%252BProtein%252BKinase%252B%252528MAPK%252529%25253A%252BImplications%252Bfor%252BCOVID-19-Induced%252BCytokine%252BStorm%26aulast%3DAsiedu%26aufirst%3DSeth%2BO.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D5%26spage%3D653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Haibo  Sun</span>, <span class="hlFld-ContribAuthor ">Laixue  Pang</span>, <span class="hlFld-ContribAuthor ">Huayin  Bao</span>. </span><span class="cited-content_cbyCitation_article-title">Binding mechanism of inhibitors to p38α MAP kinase deciphered by using multiple replica Gaussian accelerated molecular dynamics and calculations of binding free energies. </span><span class="cited-content_cbyCitation_journal-name">Computers in Biology and Medicine</span><span> <strong>2021,</strong> <em>92 </em>, 104485. <a href="https://doi.org/10.1016/j.compbiomed.2021.104485" title="DOI URL">https://doi.org/10.1016/j.compbiomed.2021.104485</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiomed.2021.104485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiomed.2021.104485%26sid%3Dliteratum%253Aachs%26jtitle%3DComputers%2520in%2520Biology%2520and%2520Medicine%26atitle%3DBinding%252Bmechanism%252Bof%252Binhibitors%252Bto%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%252Bdeciphered%252Bby%252Busing%252Bmultiple%252Breplica%252BGaussian%252Baccelerated%252Bmolecular%252Bdynamics%252Band%252Bcalculations%252Bof%252Bbinding%252Bfree%252Benergies%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2021%26volume%3D92%26spage%3D104485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corrado  Pelaia</span>, <span class="hlFld-ContribAuthor ">Alessandro  Vatrella</span>, <span class="hlFld-ContribAuthor ">Luca  Gallelli</span>, <span class="hlFld-ContribAuthor ">Nicola  Lombardo</span>, <span class="hlFld-ContribAuthor ">Angela  Sciacqua</span>, <span class="hlFld-ContribAuthor ">Rocco  Savino</span>, <span class="hlFld-ContribAuthor ">Girolamo  Pelaia</span>. </span><span class="cited-content_cbyCitation_article-title">Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies. </span><span class="cited-content_cbyCitation_journal-name">Drug Design, Development and Therapy</span><span> <strong>2021,</strong> <em>Volume 15 </em>, 1275-1284. <a href="https://doi.org/10.2147/DDDT.S300988" title="DOI URL">https://doi.org/10.2147/DDDT.S300988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/DDDT.S300988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FDDDT.S300988%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Design%252C%2520Development%2520and%2520Therapy%26atitle%3DRole%252Bof%252Bp38%252BMitogen-Activated%252BProtein%252BKinase%252Bin%252BAsthma%252Band%252BCOPD%25253A%252BPathogenic%252BAspects%252Band%252BPotential%252BTargeted%252BTherapies%26aulast%3DPelaia%26aufirst%3DCorrado%26date%3D2021%26date%3D2021%26volume%3DVolume%252015%26spage%3D1275%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Midori  Yoshikawa</span>, <span class="hlFld-ContribAuthor ">Takayuki  Iriyama</span>, <span class="hlFld-ContribAuthor ">Kensuke  Suzuki</span>, <span class="hlFld-ContribAuthor ">Seisuke  Sayama</span>, <span class="hlFld-ContribAuthor ">Tetsushi  Tsuruga</span>, <span class="hlFld-ContribAuthor ">Keiichi  Kumasawa</span>, <span class="hlFld-ContribAuthor ">Takeshi  Nagamatsu</span>, <span class="hlFld-ContribAuthor ">Kengo  Homma</span>, <span class="hlFld-ContribAuthor ">Isao  Naguro</span>, <span class="hlFld-ContribAuthor ">Yutaka  Osuga</span>, <span class="hlFld-ContribAuthor ">Hidenori  Ichijo</span>, <span class="hlFld-ContribAuthor ">Tomoyuki  Fujii</span>. </span><span class="cited-content_cbyCitation_article-title">ASK1 promotes uterine inflammation leading to pathological preterm birth. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-58653-9" title="DOI URL">https://doi.org/10.1038/s41598-020-58653-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-58653-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-58653-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DASK1%252Bpromotes%252Buterine%252Binflammation%252Bleading%252Bto%252Bpathological%252Bpreterm%252Bbirth%26aulast%3DYoshikawa%26aufirst%3DMidori%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendi S.  Lambert</span>, <span class="hlFld-ContribAuthor ">Silvia  Pasini</span>, <span class="hlFld-ContribAuthor ">John W.  Collyer</span>, <span class="hlFld-ContribAuthor ">Cathryn R.  Formichella</span>, <span class="hlFld-ContribAuthor ">Purnima  Ghose</span>, <span class="hlFld-ContribAuthor ">Brian J.  Carlson</span>, <span class="hlFld-ContribAuthor ">David J.  Calkins</span>. </span><span class="cited-content_cbyCitation_article-title">Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-65374-6" title="DOI URL">https://doi.org/10.1038/s41598-020-65374-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-65374-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-65374-6%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DOf%252BMice%252Band%252BMonkeys%25253A%252BNeuroprotective%252BEfficacy%252Bof%252Bthe%252Bp38%252BInhibitor%252BBIRB%252B796%252BDepends%252Bon%252BModel%252BDuration%252Bin%252BExperimental%252BGlaucoma%26aulast%3DLambert%26aufirst%3DWendi%2BS.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. C.  Wilkes</span>, <span class="hlFld-ContribAuthor ">K.  Siva</span>, <span class="hlFld-ContribAuthor ">J.  Chen</span>, <span class="hlFld-ContribAuthor ">G.  Varetti</span>, <span class="hlFld-ContribAuthor ">M. Y.  Youn</span>, <span class="hlFld-ContribAuthor ">H.  Chae</span>, <span class="hlFld-ContribAuthor ">F.  Ek</span>, <span class="hlFld-ContribAuthor ">R.  Olsson</span>, <span class="hlFld-ContribAuthor ">T.  Lundbäck</span>, <span class="hlFld-ContribAuthor ">D. P.  Dever</span>, <span class="hlFld-ContribAuthor ">T.  Nishimura</span>, <span class="hlFld-ContribAuthor ">A.  Narla</span>, <span class="hlFld-ContribAuthor ">B.  Glader</span>, <span class="hlFld-ContribAuthor ">H.  Nakauchi</span>, <span class="hlFld-ContribAuthor ">M. H.  Porteus</span>, <span class="hlFld-ContribAuthor ">C. E.  Repellin</span>, <span class="hlFld-ContribAuthor ">H. T.  Gazda</span>, <span class="hlFld-ContribAuthor ">S.  Lin</span>, <span class="hlFld-ContribAuthor ">M.  Serrano</span>, <span class="hlFld-ContribAuthor ">J.  Flygare</span>, <span class="hlFld-ContribAuthor ">K. M.  Sakamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Diamond Blackfan anemia is mediated by hyperactive Nemo-like kinase. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-17100-z" title="DOI URL">https://doi.org/10.1038/s41467-020-17100-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-17100-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-17100-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DDiamond%252BBlackfan%252Banemia%252Bis%252Bmediated%252Bby%252Bhyperactive%252BNemo-like%252Bkinase%26aulast%3DWilkes%26aufirst%3DM.%2BC.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piotr  Raubo</span>, <span class="hlFld-ContribAuthor ">Richard  Evans</span>, <span class="hlFld-ContribAuthor ">Paul  Willis</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and evaluation of 3-amino-2(1H)-pyrazinones as a novel series of selective p38α MAP kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (18)
                                     , 127412. <a href="https://doi.org/10.1016/j.bmcl.2020.127412" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127412%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Band%252Bevaluation%252Bof%252B3-amino-2%2525281H%252529-pyrazinones%252Bas%252Ba%252Bnovel%252Bseries%252Bof%252Bselective%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%252Binhibitors%26aulast%3DRaubo%26aufirst%3DPiotr%26date%3D2020%26volume%3D30%26issue%3D18%26spage%3D127412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig  Donoghue</span>, <span class="hlFld-ContribAuthor ">Monica  Cubillos-Rojas</span>, <span class="hlFld-ContribAuthor ">Nuria  Gutierrez-Prat</span>, <span class="hlFld-ContribAuthor ">Carolina  Sanchez-Zarzalejo</span>, <span class="hlFld-ContribAuthor ">Xavier  Verdaguer</span>, <span class="hlFld-ContribAuthor ">Antoni  Riera</span>, <span class="hlFld-ContribAuthor ">Angel R.  Nebreda</span>. </span><span class="cited-content_cbyCitation_article-title">Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>201 </em>, 112451. <a href="https://doi.org/10.1016/j.ejmech.2020.112451" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112451%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimal%252Blinker%252Blength%252Bfor%252Bsmall%252Bmolecule%252BPROTACs%252Bthat%252Bselectively%252Btarget%252Bp38%2525CE%2525B1%252Band%252Bp38%2525CE%2525B2%252Bfor%252Bdegradation%26aulast%3DDonoghue%26aufirst%3DCraig%26date%3D2020%26volume%3D201%26spage%3D112451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pravin  Patel</span>, <span class="hlFld-ContribAuthor ">Ulhas P.  Naik</span>. </span><span class="cited-content_cbyCitation_article-title">Platelet MAPKs—a 20+ year history: What do we really know?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Thrombosis and Haemostasis</span><span> <strong>2020,</strong> <em>18 </em>
                                    (9)
                                     , 2087-2102. <a href="https://doi.org/10.1111/jth.14967" title="DOI URL">https://doi.org/10.1111/jth.14967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jth.14967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjth.14967%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thrombosis%2520and%2520Haemostasis%26atitle%3DPlatelet%252BMAPKs%2525E2%252580%252594a%252B20%25252B%2525C2%2525A0year%252Bhistory%25253A%252BWhat%252Bdo%252Bwe%252Breally%252Bknow%25253F%26aulast%3DPatel%26aufirst%3DPravin%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D9%26spage%3D2087%26epage%3D2102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer  Bauquier</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Tudor</span>, <span class="hlFld-ContribAuthor ">Simon  Bailey</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of the p38
              MAPK
              inhibitor doramapimod on the systemic inflammatory response to intravenous lipopolysaccharide in horses. </span><span class="cited-content_cbyCitation_journal-name">Journal of Veterinary Internal Medicine</span><span> <strong>2020,</strong> <em>34 </em>
                                    (5)
                                     , 2109-2116. <a href="https://doi.org/10.1111/jvim.15847" title="DOI URL">https://doi.org/10.1111/jvim.15847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jvim.15847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjvim.15847%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Veterinary%2520Internal%2520Medicine%26atitle%3DEffect%252Bof%252Bthe%252Bp38%252BMAPK%252Binhibitor%252Bdoramapimod%252Bon%252Bthe%252Bsystemic%252Binflammatory%252Bresponse%252Bto%252Bintravenous%252Blipopolysaccharide%252Bin%252Bhorses%26aulast%3DBauquier%26aufirst%3DJennifer%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D5%26spage%3D2109%26epage%3D2116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Georg  Sandner</span>, <span class="hlFld-ContribAuthor ">Mara  Heckmann</span>, <span class="hlFld-ContribAuthor ">Julian  Weghuber</span>. </span><span class="cited-content_cbyCitation_article-title">Immunomodulatory Activities of Selected Essential Oils. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (8)
                                     , 1139. <a href="https://doi.org/10.3390/biom10081139" title="DOI URL">https://doi.org/10.3390/biom10081139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10081139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10081139%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DImmunomodulatory%252BActivities%252Bof%252BSelected%252BEssential%252BOils%26aulast%3DSandner%26aufirst%3DGeorg%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D8%26spage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ursula A.  Germann</span>, <span class="hlFld-ContribAuthor ">John J.  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">P38α MAPK Signaling—A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (15)
                                     , 5485. <a href="https://doi.org/10.3390/ijms21155485" title="DOI URL">https://doi.org/10.3390/ijms21155485</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21155485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21155485%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DP38%2525CE%2525B1%252BMAPK%252BSignaling%2525E2%252580%252594A%252BRobust%252BTherapeutic%252BTarget%252Bfor%252BRab5-Mediated%252BNeurodegenerative%252BDisease%26aulast%3DGermann%26aufirst%3DUrsula%2BA.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D15%26spage%3D5485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corrado  Pelaia</span>, <span class="hlFld-ContribAuthor ">Alessandro  Vatrella</span>, <span class="hlFld-ContribAuthor ">Angela  Sciacqua</span>, <span class="hlFld-ContribAuthor ">Rosa  Terracciano</span>, <span class="hlFld-ContribAuthor ">Girolamo  Pelaia</span>. </span><span class="cited-content_cbyCitation_article-title">Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Respiratory Medicine</span><span> <strong>2020,</strong> <em>14 </em>
                                    (5)
                                     , 485-491. <a href="https://doi.org/10.1080/17476348.2020.1732821" title="DOI URL">https://doi.org/10.1080/17476348.2020.1732821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17476348.2020.1732821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17476348.2020.1732821%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Respiratory%2520Medicine%26atitle%3DRole%252Bof%252Bp38-mitogen-activated%252Bprotein%252Bkinase%252Bin%252BCOPD%25253A%252Bpathobiological%252Bimplications%252Band%252Btherapeutic%252Bperspectives%26aulast%3DPelaia%26aufirst%3DCorrado%26date%3D2020%26date%3D2020%26volume%3D14%26issue%3D5%26spage%3D485%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer R.  Bauquier</span>, <span class="hlFld-ContribAuthor ">Brett S.  Tennent-Brown</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Tudor</span>, <span class="hlFld-ContribAuthor ">Simon R.  Bailey</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-inflammatory effects of a p38 MAP kinase inhibitor, doramapimod, against bacterial cell wall toxins in equine whole blood. </span><span class="cited-content_cbyCitation_journal-name">Veterinary Immunology and Immunopathology</span><span> <strong>2020,</strong> <em>220 </em>, 109994. <a href="https://doi.org/10.1016/j.vetimm.2019.109994" title="DOI URL">https://doi.org/10.1016/j.vetimm.2019.109994</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.vetimm.2019.109994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.vetimm.2019.109994%26sid%3Dliteratum%253Aachs%26jtitle%3DVeterinary%2520Immunology%2520and%2520Immunopathology%26atitle%3DAnti-inflammatory%252Beffects%252Bof%252Ba%252Bp38%252BMAP%252Bkinase%252Binhibitor%25252C%252Bdoramapimod%25252C%252Bagainst%252Bbacterial%252Bcell%252Bwall%252Btoxins%252Bin%252Bequine%252Bwhole%252Bblood%26aulast%3DBauquier%26aufirst%3DJennifer%2BR.%26date%3D2020%26volume%3D220%26spage%3D109994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reginald  Brys</span>, <span class="hlFld-ContribAuthor ">Karl  Gibson</span>, <span class="hlFld-ContribAuthor ">Tanja  Poljak</span>, <span class="hlFld-ContribAuthor ">Steven  Van Der Plas</span>, <span class="hlFld-ContribAuthor ">David  Amantini</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of ASK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 101-179. <a href="https://doi.org/10.1016/bs.pmch.2020.02.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2020.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2020.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2020.02.001%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252BASK1%252Binhibitors%26aulast%3DBrys%26aufirst%3DReginald%26date%3D2020%26spage%3D101%26epage%3D179%26pub%3DElsevier%26date%3D2020%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Kaieda</span>, <span class="hlFld-ContribAuthor ">Masashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Hiromi  Fukuda</span>, <span class="hlFld-ContribAuthor ">Rei  Okamoto</span>, <span class="hlFld-ContribAuthor ">Shinji  Morimoto</span>, <span class="hlFld-ContribAuthor ">Masayuki  Gotoh</span>, <span class="hlFld-ContribAuthor ">Takahiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Yuri  Hori</span>, <span class="hlFld-ContribAuthor ">Satoko  Unno</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Toshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Sachiko  Itono</span>, <span class="hlFld-ContribAuthor ">Terufumi  Takagi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sugimoto</span>, <span class="hlFld-ContribAuthor ">Kengo  Okada</span>, <span class="hlFld-ContribAuthor ">Weston  Lane</span>, <span class="hlFld-ContribAuthor ">Bi‐Ching  Sang</span>, <span class="hlFld-ContribAuthor ">Kumar  Saikatendu</span>, <span class="hlFld-ContribAuthor ">Shinichiro  Matsunaga</span>, <span class="hlFld-ContribAuthor ">Seiji  Miwatashi</span>. </span><span class="cited-content_cbyCitation_article-title">Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐
              b
              ]Pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 2. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (24)
                                     , 2093-2101. <a href="https://doi.org/10.1002/cmdc.201900373" title="DOI URL">https://doi.org/10.1002/cmdc.201900373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900373%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure%2525E2%252580%252590Based%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BImidazo%25255B4%25252C5%2525E2%252580%252590%252Bb%252B%25255DPyridin%2525E2%252580%2525902%2525E2%252580%252590one%2525E2%252580%252590Based%252Bp38%252BMAP%252BKinase%252BInhibitors%25253A%252BPart%2525E2%252580%2525852%26aulast%3DKaieda%26aufirst%3DAkira%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D24%26spage%3D2093%26epage%3D2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philipp  Guenthoer</span>, <span class="hlFld-ContribAuthor ">Kerstin  Fuchs</span>, <span class="hlFld-ContribAuthor ">Gerald  Reischl</span>, <span class="hlFld-ContribAuthor ">Leticia  Quintanilla-Martinez</span>, <span class="hlFld-ContribAuthor ">Irene  Gonzalez-Menendez</span>, <span class="hlFld-ContribAuthor ">Stefan  Laufer</span>, <span class="hlFld-ContribAuthor ">Bernd J.  Pichler</span>, <span class="hlFld-ContribAuthor ">Manfred  Kneilling</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis. </span><span class="cited-content_cbyCitation_journal-name">Inflammopharmacology</span><span> <strong>2019,</strong> <em>27 </em>
                                    (6)
                                     , 1217-1227. <a href="https://doi.org/10.1007/s10787-019-00593-6" title="DOI URL">https://doi.org/10.1007/s10787-019-00593-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10787-019-00593-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10787-019-00593-6%26sid%3Dliteratum%253Aachs%26jtitle%3DInflammopharmacology%26atitle%3DEvaluation%252Bof%252Bthe%252Btherapeutic%252Bpotential%252Bof%252Bthe%252Bselective%252Bp38%252BMAPK%252Binhibitor%252BSkepinone-L%252Band%252Bthe%252Bdual%252Bp38%25252FJNK%252B3%252Binhibitor%252BLN%252B950%252Bin%252Bexperimental%252BK%25252FBxN%252Bserum%252Btransfer%252Barthritis%26aulast%3DGuenthoer%26aufirst%3DPhilipp%26date%3D2019%26date%3D2019%26volume%3D27%26issue%3D6%26spage%3D1217%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Hanan S.  Anbar</span>, <span class="hlFld-ContribAuthor ">Hamadeh  Tarazi</span>, <span class="hlFld-ContribAuthor ">Chang-Hyun  Oh</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a potent p38α/MAPK14 kinase inhibitor: Synthesis, in vitro/in vivo biological evaluation, and docking studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111684. <a href="https://doi.org/10.1016/j.ejmech.2019.111684" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111684%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bpotent%252Bp38%2525CE%2525B1%25252FMAPK14%252Bkinase%252Binhibitor%25253A%252BSynthesis%25252C%252Bin%2525C2%2525A0vitro%25252Fin%2525C2%2525A0vivo%252Bbiological%252Bevaluation%25252C%252Band%252Bdocking%252Bstudies%26aulast%3DEl-Gamal%26aufirst%3DMohammed%2BI.%26date%3D2019%26volume%3D183%26spage%3D111684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cayetano  von Kobbe</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting senescent cells: approaches, opportunities, challenges. </span><span class="cited-content_cbyCitation_journal-name">Aging</span><span> <strong>2019,</strong> <em>11 </em>
                                    (24)
                                     , 12844-12861. <a href="https://doi.org/10.18632/aging.102557" title="DOI URL">https://doi.org/10.18632/aging.102557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/aging.102557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Faging.102557%26sid%3Dliteratum%253Aachs%26jtitle%3DAging%26atitle%3DTargeting%252Bsenescent%252Bcells%25253A%252Bapproaches%25252C%252Bopportunities%25252C%252Bchallenges%26aulast%3Dvon%2BKobbe%26aufirst%3DCayetano%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D24%26spage%3D12844%26epage%3D12861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Astolfi</span>, <span class="hlFld-ContribAuthor ">Mark  Kudolo</span>, <span class="hlFld-ContribAuthor ">Jose  Brea</span>, <span class="hlFld-ContribAuthor ">Giorgia  Manni</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Manfroni</span>, <span class="hlFld-ContribAuthor ">Deborah  Palazzotti</span>, <span class="hlFld-ContribAuthor ">Stefano  Sabatini</span>, <span class="hlFld-ContribAuthor ">Federica  Cecchetti</span>, <span class="hlFld-ContribAuthor ">Tommaso  Felicetti</span>, <span class="hlFld-ContribAuthor ">Rolando  Cannalire</span>, <span class="hlFld-ContribAuthor ">Serena  Massari</span>, <span class="hlFld-ContribAuthor ">Oriana  Tabarrini</span>, <span class="hlFld-ContribAuthor ">Maria Isabel  Loza</span>, <span class="hlFld-ContribAuthor ">Francesca  Fallarino</span>, <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111624. <a href="https://doi.org/10.1016/j.ejmech.2019.111624" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111624%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Bp38%2525CE%2525B1%252BMAPK%252Binhibitors%252Bthrough%252Ba%252Bfunnel%252Blike%252Bworkflow%252Bcombining%252Bin%252Bsilico%252Bscreening%252Band%252Bin%2525C2%2525A0vitro%252Bvalidation%26aulast%3DAstolfi%26aufirst%3DAndrea%26date%3D2019%26volume%3D182%26spage%3D111624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Properties of FDA-approved small molecule protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>144 </em>, 19-50. <a href="https://doi.org/10.1016/j.phrs.2019.03.006" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DProperties%252Bof%252BFDA-approved%252Bsmall%252Bmolecule%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2019%26volume%3D144%26spage%3D19%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Kaieda</span>, <span class="hlFld-ContribAuthor ">Masashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Hiromi  Fukuda</span>, <span class="hlFld-ContribAuthor ">Rei  Okamoto</span>, <span class="hlFld-ContribAuthor ">Shinji  Morimoto</span>, <span class="hlFld-ContribAuthor ">Masayuki  Gotoh</span>, <span class="hlFld-ContribAuthor ">Takahiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Yuri  Hori</span>, <span class="hlFld-ContribAuthor ">Satoko  Unno</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Toshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Sachiko  Itono</span>, <span class="hlFld-ContribAuthor ">Terufumi  Takagi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sugimoto</span>, <span class="hlFld-ContribAuthor ">Kengo  Okada</span>, <span class="hlFld-ContribAuthor ">Gyorgy  Snell</span>, <span class="hlFld-ContribAuthor ">Ryan  Bertsch</span>, <span class="hlFld-ContribAuthor ">Jasmine  Nguyen</span>, <span class="hlFld-ContribAuthor ">Bi‐Ching  Sang</span>, <span class="hlFld-ContribAuthor ">Seiji  Miwatashi</span>. </span><span class="cited-content_cbyCitation_article-title">Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐
              b
              ]pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 1. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 1022-1030. <a href="https://doi.org/10.1002/cmdc.201900129" title="DOI URL">https://doi.org/10.1002/cmdc.201900129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900129%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure%2525E2%252580%252590Based%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BImidazo%25255B4%25252C5%2525E2%252580%252590%252Bb%252B%25255Dpyridin%2525E2%252580%2525902%2525E2%252580%252590one%2525E2%252580%252590Based%252Bp38%252BMAP%252BKinase%252BInhibitors%25253A%252BPart%252B1%26aulast%3DKaieda%26aufirst%3DAkira%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D10%26spage%3D1022%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting ERK1/2 protein-serine/threonine kinases in human cancers. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>142 </em>, 151-168. <a href="https://doi.org/10.1016/j.phrs.2019.01.039" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.01.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.01.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.01.039%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252BERK1%25252F2%252Bprotein-serine%25252Fthreonine%252Bkinases%252Bin%252Bhuman%252Bcancers%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2019%26volume%3D142%26spage%3D151%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rakesh Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Abul Kalam  Najmi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2019,</strong> <em>20 </em>
                                    (4)
                                     , 367-379. <a href="https://doi.org/10.2174/1389450119666180816121323" title="DOI URL">https://doi.org/10.2174/1389450119666180816121323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389450119666180816121323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389450119666180816121323%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DNovel%252BTherapeutic%252BPotential%252Bof%252BMitogen-Activated%252BProtein%252BKinase%252BActivated%252BProtein%252BKinase%252B2%252B%252528MK2%252529%252Bin%252BChronic%252BAirway%252BInflammatory%252BDisorders%26aulast%3DSingh%26aufirst%3DRakesh%2BKumar%26date%3D2019%26volume%3D20%26issue%3D4%26spage%3D367%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luis Ángel  Maciel-Barón</span>, <span class="hlFld-ContribAuthor ">Daniel  Moreno-Blas</span>, <span class="hlFld-ContribAuthor ">Sandra Lizbeth  Morales-Rosales</span>, <span class="hlFld-ContribAuthor ">Viridiana Yazmín  González-Puertos</span>, <span class="hlFld-ContribAuthor ">Norma Edith  López-Díazguerrero</span>, <span class="hlFld-ContribAuthor ">Claudio  Torres</span>, <span class="hlFld-ContribAuthor ">Susana  Castro-Obregón</span>, <span class="hlFld-ContribAuthor ">Mina  Königsberg</span>. </span><span class="cited-content_cbyCitation_article-title">Cellular Senescence, Neurological Function, and Redox State. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants & Redox Signaling</span><span> <strong>2018,</strong> <em>28 </em>
                                    (18)
                                     , 1704-1723. <a href="https://doi.org/10.1089/ars.2017.7112" title="DOI URL">https://doi.org/10.1089/ars.2017.7112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/ars.2017.7112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fars.2017.7112%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%2520%2526%2520Redox%2520Signaling%26atitle%3DCellular%252BSenescence%25252C%252BNeurological%252BFunction%25252C%252Band%252BRedox%252BState%26aulast%3DMaciel-Bar%25C3%25B3n%26aufirst%3DLuis%2B%25C3%2581ngel%26date%3D2018%26volume%3D28%26issue%3D18%26spage%3D1704%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Begoña  Cánovas</span>, <span class="hlFld-ContribAuthor ">Ana  Igea</span>, <span class="hlFld-ContribAuthor ">Alessandro A.  Sartori</span>, <span class="hlFld-ContribAuthor ">Roger R.  Gomis</span>, <span class="hlFld-ContribAuthor ">Tanya T.  Paull</span>, <span class="hlFld-ContribAuthor ">Michitaka  Isoda</span>, <span class="hlFld-ContribAuthor ">Héctor  Pérez-Montoyo</span>, <span class="hlFld-ContribAuthor ">Violeta  Serra</span>, <span class="hlFld-ContribAuthor ">Eva  González-Suárez</span>, <span class="hlFld-ContribAuthor ">Travis H.  Stracker</span>, <span class="hlFld-ContribAuthor ">Angel R.  Nebreda</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell</span><span> <strong>2018,</strong> <em>33 </em>
                                    (6)
                                     , 1094-1110.e8. <a href="https://doi.org/10.1016/j.ccell.2018.04.010" title="DOI URL">https://doi.org/10.1016/j.ccell.2018.04.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccell.2018.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccell.2018.04.010%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%26atitle%3DTargeting%252Bp38%2525CE%2525B1%252BIncreases%252BDNA%252BDamage%25252C%252BChromosome%252BInstability%25252C%252Band%252Bthe%252BAnti-tumoral%252BResponse%252Bto%252BTaxanes%252Bin%252BBreast%252BCancer%252BCells%26aulast%3DC%25C3%25A1novas%26aufirst%3DBego%25C3%25B1a%26date%3D2018%26volume%3D33%26issue%3D6%26spage%3D1094%26epage%3D1110.e8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gyrid  Nygaard</span>, <span class="hlFld-ContribAuthor ">Julie A.  Di Paolo</span>, <span class="hlFld-ContribAuthor ">Deepa  Hammaker</span>, <span class="hlFld-ContribAuthor ">David L.  Boyle</span>, <span class="hlFld-ContribAuthor ">Grant  Budas</span>, <span class="hlFld-ContribAuthor ">Gregory T.  Notte</span>, <span class="hlFld-ContribAuthor ">Igor  Mikaelian</span>, <span class="hlFld-ContribAuthor ">Vivian  Barry</span>, <span class="hlFld-ContribAuthor ">Gary S.  Firestein</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation and function of apoptosis signal-regulating kinase 1 in rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>151 </em>, 282-290. <a href="https://doi.org/10.1016/j.bcp.2018.01.041" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.01.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.01.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DRegulation%252Band%252Bfunction%252Bof%252Bapoptosis%252Bsignal-regulating%252Bkinase%252B1%252Bin%252Brheumatoid%252Barthritis%26aulast%3DNygaard%26aufirst%3DGyrid%26date%3D2018%26volume%3D151%26spage%3D282%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galia  Maik-Rachline</span>, <span class="hlFld-ContribAuthor ">Elder  Zehorai</span>, <span class="hlFld-ContribAuthor ">Tamar  Hanoch</span>, <span class="hlFld-ContribAuthor ">John  Blenis</span>, <span class="hlFld-ContribAuthor ">Rony  Seger</span>. </span><span class="cited-content_cbyCitation_article-title">The nuclear translocation of the kinases p38 and JNK promotes inflammation-induced cancer. </span><span class="cited-content_cbyCitation_journal-name">Science Signaling</span><span> <strong>2018,</strong> <em>11 </em>
                                    (525)
                                     , eaao3428. <a href="https://doi.org/10.1126/scisignal.aao3428" title="DOI URL">https://doi.org/10.1126/scisignal.aao3428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scisignal.aao3428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscisignal.aao3428%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Signaling%26atitle%3DThe%252Bnuclear%252Btranslocation%252Bof%252Bthe%252Bkinases%252Bp38%252Band%252BJNK%252Bpromotes%252Binflammation-induced%252Bcancer%26aulast%3DMaik-Rachline%26aufirst%3DGalia%26date%3D2018%26date%3D2018%26volume%3D11%26issue%3D525%26spage%3Deaao3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Jones</span>, <span class="hlFld-ContribAuthor ">Anne P.  Jenney</span>, <span class="hlFld-ContribAuthor ">Brian A.  Joughin</span>, <span class="hlFld-ContribAuthor ">Peter K.  Sorger</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Lauffenburger</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammatory but not mitogenic contexts prime synovial fibroblasts for compensatory signaling responses to p38 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Science Signaling</span><span> <strong>2018,</strong> <em>11 </em>
                                    (520)
                                     , eaal1601. <a href="https://doi.org/10.1126/scisignal.aal1601" title="DOI URL">https://doi.org/10.1126/scisignal.aal1601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scisignal.aal1601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscisignal.aal1601%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Signaling%26atitle%3DInflammatory%252Bbut%252Bnot%252Bmitogenic%252Bcontexts%252Bprime%252Bsynovial%252Bfibroblasts%252Bfor%252Bcompensatory%252Bsignaling%252Bresponses%252Bto%252Bp38%252Binhibition%26aulast%3DJones%26aufirst%3DDouglas%2BS.%26date%3D2018%26date%3D2018%26volume%3D11%26issue%3D520%26spage%3Deaal1601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Kaieda</span>, <span class="hlFld-ContribAuthor ">Masashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Takafumi  Takai</span>, <span class="hlFld-ContribAuthor ">Masayuki  Goto</span>, <span class="hlFld-ContribAuthor ">Takahiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Yuri  Hori</span>, <span class="hlFld-ContribAuthor ">Satoko  Unno</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Toshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Sachiko  Itono</span>, <span class="hlFld-ContribAuthor ">Terufumi  Takagi</span>, <span class="hlFld-ContribAuthor ">Teruki  Hamada</span>, <span class="hlFld-ContribAuthor ">Mikio  Shirasaki</span>, <span class="hlFld-ContribAuthor ">Kengo  Okada</span>, <span class="hlFld-ContribAuthor ">Gyorgy  Snell</span>, <span class="hlFld-ContribAuthor ">Ken  Bragstad</span>, <span class="hlFld-ContribAuthor ">Bi-Ching  Sang</span>, <span class="hlFld-ContribAuthor ">Osamu  Uchikawa</span>, <span class="hlFld-ContribAuthor ">Seiji  Miwatashi</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (3)
                                     , 647-660. <a href="https://doi.org/10.1016/j.bmc.2017.12.031" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.12.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.12.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bimidazo%25255B1%25252C2-b%25255Dpyridazine-based%252Bp38%252BMAP%252Bkinase%252Binhibitors%26aulast%3DKaieda%26aufirst%3DAkira%26date%3D2018%26volume%3D26%26issue%3D3%26spage%3D647%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Astolfi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Manfroni</span>, <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>, <span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>. </span><span class="cited-content_cbyCitation_article-title">A Comprehensive Structural Overview of p38α Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (1)
                                     , 7-14. <a href="https://doi.org/10.1002/cmdc.201700636" title="DOI URL">https://doi.org/10.1002/cmdc.201700636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700636%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BComprehensive%252BStructural%252BOverview%252Bof%252Bp38%2525CE%2525B1%252BMitogen-Activated%252BProtein%252BKinase%252Bin%252BComplex%252Bwith%252BATP-Site%252Band%252BNon-ATP-Site%252BBinders%26aulast%3DAstolfi%26aufirst%3DAndrea%26date%3D2018%26date%3D2017%26volume%3D13%26issue%3D1%26spage%3D7%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter M.  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2017,</strong> <em>37 </em>
                                    (2)
                                     , 314-367. <a href="https://doi.org/10.1002/med.21409" title="DOI URL">https://doi.org/10.1002/med.21409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21409%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DApproved%252Band%252BExperimental%252BSmall-Molecule%252BOncology%252BKinase%252BInhibitor%252BDrugs%25253A%252BA%252BMid-2016%252BOverview%26aulast%3DFischer%26aufirst%3DPeter%2BM.%26date%3D2017%26date%3D2016%26volume%3D37%26issue%3D2%26spage%3D314%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Xing</span>, <span class="hlFld-ContribAuthor ">J.  Mathias</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Case History: Structure-Based Drug Design of Oral and Inhaled p38 MAP Kinase Inhibitors as Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-430. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12458-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12458-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12458-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12458-8%26sid%3Dliteratum%253Aachs%26atitle%3DMedicinal%252BChemistry%252BCase%252BHistory%25253A%252BStructure-Based%252BDrug%252BDesign%252Bof%252BOral%252Band%252BInhaled%252Bp38%252BMAP%252BKinase%252BInhibitors%252Bas%252BClinical%252BCandidates%26aulast%3DXing%26aufirst%3DL.%26date%3D2017%26spage%3D408%26epage%3D430%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Tsui</span>, <span class="hlFld-ContribAuthor ">Q.  Zeng</span>, <span class="hlFld-ContribAuthor ">K.  Chen</span>, <span class="hlFld-ContribAuthor ">X.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Kinases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-446. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13815-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13815-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13815-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13815-6%26sid%3Dliteratum%253Aachs%26atitle%3DInhibiting%252BKinases%252Bin%252Bthe%252BCNS%26aulast%3DTsui%26aufirst%3DH.%26date%3D2017%26spage%3D408%26epage%3D446%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Könemann</span>, <span class="hlFld-ContribAuthor ">M.  Dörr</span>, <span class="hlFld-ContribAuthor ">S.B.  Felix</span>. </span><span class="cited-content_cbyCitation_article-title">Cardiac Immunomodulation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 681-714. <a href="https://doi.org/10.1016/B978-0-12-803267-1.00028-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-803267-1.00028-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803267-1.00028-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803267-1.00028-4%26sid%3Dliteratum%253Aachs%26atitle%3DCardiac%252BImmunomodulation%26aulast%3DK%25C3%25B6nemann%26aufirst%3DS.%26date%3D2017%26spage%3D681%26epage%3D714%26pub%3DElsevier%26atitle%3DThe%252BHeart%252Bin%252BRheumatic%25252C%252BAutoimmune%252Band%252BInflammatory%252BDiseases%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Alam</span>, <span class="hlFld-ContribAuthor ">Wiep  Scheper</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting neuronal MAPK14/p38α activity to modulate autophagy in the Alzheimer disease brain. </span><span class="cited-content_cbyCitation_journal-name">Autophagy</span><span> <strong>2016,</strong> <em>12 </em>
                                    (12)
                                     , 2516-2520. <a href="https://doi.org/10.1080/15548627.2016.1238555" title="DOI URL">https://doi.org/10.1080/15548627.2016.1238555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15548627.2016.1238555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15548627.2016.1238555%26sid%3Dliteratum%253Aachs%26jtitle%3DAutophagy%26atitle%3DTargeting%252Bneuronal%252BMAPK14%25252Fp38%2525CE%2525B1%252Bactivity%252Bto%252Bmodulate%252Bautophagy%252Bin%252Bthe%252BAlzheimer%252Bdisease%252Bbrain%26aulast%3DAlam%26aufirst%3DJohn%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D12%26spage%3D2516%26epage%3D2520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sinead A.  O’Sullivan</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Gasparini</span>, <span class="hlFld-ContribAuthor ">Anis K.  Mir</span>, <span class="hlFld-ContribAuthor ">Kumlesh K.  Dev</span>. </span><span class="cited-content_cbyCitation_article-title">Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroinflammation</span><span> <strong>2016,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12974-016-0659-7" title="DOI URL">https://doi.org/10.1186/s12974-016-0659-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12974-016-0659-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12974-016-0659-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroinflammation%26atitle%3DFractalkine%252Bshedding%252Bis%252Bmediated%252Bby%252Bp38%252Band%252Bthe%252BADAM10%252Bprotease%252Bunder%252Bpro-inflammatory%252Bconditions%252Bin%252Bhuman%252Bastrocytes%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DSinead%2BA.%26date%3D2016%26date%3D2016%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nasser S.M.  Ismail</span>, <span class="hlFld-ContribAuthor ">Eslam M.H.  Ali</span>, <span class="hlFld-ContribAuthor ">Diaa A.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Rabah A.T.  Serya</span>, <span class="hlFld-ContribAuthor ">Dalal A.  Abou El Ella</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Journal of Pharmaceutical Sciences</span><span> <strong>2016,</strong> <em>2 </em>
                                    (1)
                                     , 20-30. <a href="https://doi.org/10.1016/j.fjps.2016.02.002" title="DOI URL">https://doi.org/10.1016/j.fjps.2016.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fjps.2016.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fjps.2016.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DPyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252Bbased%252Bscaffold%252Bderivatives%252Btargeting%252Bkinases%252Bas%252Banticancer%252Bagents%26aulast%3DIsmail%26aufirst%3DNasser%2BS.M.%26date%3D2016%26volume%3D2%26issue%3D1%26spage%3D20%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dianxi  Zhu</span>, <span class="hlFld-ContribAuthor ">Qifeng  Xing</span>, <span class="hlFld-ContribAuthor ">Ruiyuan  Cao</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Wu  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and p38 Inhibitory Activity of Some Novel Substituted N,N′-Diarylurea Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (5)
                                     , 677. <a href="https://doi.org/10.3390/molecules21050677" title="DOI URL">https://doi.org/10.3390/molecules21050677</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21050677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21050677%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252Bp38%252BInhibitory%252BActivity%252Bof%252BSome%252BNovel%252BSubstituted%252BN%25252CN%2525E2%252580%2525B2-Diarylurea%252BDerivatives%26aulast%3DZhu%26aufirst%3DDianxi%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D5%26spage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dauren  Alimbetov</span>, <span class="hlFld-ContribAuthor ">Terence  Davis</span>, <span class="hlFld-ContribAuthor ">Amy J. C.  Brook</span>, <span class="hlFld-ContribAuthor ">Lynne S.  Cox</span>, <span class="hlFld-ContribAuthor ">Richard G. A.  Faragher</span>, <span class="hlFld-ContribAuthor ">Talgat  Nurgozhin</span>, <span class="hlFld-ContribAuthor ">Zhaxybay  Zhumadilov</span>, <span class="hlFld-ContribAuthor ">David  Kipling</span>. </span><span class="cited-content_cbyCitation_article-title">Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2. </span><span class="cited-content_cbyCitation_journal-name">Biogerontology</span><span> <strong>2016,</strong> <em>17 </em>
                                    (2)
                                     , 305-315. <a href="https://doi.org/10.1007/s10522-015-9610-z" title="DOI URL">https://doi.org/10.1007/s10522-015-9610-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10522-015-9610-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10522-015-9610-z%26sid%3Dliteratum%253Aachs%26jtitle%3DBiogerontology%26atitle%3DSuppression%252Bof%252Bthe%252Bsenescence-associated%252Bsecretory%252Bphenotype%252B%252528SASP%252529%252Bin%252Bhuman%252Bfibroblasts%252Busing%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252Bp38%252BMAP%252Bkinase%252Band%252BMK2%26aulast%3DAlimbetov%26aufirst%3DDauren%26date%3D2016%26date%3D2015%26volume%3D17%26issue%3D2%26spage%3D305%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Kyriakis</span>, <span class="hlFld-ContribAuthor ">Joseph  Avruch</span>. </span><span class="cited-content_cbyCitation_article-title">MAP Kinase Pathways. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 892-908. <a href="https://doi.org/10.1007/978-3-7643-8550-7_37" title="DOI URL">https://doi.org/10.1007/978-3-7643-8550-7_37</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-7643-8550-7_37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-7643-8550-7_37%26sid%3Dliteratum%253Aachs%26atitle%3DMAP%252BKinase%252BPathways%26aulast%3DKyriakis%26aufirst%3DJohn%2BM.%26date%3D2016%26date%3D2017%26spage%3D892%26epage%3D908%26pub%3DSpringer%2520Basel%26atitle%3DCompendium%252Bof%252BInflammatory%252BDiseases%26aulast%3DParnham%26aufirst%3DMichael%2BJ.%26date%3D2016%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew C.T.  Fyfe</span>. </span><span class="cited-content_cbyCitation_article-title">Non-systemic Intestine-Targeted Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-44. <a href="https://doi.org/10.1016/bs.pmch.2015.10.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2015.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2015.10.001%26sid%3Dliteratum%253Aachs%26atitle%3DNon-systemic%252BIntestine-Targeted%252BDrugs%26aulast%3DFyfe%26aufirst%3DMatthew%2BC.T.%26date%3D2016%26spage%3D1%26epage%3D44%26pub%3DElsevier%26date%3D2016%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander V.  Aksenov</span>, <span class="hlFld-ContribAuthor ">Nicolai A.  Aksenov</span>, <span class="hlFld-ContribAuthor ">Zarema V.  Dzhandigova</span>, <span class="hlFld-ContribAuthor ">Dmitrii A.  Aksenov</span>, <span class="hlFld-ContribAuthor ">Leonid G.  Voskressensky</span>, <span class="hlFld-ContribAuthor ">Valentine G.  Nenajdenko</span>, <span class="hlFld-ContribAuthor ">Michael  Rubin</span>. </span><span class="cited-content_cbyCitation_article-title">Direct reductive coupling of indoles to nitrostyrenes en route to (indol-3-yl)acetamides. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (96)
                                     , 93881-93886. <a href="https://doi.org/10.1039/C6RA21399E" title="DOI URL">https://doi.org/10.1039/C6RA21399E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA21399E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA21399E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDirect%252Breductive%252Bcoupling%252Bof%252Bindoles%252Bto%252Bnitrostyrenes%252Ben%252Broute%252Bto%252B%252528indol-3-yl%252529acetamides%26aulast%3DAksenov%26aufirst%3DAlexander%2BV.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D96%26spage%3D93881%26epage%3D93886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S  De Buck</span>, <span class="hlFld-ContribAuthor ">W  Hueber</span>, <span class="hlFld-ContribAuthor ">A  Vitaliti</span>, <span class="hlFld-ContribAuthor ">F  Straube</span>, <span class="hlFld-ContribAuthor ">C  Emotte</span>, <span class="hlFld-ContribAuthor ">G  Bruin</span>, <span class="hlFld-ContribAuthor ">R  Woessner</span>. </span><span class="cited-content_cbyCitation_article-title">Population PK‐PD Model for Tolerance Evaluation to the p38 MAP Kinase Inhibitor BCT197. </span><span class="cited-content_cbyCitation_journal-name">CPT: Pharmacometrics & Systems Pharmacology</span><span> <strong>2015,</strong> <em>4 </em>
                                    (12)
                                     , 691-700. <a href="https://doi.org/10.1002/psp4.12037" title="DOI URL">https://doi.org/10.1002/psp4.12037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/psp4.12037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpsp4.12037%26sid%3Dliteratum%253Aachs%26jtitle%3DCPT%253A%2520Pharmacometrics%2520%2526%2520Systems%2520Pharmacology%26atitle%3DPopulation%252BPK%2525E2%252580%252590PD%252BModel%252Bfor%252BTolerance%252BEvaluation%252Bto%252Bthe%252Bp38%252BMAP%252BKinase%252BInhibitor%252BBCT197%26aulast%3DDe%2BBuck%26aufirst%3DS%26date%3D2015%26date%3D2015%26volume%3D4%26issue%3D12%26spage%3D691%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhigang  Li</span>, <span class="hlFld-ContribAuthor ">Adam  Peres</span>, <span class="hlFld-ContribAuthor ">Andreea  Damian</span>, <span class="hlFld-ContribAuthor ">Joaquín  Madrenas</span>. </span><span class="cited-content_cbyCitation_article-title">Immunomodulation and Disease Tolerance to Staphylococcus aureus. </span><span class="cited-content_cbyCitation_journal-name">Pathogens</span><span> <strong>2015,</strong> <em>4 </em>
                                    (4)
                                     , 793-815. <a href="https://doi.org/10.3390/pathogens4040793" title="DOI URL">https://doi.org/10.3390/pathogens4040793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pathogens4040793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpathogens4040793%26sid%3Dliteratum%253Aachs%26jtitle%3DPathogens%26atitle%3DImmunomodulation%252Band%252BDisease%252BTolerance%252Bto%252BStaphylococcus%252Baureus%26aulast%3DLi%26aufirst%3DZhigang%26date%3D2015%26date%3D2015%26volume%3D4%26issue%3D4%26spage%3D793%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhito  Naka</span>, <span class="hlFld-ContribAuthor ">Yoshie  Jomen</span>, <span class="hlFld-ContribAuthor ">Kaori  Ishihara</span>, <span class="hlFld-ContribAuthor ">Junil  Kim</span>, <span class="hlFld-ContribAuthor ">Takahiro  Ishimoto</span>, <span class="hlFld-ContribAuthor ">Eun-Jin  Bae</span>, <span class="hlFld-ContribAuthor ">Robert P.  Mohney</span>, <span class="hlFld-ContribAuthor ">Steven M.  Stirdivant</span>, <span class="hlFld-ContribAuthor ">Hiroko  Oshima</span>, <span class="hlFld-ContribAuthor ">Masanobu  Oshima</span>, <span class="hlFld-ContribAuthor ">Dong-Wook  Kim</span>, <span class="hlFld-ContribAuthor ">Hiromitsu  Nakauchi</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Takihara</span>, <span class="hlFld-ContribAuthor ">Yukio  Kato</span>, <span class="hlFld-ContribAuthor ">Akira  Ooshima</span>, <span class="hlFld-ContribAuthor ">Seong-Jin  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Dipeptide species regulate p38MAPK–Smad3 signalling to maintain chronic myelogenous leukaemia stem cells. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms9039" title="DOI URL">https://doi.org/10.1038/ncomms9039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms9039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms9039%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DDipeptide%252Bspecies%252Bregulate%252Bp38MAPK%2525E2%252580%252593Smad3%252Bsignalling%252Bto%252Bmaintain%252Bchronic%252Bmyelogenous%252Bleukaemia%252Bstem%252Bcells%26aulast%3DNaka%26aufirst%3DKazuhito%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  Sabatini</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Manfroni</span>, <span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>, <span class="hlFld-ContribAuthor ">Silke M.  Bauer</span>, <span class="hlFld-ContribAuthor ">Marco  Gargaro</span>, <span class="hlFld-ContribAuthor ">Rolando  Cannalire</span>, <span class="hlFld-ContribAuthor ">Andrea  Astolfi</span>, <span class="hlFld-ContribAuthor ">Jose  Brea</span>, <span class="hlFld-ContribAuthor ">Carmine  Vacca</span>, <span class="hlFld-ContribAuthor ">Matteo  Pirro</span>, <span class="hlFld-ContribAuthor ">Serena  Massari</span>, <span class="hlFld-ContribAuthor ">Oriana  Tabarrini</span>, <span class="hlFld-ContribAuthor ">Maria Isabel  Loza</span>, <span class="hlFld-ContribAuthor ">Francesca  Fallarino</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>. </span><span class="cited-content_cbyCitation_article-title">The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (4)
                                     , 531-545. <a href="https://doi.org/10.1111/cbdd.12516" title="DOI URL">https://doi.org/10.1111/cbdd.12516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12516%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DThe%252BPyrazolobenzothiazine%252BCore%252Bas%252Ba%252BNew%252BChemotype%252Bof%252Bp38%252BAlpha%252BMitogen-Activated%252BProtein%252BKinase%252BInhibitors%26aulast%3DSabatini%26aufirst%3DStefano%26date%3D2015%26date%3D2015%26volume%3D86%26issue%3D4%26spage%3D531%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diletta  Di Mitri</span>, <span class="hlFld-ContribAuthor ">Manolo  Sambucci</span>, <span class="hlFld-ContribAuthor ">Maria  Loiarro</span>, <span class="hlFld-ContribAuthor ">Marco  De Bardi</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Volpe</span>, <span class="hlFld-ContribAuthor ">Maria Teresa  Cencioni</span>, <span class="hlFld-ContribAuthor ">Claudio  Gasperini</span>, <span class="hlFld-ContribAuthor ">Diego  Centonze</span>, <span class="hlFld-ContribAuthor ">Claudio  Sette</span>, <span class="hlFld-ContribAuthor ">Arne N.  Akbar</span>, <span class="hlFld-ContribAuthor ">Giovanna  Borsellino</span>, <span class="hlFld-ContribAuthor ">Luca  Battistini</span>. </span><span class="cited-content_cbyCitation_article-title">The p38 mitogen-activated protein kinase cascade modulates T helper type 17 differentiation and functionality in multiple sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Immunology</span><span> <strong>2015,</strong> <em>146 </em>
                                    (2)
                                     , 251-263. <a href="https://doi.org/10.1111/imm.12497" title="DOI URL">https://doi.org/10.1111/imm.12497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/imm.12497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fimm.12497%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunology%26atitle%3DThe%252Bp38%252Bmitogen-activated%252Bprotein%252Bkinase%252Bcascade%252Bmodulates%252BT%252Bhelper%252Btype%252B17%252Bdifferentiation%252Band%252Bfunctionality%252Bin%252Bmultiple%252Bsclerosis%26aulast%3DDi%2BMitri%26aufirst%3DDiletta%26date%3D2015%26date%3D2015%26volume%3D146%26issue%3D2%26spage%3D251%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John J.  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Brain-Targeted Antagonism of p38 MAPKα Reduces Hippocampal IL-1β Levels and Improves Morris Water Maze Performance in Aged Rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2015,</strong> <em>48 </em>
                                    (1)
                                     , 219-227. <a href="https://doi.org/10.3233/JAD-150277" title="DOI URL">https://doi.org/10.3233/JAD-150277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-150277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-150277%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DSelective%252BBrain-Targeted%252BAntagonism%252Bof%252Bp38%252BMAPK%2525CE%2525B1%252BReduces%252BHippocampal%252BIL-1%2525CE%2525B2%252BLevels%252Band%252BImproves%252BMorris%252BWater%252BMaze%252BPerformance%252Bin%252BAged%252BRats%26aulast%3DAlam%26aufirst%3DJohn%2BJ.%26date%3D2015%26volume%3D48%26issue%3D1%26spage%3D219%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">DE  Coutant</span>, <span class="hlFld-ContribAuthor ">P  Kulanthaivel</span>, <span class="hlFld-ContribAuthor ">PK  Turner</span>, <span class="hlFld-ContribAuthor ">RL  Bell</span>, <span class="hlFld-ContribAuthor ">J  Baldwin</span>, <span class="hlFld-ContribAuthor ">SR  Wijayawardana</span>, <span class="hlFld-ContribAuthor ">C  Pitou</span>, <span class="hlFld-ContribAuthor ">SD  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology & Therapeutics</span><span> <strong>2015,</strong> <em>98 </em>
                                    (1)
                                     , 76-86. <a href="https://doi.org/10.1002/cpt.128" title="DOI URL">https://doi.org/10.1002/cpt.128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpt.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpt.128%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DUnderstanding%252BDisease-Drug%252BInteractions%252Bin%252BCancer%252BPatients%25253A%252BImplications%252Bfor%252BDosing%252BWithin%252Bthe%252BTherapeutic%252BWindow%26aulast%3DCoutant%26aufirst%3DDE%26date%3D2015%26date%3D2015%26volume%3D98%26issue%3D1%26spage%3D76%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Astolfi</span>, <span class="hlFld-ContribAuthor ">Nunzio  Iraci</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Manfroni</span>, <span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>, <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>. </span><span class="cited-content_cbyCitation_article-title">A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (6)
                                     , 957-969. <a href="https://doi.org/10.1002/cmdc.201500030" title="DOI URL">https://doi.org/10.1002/cmdc.201500030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500030%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BComprehensive%252BStructural%252BOverview%252Bof%252Bp38%2525CE%2525B1%252BMAPK%252Bin%252BComplex%252Bwith%252BType%2525E2%252580%252585I%252BInhibitors%26aulast%3DAstolfi%26aufirst%3DAndrea%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D6%26spage%3D957%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Jun  Kang</span>, <span class="hlFld-ContribAuthor ">Bo-Ram  Bang</span>, <span class="hlFld-ContribAuthor ">Motoyuki  Otsuka</span>, <span class="hlFld-ContribAuthor ">Kinya  Otsu</span>. </span><span class="cited-content_cbyCitation_article-title">Tissue-Specific Regulation of p38α-Mediated Inflammation in Con A–Induced Acute Liver Damage. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Immunology</span><span> <strong>2015,</strong> <em>194 </em>
                                    (10)
                                     , 4759-4766. <a href="https://doi.org/10.4049/jimmunol.1402954" title="DOI URL">https://doi.org/10.4049/jimmunol.1402954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4049/jimmunol.1402954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4049%2Fjimmunol.1402954%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Immunology%26atitle%3DTissue-Specific%252BRegulation%252Bof%252Bp38%2525CE%2525B1-Mediated%252BInflammation%252Bin%252BCon%252BA%2525E2%252580%252593Induced%252BAcute%252BLiver%252BDamage%26aulast%3DKang%26aufirst%3DYoung%2BJun%26date%3D2015%26date%3D2015%26volume%3D194%26issue%3D10%26spage%3D4759%26epage%3D4766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jalaj  Gupta</span>, <span class="hlFld-ContribAuthor ">Angel R.  Nebreda</span>. </span><span class="cited-content_cbyCitation_article-title">Roles of p38α mitogen‐activated protein kinase in mouse models of inflammatory diseases and cancer. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2015,</strong> <em>282 </em>
                                    (10)
                                     , 1841-1857. <a href="https://doi.org/10.1111/febs.13250" title="DOI URL">https://doi.org/10.1111/febs.13250</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.13250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.13250%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DRoles%252Bof%252Bp38%2525CE%2525B1%252Bmitogen%2525E2%252580%252590activated%252Bprotein%252Bkinase%252Bin%252Bmouse%252Bmodels%252Bof%252Binflammatory%252Bdiseases%252Band%252Bcancer%26aulast%3DGupta%26aufirst%3DJalaj%26date%3D2015%26date%3D2015%26volume%3D282%26issue%3D10%26spage%3D1841%26epage%3D1857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jalaj  Gupta</span>, <span class="hlFld-ContribAuthor ">Ana  Igea</span>, <span class="hlFld-ContribAuthor ">Marilena  Papaioannou</span>, <span class="hlFld-ContribAuthor ">Pedro Pablo  Lopez-Casas</span>, <span class="hlFld-ContribAuthor ">Elisabet  Llonch</span>, <span class="hlFld-ContribAuthor ">Manuel  Hidalgo</span>, <span class="hlFld-ContribAuthor ">Vassilis G.  Gorgoulis</span>, <span class="hlFld-ContribAuthor ">Angel R.  Nebreda</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (11)
                                     , 8539-8551. <a href="https://doi.org/10.18632/oncotarget.3816" title="DOI URL">https://doi.org/10.18632/oncotarget.3816</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.3816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.3816%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DPharmacological%252Binhibition%252Bof%252Bp38%252BMAPK%252Breduces%252Btumor%252Bgrowth%252Bin%252Bpatient-derived%252Bxenografts%252Bfrom%252Bcolon%252Btumors%26aulast%3DGupta%26aufirst%3DJalaj%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D11%26spage%3D8539%26epage%3D8551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thor  Ostenfeld</span>, <span class="hlFld-ContribAuthor ">Alok  Krishen</span>, <span class="hlFld-ContribAuthor ">Robert Y.  Lai</span>, <span class="hlFld-ContribAuthor ">Jonathan  Bullman</span>, <span class="hlFld-ContribAuthor ">Joanne  Green</span>, <span class="hlFld-ContribAuthor ">Praveen  Anand</span>, <span class="hlFld-ContribAuthor ">Joachim  Scholz</span>, <span class="hlFld-ContribAuthor ">Madeline  Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">A Randomized, Placebo-controlled Trial of the Analgesic Efficacy and Safety of the p38 MAP Kinase Inhibitor, Losmapimod, in Patients With Neuropathic Pain From Lumbosacral Radiculopathy. </span><span class="cited-content_cbyCitation_journal-name">The Clinical Journal of Pain</span><span> <strong>2015,</strong> <em>31 </em>
                                    (4)
                                     , 283-293. <a href="https://doi.org/10.1097/AJP.0000000000000122" title="DOI URL">https://doi.org/10.1097/AJP.0000000000000122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/AJP.0000000000000122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FAJP.0000000000000122%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Clinical%2520Journal%2520of%2520Pain%26atitle%3DA%252BRandomized%25252C%252BPlacebo-controlled%252BTrial%252Bof%252Bthe%252BAnalgesic%252BEfficacy%252Band%252BSafety%252Bof%252Bthe%252Bp38%252BMAP%252BKinase%252BInhibitor%25252C%252BLosmapimod%25252C%252Bin%252BPatients%252BWith%252BNeuropathic%252BPain%252BFrom%252BLumbosacral%252BRadiculopathy%26aulast%3DOstenfeld%26aufirst%3DThor%26date%3D2015%26volume%3D31%26issue%3D4%26spage%3D283%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie B.  Vinh</span>, <span class="hlFld-ContribAuthor ">Shane M.  Devine</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>, <span class="hlFld-ContribAuthor ">Renae M.  Ryan</span>, <span class="hlFld-ContribAuthor ">Bing H.  Wang</span>, <span class="hlFld-ContribAuthor ">Henry  Krum</span>, <span class="hlFld-ContribAuthor ">David K.  Chalmers</span>, <span class="hlFld-ContribAuthor ">Jamie S.  Simpson</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Tetra-Substituted Thiophenes as Inhibitors of p38α MAPK. </span><span class="cited-content_cbyCitation_journal-name">ChemistryOpen</span><span> <strong>2015,</strong> <em>4 </em>
                                    (1)
                                     , 56-64. <a href="https://doi.org/10.1002/open.201402076" title="DOI URL">https://doi.org/10.1002/open.201402076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/open.201402076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fopen.201402076%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistryOpen%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BTetra-Substituted%252BThiophenes%252Bas%252BInhibitors%252Bof%252Bp38%2525CE%2525B1%252BMAPK%26aulast%3DVinh%26aufirst%3DNatalie%2BB.%26date%3D2015%26date%3D2014%26volume%3D4%26issue%3D1%26spage%3D56%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling-Jun  Ho</span>, <span class="hlFld-ContribAuthor ">Jenn-Haung  Lai</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule inhibitors for autoimmune arthritis: Success, failure and the future. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2015,</strong> <em>747 </em>, 200-205. <a href="https://doi.org/10.1016/j.ejphar.2014.08.031" title="DOI URL">https://doi.org/10.1016/j.ejphar.2014.08.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2014.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2014.08.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DSmall-molecule%252Binhibitors%252Bfor%252Bautoimmune%252Barthritis%25253A%252BSuccess%25252C%252Bfailure%252Band%252Bthe%252Bfuture%26aulast%3DHo%26aufirst%3DLing-Jun%26date%3D2015%26volume%3D747%26spage%3D200%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark C.  Bagley</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Dwyer</span>, <span class="hlFld-ContribAuthor ">Maria D. Beltran  Molina</span>, <span class="hlFld-ContribAuthor ">Alexander W.  Rand</span>, <span class="hlFld-ContribAuthor ">Hayley L.  Rand</span>, <span class="hlFld-ContribAuthor ">Nicholas C. O.  Tomkinson</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted synthesis of 3-aminobenzo[b]thiophene scaffolds for the preparation of kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (24)
                                     , 6814-6824. <a href="https://doi.org/10.1039/C5OB00819K" title="DOI URL">https://doi.org/10.1039/C5OB00819K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB00819K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB00819K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMicrowave-assisted%252Bsynthesis%252Bof%252B3-aminobenzo%25255Bb%25255Dthiophene%252Bscaffolds%252Bfor%252Bthe%252Bpreparation%252Bof%252Bkinase%252Binhibitors%26aulast%3DBagley%26aufirst%3DMark%2BC.%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D24%26spage%3D6814%26epage%3D6824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Mion</span>, <span class="hlFld-ContribAuthor ">Silvia  Tonon</span>, <span class="hlFld-ContribAuthor ">Barbara  Toffoletto</span>, <span class="hlFld-ContribAuthor ">Daniela  Cesselli</span>, <span class="hlFld-ContribAuthor ">Carlo E.  Pucillo</span>, <span class="hlFld-ContribAuthor ">Gaetano  Vitale</span>. </span><span class="cited-content_cbyCitation_article-title">IL-10 production by B cells is differentially regulated by immune-mediated and infectious stimuli and requires p38 activation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Immunology</span><span> <strong>2014,</strong> <em>62 </em>
                                    (2)
                                     , 266-276. <a href="https://doi.org/10.1016/j.molimm.2014.05.018" title="DOI URL">https://doi.org/10.1016/j.molimm.2014.05.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molimm.2014.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molimm.2014.05.018%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Immunology%26atitle%3DIL-10%252Bproduction%252Bby%252BB%252Bcells%252Bis%252Bdifferentially%252Bregulated%252Bby%252Bimmune-mediated%252Band%252Binfectious%252Bstimuli%252Band%252Brequires%252Bp38%252Bactivation%26aulast%3DMion%26aufirst%3DFrancesca%26date%3D2014%26volume%3D62%26issue%3D2%26spage%3D266%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramona  Rudalska</span>, <span class="hlFld-ContribAuthor ">Daniel  Dauch</span>, <span class="hlFld-ContribAuthor ">Thomas  Longerich</span>, <span class="hlFld-ContribAuthor ">Katherine  McJunkin</span>, <span class="hlFld-ContribAuthor ">Torsten  Wuestefeld</span>, <span class="hlFld-ContribAuthor ">Tae-Won  Kang</span>, <span class="hlFld-ContribAuthor ">Anja  Hohmeyer</span>, <span class="hlFld-ContribAuthor ">Marina  Pesic</span>, <span class="hlFld-ContribAuthor ">Josef  Leibold</span>, <span class="hlFld-ContribAuthor ">Anne  von Thun</span>, <span class="hlFld-ContribAuthor ">Peter  Schirmacher</span>, <span class="hlFld-ContribAuthor ">Johannes  Zuber</span>, <span class="hlFld-ContribAuthor ">Karl-Heinz  Weiss</span>, <span class="hlFld-ContribAuthor ">Scott  Powers</span>, <span class="hlFld-ContribAuthor ">Nisar P  Malek</span>, <span class="hlFld-ContribAuthor ">Martin  Eilers</span>, <span class="hlFld-ContribAuthor ">Bence  Sipos</span>, <span class="hlFld-ContribAuthor ">Scott W  Lowe</span>, <span class="hlFld-ContribAuthor ">Robert  Geffers</span>, <span class="hlFld-ContribAuthor ">Stefan  Laufer</span>, <span class="hlFld-ContribAuthor ">Lars  Zender</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature Medicine</span><span> <strong>2014,</strong> <em>20 </em>
                                    (10)
                                     , 1138-1146. <a href="https://doi.org/10.1038/nm.3679" title="DOI URL">https://doi.org/10.1038/nm.3679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nm.3679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnm.3679%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Medicine%26atitle%3DIn%252Bvivo%252BRNAi%252Bscreening%252Bidentifies%252Ba%252Bmechanism%252Bof%252Bsorafenib%252Bresistance%252Bin%252Bliver%252Bcancer%26aulast%3DRudalska%26aufirst%3DRamona%26date%3D2014%26date%3D2014%26volume%3D20%26issue%3D10%26spage%3D1138%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark C  Bagley</span>, <span class="hlFld-ContribAuthor ">Mohammed  Baashen</span>, <span class="hlFld-ContribAuthor ">Jessica  Dwyer</span>, <span class="hlFld-ContribAuthor ">Pierre  Milbeo</span>, <span class="hlFld-ContribAuthor ">David  Kipling</span>, <span class="hlFld-ContribAuthor ">Terence  Davis</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted synthesis of MK2 inhibitors for targeting p38 MAPK signal transduction in Werner syndrome cells. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 86-104. <a href="https://doi.org/10.4155/fseb2013.13.130" title="DOI URL">https://doi.org/10.4155/fseb2013.13.130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fseb2013.13.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffseb2013.13.130%26sid%3Dliteratum%253Aachs%26atitle%3DMicrowave-assisted%252Bsynthesis%252Bof%252BMK2%252Binhibitors%252Bfor%252Btargeting%252Bp38%252BMAPK%252Bsignal%252Btransduction%252Bin%252BWerner%252Bsyndrome%252Bcells%26aulast%3DBagley%26aufirst%3DMark%2BC%26date%3D2014%26date%3D2014%26spage%3D86%26epage%3D104%26pub%3DFuture%2520Science%2520Ltd%26atitle%3DMicrowaves%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BAdvances%26aulast%3DSpencer%26aufirst%3DJohn%26date%3D2014%26date%3D2014%26volume%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Q.  Liu</span>, <span class="hlFld-ContribAuthor ">C. Y.  Wang</span>, <span class="hlFld-ContribAuthor ">Z.  Liu</span>, <span class="hlFld-ContribAuthor ">X. S.  Ma</span>, <span class="hlFld-ContribAuthor ">Y. H.  He</span>, <span class="hlFld-ContribAuthor ">S. S.  Chen</span>, <span class="hlFld-ContribAuthor ">X. Y.  Bai</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Biology</span><span> <strong>2014,</strong> <em>52 </em>
                                    (9)
                                     , 1085-1093. <a href="https://doi.org/10.3109/13880209.2013.877491" title="DOI URL">https://doi.org/10.3109/13880209.2013.877491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/13880209.2013.877491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F13880209.2013.877491%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Biology%26atitle%3DHydroxysafflor%252Byellow%252BA%252Bsuppresses%252Bliver%252Bfibrosis%252Binduced%252Bby%252Bcarbon%252Btetrachloride%252Bwith%252Bhigh-fat%252Bdiet%252Bby%252Bregulating%252BPPAR-%2525CE%2525B3%25252Fp38%252BMAPK%252Bsignaling%26aulast%3DLiu%26aufirst%3DQ.%26date%3D2014%26date%3D2014%26volume%3D52%26issue%3D9%26spage%3D1085%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Hasumi</span>, <span class="hlFld-ContribAuthor ">Shuichiro  Sato</span>, <span class="hlFld-ContribAuthor ">Takahisa  Saito</span>, <span class="hlFld-ContribAuthor ">Jun-ya  Kato</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Shirota</span>, <span class="hlFld-ContribAuthor ">Jun  Sato</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Suzuki</span>, <span class="hlFld-ContribAuthor ">Shuji  Ohta</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 5-[(2-chloro-6-fluorophenyl)acetylamino]-3-(4-fluorophenyl)-4-(4-pyrimidinyl)isoxazole (AKP-001), a novel inhibitor of p38 MAP kinase with reduced side effects based on the antedrug concept. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (15)
                                     , 4162-4176. <a href="https://doi.org/10.1016/j.bmc.2014.05.045" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.05.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.05.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.05.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B5-%25255B%2525282-chloro-6-fluorophenyl%252529acetylamino%25255D-3-%2525284-fluorophenyl%252529-4-%2525284-pyrimidinyl%252529isoxazole%252B%252528AKP-001%252529%25252C%252Ba%252Bnovel%252Binhibitor%252Bof%252Bp38%252BMAP%252Bkinase%252Bwith%252Breduced%252Bside%252Beffects%252Bbased%252Bon%252Bthe%252Bantedrug%252Bconcept%26aulast%3DHasumi%26aufirst%3DKoichi%26date%3D2014%26volume%3D22%26issue%3D15%26spage%3D4162%26epage%3D4176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK inhibitors in development for rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2014,</strong> <em>23 </em>
                                    (8)
                                     , 1067-1077. <a href="https://doi.org/10.1517/13543784.2014.918604" title="DOI URL">https://doi.org/10.1517/13543784.2014.918604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2014.918604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2014.918604%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DSelective%252BJAK%252Binhibitors%252Bin%252Bdevelopment%252Bfor%252Brheumatoid%252Barthritis%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D8%26spage%3D1067%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Fisk</span>, <span class="hlFld-ContribAuthor ">Parag R.  Gajendragadkar</span>, <span class="hlFld-ContribAuthor ">Kaisa M.  Mäki-Petäjä</span>, <span class="hlFld-ContribAuthor ">Ian B.  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Joseph  Cheriyan</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Cardiovascular Drugs</span><span> <strong>2014,</strong> <em>14 </em>
                                    (3)
                                     , 155-165. <a href="https://doi.org/10.1007/s40256-014-0063-6" title="DOI URL">https://doi.org/10.1007/s40256-014-0063-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40256-014-0063-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40256-014-0063-6%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Cardiovascular%2520Drugs%26atitle%3DTherapeutic%252BPotential%252Bof%252Bp38%252BMAP%252BKinase%252BInhibition%252Bin%252Bthe%252BManagement%252Bof%252BCardiovascular%252BDisease%26aulast%3DFisk%26aufirst%3DMarie%26date%3D2014%26date%3D2014%26volume%3D14%26issue%3D3%26spage%3D155%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Salgado</span>, <span class="hlFld-ContribAuthor ">Jose R  Maneiro</span>, <span class="hlFld-ContribAuthor ">Loreto  Carmona</span>, <span class="hlFld-ContribAuthor ">Juan J  Gomez-Reino</span>. </span><span class="cited-content_cbyCitation_article-title">Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis. </span><span class="cited-content_cbyCitation_journal-name">Annals of the Rheumatic Diseases</span><span> <strong>2014,</strong> <em>73 </em>
                                    (5)
                                     , 871-882. <a href="https://doi.org/10.1136/annrheumdis-2012-203116" title="DOI URL">https://doi.org/10.1136/annrheumdis-2012-203116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1136/annrheumdis-2012-203116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1136%2Fannrheumdis-2012-203116%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520the%2520Rheumatic%2520Diseases%26atitle%3DSafety%252Bprofile%252Bof%252Bprotein%252Bkinase%252Binhibitors%252Bin%252Brheumatoid%252Barthritis%25253A%252Bsystematic%252Breview%252Band%252Bmeta-analysis%26aulast%3DSalgado%26aufirst%3DEva%26date%3D2014%26date%3D2013%26volume%3D73%26issue%3D5%26spage%3D871%26epage%3D882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefanie  Bühler</span>, <span class="hlFld-ContribAuthor ">Stefan A  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">p38 MAPK inhibitors: a patent review (2012 – 2013). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (5)
                                     , 535-554. <a href="https://doi.org/10.1517/13543776.2014.894977" title="DOI URL">https://doi.org/10.1517/13543776.2014.894977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.894977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.894977%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3Dp38%252BMAPK%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282012%252B%2525E2%252580%252593%252B2013%252529%26aulast%3DB%25C3%25BChler%26aufirst%3DStefanie%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D5%26spage%3D535%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jalaj  Gupta</span>, <span class="hlFld-ContribAuthor ">Ivan  del Barco Barrantes</span>, <span class="hlFld-ContribAuthor ">Ana  Igea</span>, <span class="hlFld-ContribAuthor ">Stratigoula  Sakellariou</span>, <span class="hlFld-ContribAuthor ">Ioannis S.  Pateras</span>, <span class="hlFld-ContribAuthor ">Vassilis G.  Gorgoulis</span>, <span class="hlFld-ContribAuthor ">Angel R.  Nebreda</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Function of p38α MAPK in Colon Cancer: Suppression of Colitis-Associated Tumor Initiation but Requirement for Cancer Cell Survival. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell</span><span> <strong>2014,</strong> <em>25 </em>
                                    (4)
                                     , 484-500. <a href="https://doi.org/10.1016/j.ccr.2014.02.019" title="DOI URL">https://doi.org/10.1016/j.ccr.2014.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2014.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2014.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%26atitle%3DDual%252BFunction%252Bof%252Bp38%2525CE%2525B1%252BMAPK%252Bin%252BColon%252BCancer%25253A%252BSuppression%252Bof%252BColitis-Associated%252BTumor%252BInitiation%252Bbut%252BRequirement%252Bfor%252BCancer%252BCell%252BSurvival%26aulast%3DGupta%26aufirst%3DJalaj%26date%3D2014%26volume%3D25%26issue%3D4%26spage%3D484%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranjana  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Anshul  Bansal</span>, <span class="hlFld-ContribAuthor ">Isabel  Rozas</span>, <span class="hlFld-ContribAuthor ">Elena  Diez-Cecilia</span>, <span class="hlFld-ContribAuthor ">Amanjot  Kaur</span>, <span class="hlFld-ContribAuthor ">Ritu  Mahajan</span>, <span class="hlFld-ContribAuthor ">Jitender  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">p-Toluenesulfonic acid-catalyzed solvent-free synthesis and biological evaluation of new 1-(4′,6′-dimethylpyrimidin-2′-yl)-5-amino-4H-3-arylpyrazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (3)
                                     , 1454-1464. <a href="https://doi.org/10.1007/s00044-013-0751-9" title="DOI URL">https://doi.org/10.1007/s00044-013-0751-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-013-0751-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-013-0751-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3Dp-Toluenesulfonic%252Bacid-catalyzed%252Bsolvent-free%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252B1-%2525284%2525E2%252580%2525B2%25252C6%2525E2%252580%2525B2-dimethylpyrimidin-2%2525E2%252580%2525B2-yl%252529-5-amino-4H-3-arylpyrazole%252Bderivatives%26aulast%3DAggarwal%26aufirst%3DRanjana%26date%3D2014%26date%3D2013%26volume%3D23%26issue%3D3%26spage%3D1454%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elina  Siljamäki</span>, <span class="hlFld-ContribAuthor ">Laura  Raiko</span>, <span class="hlFld-ContribAuthor ">Mervi  Toriseva</span>, <span class="hlFld-ContribAuthor ">Liisa  Nissinen</span>, <span class="hlFld-ContribAuthor ">Tuomas  Näreoja</span>, <span class="hlFld-ContribAuthor ">Juha  Peltonen</span>, <span class="hlFld-ContribAuthor ">Veli-Matti  Kähäri</span>, <span class="hlFld-ContribAuthor ">Sirkku  Peltonen</span>. </span><span class="cited-content_cbyCitation_article-title">p38δ mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes. </span><span class="cited-content_cbyCitation_journal-name">Archives of Dermatological Research</span><span> <strong>2014,</strong> <em>306 </em>
                                    (2)
                                     , 131-141. <a href="https://doi.org/10.1007/s00403-013-1391-0" title="DOI URL">https://doi.org/10.1007/s00403-013-1391-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00403-013-1391-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00403-013-1391-0%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Dermatological%2520Research%26atitle%3Dp38%2525CE%2525B4%252Bmitogen-activated%252Bprotein%252Bkinase%252Bregulates%252Bthe%252Bexpression%252Bof%252Btight%252Bjunction%252Bprotein%252BZO-1%252Bin%252Bdifferentiating%252Bhuman%252Bepidermal%252Bkeratinocytes%26aulast%3DSiljam%25C3%25A4ki%26aufirst%3DElina%26date%3D2014%26date%3D2013%26volume%3D306%26issue%3D2%26spage%3D131%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. A.  Koch</span>, <span class="hlFld-ContribAuthor ">R. B. M.  Silva</span>, <span class="hlFld-ContribAuthor ">A. H.  de Souza</span>, <span class="hlFld-ContribAuthor ">C. E.  Leite</span>, <span class="hlFld-ContribAuthor ">N. F.  Nicoletti</span>, <span class="hlFld-ContribAuthor ">M. M.  Campos</span>, <span class="hlFld-ContribAuthor ">S.  Laufer</span>, <span class="hlFld-ContribAuthor ">F. B.  Morrone</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats. </span><span class="cited-content_cbyCitation_journal-name">Rheumatology</span><span> <strong>2014,</strong> <em>53 </em>
                                    (3)
                                     , 425-432. <a href="https://doi.org/10.1093/rheumatology/ket369" title="DOI URL">https://doi.org/10.1093/rheumatology/ket369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/rheumatology/ket369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Frheumatology%2Fket369%26sid%3Dliteratum%253Aachs%26jtitle%3DRheumatology%26atitle%3DEfficacy%252Band%252Bgastrointestinal%252Btolerability%252Bof%252BML3403%25252C%252Ba%252Bselective%252Binhibitor%252Bof%252Bp38%252BMAP%252Bkinase%252Band%252BCBS-3595%25252C%252Ba%252Bdual%252Binhibitor%252Bof%252Bp38%252BMAP%252Bkinase%252Band%252Bphosphodiesterase%252B4%252Bin%252BCFA-induced%252Barthritis%252Bin%252Brats%26aulast%3DKoch%26aufirst%3DD.%2BA.%26date%3D2014%26date%3D2013%26volume%3D53%26issue%3D3%26spage%3D425%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Kyriakis</span>, <span class="hlFld-ContribAuthor ">Joseph  Avruch</span>. </span><span class="cited-content_cbyCitation_article-title">MAP Kinase Pathways. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 1-20. <a href="https://doi.org/10.1007/978-3-0348-0620-6_37-1" title="DOI URL">https://doi.org/10.1007/978-3-0348-0620-6_37-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-0348-0620-6_37-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-0348-0620-6_37-1%26sid%3Dliteratum%253Aachs%26atitle%3DMAP%252BKinase%252BPathways%26aulast%3DKyriakis%26aufirst%3DJohn%2BM.%26date%3D2014%26date%3D2015%26spage%3D1%26epage%3D20%26pub%3DSpringer%2520Basel%26atitle%3DEncyclopedia%252Bof%252BInflammatory%252BDiseases%26aulast%3DParnham%26aufirst%3DMichael%26date%3D2015%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henrik  Watz</span>, <span class="hlFld-ContribAuthor ">Helen  Barnacle</span>, <span class="hlFld-ContribAuthor ">Benjamin F  Hartley</span>, <span class="hlFld-ContribAuthor ">Robert  Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial. </span><span class="cited-content_cbyCitation_journal-name">The Lancet Respiratory Medicine</span><span> <strong>2014,</strong> <em>2 </em>
                                    (1)
                                     , 63-72. <a href="https://doi.org/10.1016/S2213-2600(13)70200-5" title="DOI URL">https://doi.org/10.1016/S2213-2600(13)70200-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S2213-2600(13)70200-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS2213-2600%2813%2970200-5%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%2520Respiratory%2520Medicine%26atitle%3DEfficacy%252Band%252Bsafety%252Bof%252Bthe%252Bp38%252BMAPK%252Binhibitor%252Blosmapimod%252Bfor%252Bpatients%252Bwith%252Bchronic%252Bobstructive%252Bpulmonary%252Bdisease%25253A%252Ba%252Brandomised%25252C%252Bdouble-blind%25252C%252Bplacebo-controlled%252Btrial%26aulast%3DWatz%26aufirst%3DHenrik%26date%3D2014%26volume%3D2%26issue%3D1%26spage%3D63%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuming  Mao</span>, <span class="hlFld-ContribAuthor ">Hong  Li</span>, <span class="hlFld-ContribAuthor ">Yasuyo  Sano</span>, <span class="hlFld-ContribAuthor ">Matthias  Gaestel</span>, <span class="hlFld-ContribAuthor ">Jin  Mo Park</span>, <span class="hlFld-ContribAuthor ">Aimee S  Payne</span>. </span><span class="cited-content_cbyCitation_article-title">MAPKAP Kinase 2 (MK2)-Dependent and -Independent Models of Blister Formation in Pemphigus Vulgaris. </span><span class="cited-content_cbyCitation_journal-name">Journal of Investigative Dermatology</span><span> <strong>2014,</strong> <em>134 </em>
                                    (1)
                                     , 68-76. <a href="https://doi.org/10.1038/jid.2013.224" title="DOI URL">https://doi.org/10.1038/jid.2013.224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/jid.2013.224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fjid.2013.224%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Investigative%2520Dermatology%26atitle%3DMAPKAP%252BKinase%252B2%252B%252528MK2%252529-Dependent%252Band%252B-Independent%252BModels%252Bof%252BBlister%252BFormation%252Bin%252BPemphigus%252BVulgaris%26aulast%3DMao%26aufirst%3DXuming%26date%3D2014%26volume%3D134%26issue%3D1%26spage%3D68%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanyan  Yang</span>, <span class="hlFld-ContribAuthor ">Seung Cheol  Kim</span>, <span class="hlFld-ContribAuthor ">Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Young-Su  Yi</span>, <span class="hlFld-ContribAuthor ">Man Hee  Rhee</span>, <span class="hlFld-ContribAuthor ">Gi-Ho  Sung</span>, <span class="hlFld-ContribAuthor ">Byong Chul  Yoo</span>, <span class="hlFld-ContribAuthor ">Jae Youl  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Roles of p38 Mitogen-Activated Protein Kinase in Macrophage-Mediated Inflammatory Responses. </span><span class="cited-content_cbyCitation_journal-name">Mediators of Inflammation</span><span> <strong>2014,</strong> <em>2014 </em>, 1-13. <a href="https://doi.org/10.1155/2014/352371" title="DOI URL">https://doi.org/10.1155/2014/352371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2014/352371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2014%2F352371%26sid%3Dliteratum%253Aachs%26jtitle%3DMediators%2520of%2520Inflammation%26atitle%3DFunctional%252BRoles%252Bof%252Bp38%252BMitogen-Activated%252BProtein%252BKinase%252Bin%252BMacrophage-Mediated%252BInflammatory%252BResponses%26aulast%3DYang%26aufirst%3DYanyan%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lorena  Pereira</span>, <span class="hlFld-ContribAuthor ">Ana  Igea</span>, <span class="hlFld-ContribAuthor ">Begoña  Canovas</span>, <span class="hlFld-ContribAuthor ">Ignacio  Dolado</span>, <span class="hlFld-ContribAuthor ">Angel R.  Nebreda</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of p38
              MAPK
              sensitizes tumour cells to cisplatin‐induced apoptosis mediated by reactive oxygen species and JNK. </span><span class="cited-content_cbyCitation_journal-name">EMBO Molecular Medicine</span><span> <strong>2013,</strong> <em>5 </em>
                                    (11)
                                     , 1759-1774. <a href="https://doi.org/10.1002/emmm.201302732" title="DOI URL">https://doi.org/10.1002/emmm.201302732</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/emmm.201302732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Femmm.201302732%26sid%3Dliteratum%253Aachs%26jtitle%3DEMBO%2520Molecular%2520Medicine%26atitle%3DInhibition%252Bof%252Bp38%252BMAPK%252Bsensitizes%252Btumour%252Bcells%252Bto%252Bcisplatin%2525E2%252580%252590induced%252Bapoptosis%252Bmediated%252Bby%252Breactive%252Boxygen%252Bspecies%252Band%252BJNK%26aulast%3DPereira%26aufirst%3DLorena%26date%3D2013%26date%3D2013%26volume%3D5%26issue%3D11%26spage%3D1759%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James R.  Brown</span>, <span class="hlFld-ContribAuthor ">David  Drewry</span>, <span class="hlFld-ContribAuthor ">Francisco-Javier  Gamo</span>, <span class="hlFld-ContribAuthor ">Jose F.  Garcia-Bustos</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors Among Hits from Malaria Cellular Screens. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 261-291. <a href="https://doi.org/10.1002/9783527675401.ch13" title="DOI URL">https://doi.org/10.1002/9783527675401.ch13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527675401.ch13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527675401.ch13%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252BAmong%252BHits%252Bfrom%252BMalaria%252BCellular%252BScreens%26aulast%3DBrown%26aufirst%3DJames%2BR.%26date%3D2013%26date%3D2013%26spage%3D261%26epage%3D291%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DProtein%252BPhosphorylation%252Bin%252BParasites%26aulast%3DDoerig%26aufirst%3DChristian%26date%3D2013%26volume%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark C.  Bagley</span>, <span class="hlFld-ContribAuthor ">Mohammed  Baashen</span>, <span class="hlFld-ContribAuthor ">Victoria L.  Paddock</span>, <span class="hlFld-ContribAuthor ">David  Kipling</span>, <span class="hlFld-ContribAuthor ">Terence  Davis</span>. </span><span class="cited-content_cbyCitation_article-title">Regiocontrolled synthesis of 3- and 5-aminopyrazoles, pyrazolo[3,4-d]pyrimidines, pyrazolo[3,4-b]pyridines and pyrazolo[3,4-b]quinolinones as MAPK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (39)
                                     , 8429-8438. <a href="https://doi.org/10.1016/j.tet.2013.07.055" title="DOI URL">https://doi.org/10.1016/j.tet.2013.07.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.07.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.07.055%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRegiocontrolled%252Bsynthesis%252Bof%252B3-%252Band%252B5-aminopyrazoles%25252C%252Bpyrazolo%25255B3%25252C4-d%25255Dpyrimidines%25252C%252Bpyrazolo%25255B3%25252C4-b%25255Dpyridines%252Band%252Bpyrazolo%25255B3%25252C4-b%25255Dquinolinones%252Bas%252BMAPK%252Binhibitors%26aulast%3DBagley%26aufirst%3DMark%2BC.%26date%3D2013%26volume%3D69%26issue%3D39%26spage%3D8429%26epage%3D8438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Simon C.  Arthur</span>, <span class="hlFld-ContribAuthor ">Steven C.  Ley</span>. </span><span class="cited-content_cbyCitation_article-title">Mitogen-activated protein kinases in innate immunity. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Immunology</span><span> <strong>2013,</strong> <em>13 </em>
                                    (9)
                                     , 679-692. <a href="https://doi.org/10.1038/nri3495" title="DOI URL">https://doi.org/10.1038/nri3495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nri3495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnri3495%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Immunology%26atitle%3DMitogen-activated%252Bprotein%252Bkinases%252Bin%252Binnate%252Bimmunity%26aulast%3DArthur%26aufirst%3DJ.%2BSimon%2BC.%26date%3D2013%26date%3D2013%26volume%3D13%26issue%3D9%26spage%3D679%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>, <span class="hlFld-ContribAuthor ">Shuqun  Lin</span>, <span class="hlFld-ContribAuthor ">T.G.  Murali Dhar</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, <span class="hlFld-ContribAuthor ">Tianle  Li</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Fan</span>, <span class="hlFld-ContribAuthor ">Arthur M.  Doweyko</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Kish</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kiefer</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">John A.  Newitt</span>, <span class="hlFld-ContribAuthor ">Mark R.  Witmer</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">John H.  Dodd</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>. </span><span class="cited-content_cbyCitation_article-title">The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (14)
                                     , 4120-4126. <a href="https://doi.org/10.1016/j.bmcl.2013.05.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bidentification%252Bof%252Bnovel%252Bp38%2525CE%2525B1%252Bisoform%252Bselective%252Bkinase%252Binhibitors%252Bhaving%252Ban%252Bunprecedented%252Bp38%2525CE%2525B1%252Bbinding%252Bmode%26aulast%3DWrobleski%26aufirst%3DStephen%2BT.%26date%3D2013%26volume%3D23%26issue%3D14%26spage%3D4120%26epage%3D4126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Falck</span>, <span class="hlFld-ContribAuthor ">J.  Kool</span>, <span class="hlFld-ContribAuthor ">M.  Honing</span>, <span class="hlFld-ContribAuthor ">W. M. A.  Niessen</span>. </span><span class="cited-content_cbyCitation_article-title">Tandem mass spectrometry study of p38α kinase inhibitors and related substances. </span><span class="cited-content_cbyCitation_journal-name">Journal of Mass Spectrometry</span><span> <strong>2013,</strong> <em>48 </em>
                                    (6)
                                     , 718-731. <a href="https://doi.org/10.1002/jms.3219" title="DOI URL">https://doi.org/10.1002/jms.3219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jms.3219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjms.3219%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Mass%2520Spectrometry%26atitle%3DTandem%252Bmass%252Bspectrometry%252Bstudy%252Bof%252Bp38%2525CE%2525B1%252Bkinase%252Binhibitors%252Band%252Brelated%252Bsubstances%26aulast%3DFalck%26aufirst%3DD.%26date%3D2013%26date%3D2013%26volume%3D48%26issue%3D6%26spage%3D718%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana M.  Tormos</span>, <span class="hlFld-ContribAuthor ">Alessandro  Arduini</span>, <span class="hlFld-ContribAuthor ">Raquel  Talens-Visconti</span>, <span class="hlFld-ContribAuthor ">Ivan  del Barco Barrantes</span>, <span class="hlFld-ContribAuthor ">Angel R.  Nebreda</span>, <span class="hlFld-ContribAuthor ">Juan  Sastre</span>. </span><span class="cited-content_cbyCitation_article-title">Liver-specific p38α deficiency causes reduced cell growth and cytokinesis failure during chronic biliary cirrhosis in mice. </span><span class="cited-content_cbyCitation_journal-name">Hepatology</span><span> <strong>2013,</strong> <em>57 </em>
                                    (5)
                                     , 1950-1961. <a href="https://doi.org/10.1002/hep.26174" title="DOI URL">https://doi.org/10.1002/hep.26174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hep.26174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhep.26174%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%26atitle%3DLiver-specific%252Bp38%2525CE%2525B1%252Bdeficiency%252Bcauses%252Breduced%252Bcell%252Bgrowth%252Band%252Bcytokinesis%252Bfailure%252Bduring%252Bchronic%252Bbiliary%252Bcirrhosis%252Bin%252Bmice%26aulast%3DTormos%26aufirst%3DAna%2BM.%26date%3D2013%26date%3D2013%26volume%3D57%26issue%3D5%26spage%3D1950%26epage%3D1961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuying  Yang</span>, <span class="hlFld-ContribAuthor ">Pauline  Lukey</span>, <span class="hlFld-ContribAuthor ">Misba  Beerahee</span>, <span class="hlFld-ContribAuthor ">Frank  Hoke</span>. </span><span class="cited-content_cbyCitation_article-title">Population Pharmacokinetics of Losmapimod in Healthy Subjects and Patients with Rheumatoid Arthritis and Chronic Obstructive Pulmonary Diseases. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2013,</strong> <em>52 </em>
                                    (3)
                                     , 187-198. <a href="https://doi.org/10.1007/s40262-012-0025-6" title="DOI URL">https://doi.org/10.1007/s40262-012-0025-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-012-0025-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-012-0025-6%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DPopulation%252BPharmacokinetics%252Bof%252BLosmapimod%252Bin%252BHealthy%252BSubjects%252Band%252BPatients%252Bwith%252BRheumatoid%252BArthritis%252Band%252BChronic%252BObstructive%252BPulmonary%252BDiseases%26aulast%3DYang%26aufirst%3DShuying%26date%3D2013%26date%3D2012%26volume%3D52%26issue%3D3%26spage%3D187%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Verica  Paunovic</span>, <span class="hlFld-ContribAuthor ">Margaret M.  Harnett</span>. </span><span class="cited-content_cbyCitation_article-title">Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Drugs</span><span> <strong>2013,</strong> <em>73 </em>
                                    (2)
                                     , 101-115. <a href="https://doi.org/10.1007/s40265-013-0014-6" title="DOI URL">https://doi.org/10.1007/s40265-013-0014-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40265-013-0014-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40265-013-0014-6%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%26atitle%3DMitogen-Activated%252BProtein%252BKinases%252Bas%252BTherapeutic%252BTargets%252Bfor%252BRheumatoid%252BArthritis%26aulast%3DPaunovic%26aufirst%3DVerica%26date%3D2013%26date%3D2013%26volume%3D73%26issue%3D2%26spage%3D101%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm9012906&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm9012906%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=136&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9012906/production/images/medium/jm-2009-012906_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9012906/production/images/large/jm-2009-012906_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystal structures: ball-and-stick representations of p38α (gray) complexed with inhibitors (yellow). Hydrogen bonds are indicated by black dashes. Water molecules are not displayed. (a) Heterobicyclic analogue of <b>2</b> (PDB accession number <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QD9">2QD9</a>, 1.7 Å resolution).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (b) Heterobicyclic analogue of <b>5</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M7Q">1M7Q</a>, 2.4 Å).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (c) <b>1</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FLW">3FLW</a>, 2.1 Å, manuscript in preparation). (d) <b>9</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HLL">3HLL</a>, 1.95 Å).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9012906/production/images/large/jm-2009-012906_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012906&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51205" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51205" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Schett, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwerina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G.</span><span> </span><span class="NLM_article-title">The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1136%2Fard.2007.074278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=17827184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2008&pages=909-916&author=G.+Schettauthor=J.+Zwerinaauthor=G.+Firestein&title=The+p38+mitogen-activated+protein+kinase+%28MAPK%29+pathway+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis</span></div><div class="casAuthors">Schett, G.; Zwerina, J.; Firestein, G.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">909-916</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chronic inflammatory processes are based on a sustained and tightly regulated communication network among different cells types.  This network comprises extracellular mediators such as cytokines, chemokines and matrix-degrading proteases, which orchestrate the participation of cells in the chronic inflammatory process.  The mirrors of this outside communication world are intracellular transcription factor pathways, which shuttle information about inflammatory stimuli to the cell nucleus.  This review examines the function of one key signal transduction pathway of inflammation-the p38 mitogen-activated protein kinases (p38MAPK).  The signalling pathway is considered as crucial for the induction and maintenance of chronic inflammation, and its components thus emerge as interesting mol. targets of small mol. inhibitors for controlling inflammation.  This review not only summarizes the current knowledge of activation, regulation and function of the p38MAPK pathway but also examines the role of this pathway in clin. disease.  It gives an overview of current evidence of p38MAPK activation in inflammatory arthritis and elaborates the key mol. determinants which contribute to p38MAPK activation in joint disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVrSODN-vBCrVg90H21EOLACvtfcHk0lg3dL5Yc1mTUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslChsL4%253D&md5=eafcfc4d371a539ef290edc39792ce33</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fard.2007.074278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2007.074278%26sid%3Dliteratum%253Aachs%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DZwerina%26aufirst%3DJ.%26aulast%3DFirestein%26aufirst%3DG.%26atitle%3DThe%2520p38%2520mitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520pathway%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2008%26volume%3D67%26spage%3D909%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Westra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limburg, P. C.</span><span> </span><span class="NLM_article-title">p38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=867-874&author=J.+Westraauthor=P.+C.+Limburg&title=p38+mitogen-activated+protein+kinase+%28MAPK%29+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestra%26aufirst%3DJ.%26aulast%3DLimburg%26aufirst%3DP.%2BC.%26atitle%3Dp38%2520mitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520in%2520rheumatoid%2520arthritis%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D867%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schett, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwerina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manger, B.</span><span> </span><span class="NLM_article-title">How antirheumatic drugs protect joints from damage in rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2936</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2Fart.23951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=18821703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12rur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=2936-2948&author=G.+Schettauthor=C.+Stachauthor=J.+Zwerinaauthor=R.+Vollauthor=B.+Manger&title=How+antirheumatic+drugs+protect+joints+from+damage+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">How antirheumatic drugs protect joints from damage in rheumatoid arthritis</span></div><div class="casAuthors">Schett, Georg; Stach, Christian; Zwerina, Jochen; Voll, Reinhard; Manger, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2936-2948</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  A review on the mechanisms of bone and cartilage destruction, conventional disease-modifying antirheumatic drugs (DMARDs), TNF, IL-1, IL-6, and costimulation blockade, and B cell-depleting therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0_h1WhG8_wLVg90H21EOLACvtfcHk0lgtNU7GWSYlXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12rur%252FI&md5=9e56cdb792defe7c69298c6c1f98445a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fart.23951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23951%26sid%3Dliteratum%253Aachs%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DStach%26aufirst%3DC.%26aulast%3DZwerina%26aufirst%3DJ.%26aulast%3DVoll%26aufirst%3DR.%26aulast%3DManger%26aufirst%3DB.%26atitle%3DHow%2520antirheumatic%2520drugs%2520protect%2520joints%2520from%2520damage%2520in%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D2936%26epage%3D2948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Strand, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J. A.</span><span> </span><span class="NLM_article-title">Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials</span> <span class="citation_source-journal">Am. J. Manag. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=18415967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A280%3ADC%252BD1c3lsVOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=234-254&author=V.+Strandauthor=J.+A.+Singh&title=Improved+health-related+quality+of+life+with+effective+disease-modifying+antirheumatic+drugs%3A+evidence+from+randomized+controlled+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials</span></div><div class="casAuthors">Strand Vibeke; Singh Jasvinder A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of managed care</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">234-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the articular synovium, resulting in bony erosions, deformity, and, ultimately, joint destruction.  With associated comorbid conditions,especially cardiovascular, it can result in significant morbidity as well as early mortality.  Patients with RA report impairments in health-related quality of life (HRQOL) in comparison with age- and sex-matched populations without arthritis.  These decreases in HRQOL are attributed to the pain, impairment in physical function, and fatigue associated with this disease.  The introduction of new disease-modifying antirheumatic drugs has revolutionized the treatment of RA, particularly the biologic agents: etanercept, infliximab,adalimumab, abatacept, and rituximab.Importantly, administration of these agents has resulted in statistically significant and clinically meaningful improvements in physical function and HRQOL.  Many clinical studies confirm that with these therapies, RA patients report improvements in HRQOL, reflected by improved physical function, less fatigue, and better emotional and mental function.  Maintenance of physical function is no longer the only treatment goal for RA but also to improve, restore, and preserve HRQOL.  Results from pivotal clinical trials are analyzed in this article and the relevance of the data derived from the clinical studies to day-to-day clinical practice are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuq2tSJWA2IDUE-swuRqsHfW6udTcc2ebNmlfkCFYU9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3lsVOhtg%253D%253D&md5=107275f9d15e8ec78e60eb462f08a1ed</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrand%26aufirst%3DV.%26aulast%3DSingh%26aufirst%3DJ.%2BA.%26atitle%3DImproved%2520health-related%2520quality%2520of%2520life%2520with%2520effective%2520disease-modifying%2520antirheumatic%2520drugs%253A%2520evidence%2520from%2520randomized%2520controlled%2520trials%26jtitle%3DAm.%2520J.%2520Manag.%2520Care%26date%3D2008%26volume%3D14%26spage%3D234%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hale, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trollinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rihanek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthey, C. L.</span><span> </span><span class="NLM_article-title">Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">4246</span><span class="NLM_x">–</span> <span class="NLM_lpage">4252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=4246-4252&author=K.+K.+Haleauthor=D.+Trollingerauthor=M.+Rihanekauthor=C.+L.+Manthey&title=Differential+expression+and+activation+of+p38+mitogen-activated+protein+kinase+alpha%2C+beta%2C+gamma%2C+and+delta+in+inflammatory+cell+lineages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DK.%2BK.%26aulast%3DTrollinger%26aufirst%3DD.%26aulast%3DRihanek%26aufirst%3DM.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26atitle%3DDifferential%2520expression%2520and%2520activation%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%2520alpha%252C%2520beta%252C%2520gamma%252C%2520and%2520delta%2520in%2520inflammatory%2520cell%2520lineages%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D162%26spage%3D4246%26epage%3D4252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Korb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tohidast-Akrad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cetin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smolen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schett, G.</span><span> </span><span class="NLM_article-title">Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2745</span><span class="NLM_x">–</span> <span class="NLM_lpage">2756</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2Fart.22080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=16947383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWksLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=2745-2756&author=A.+Korbauthor=M.+Tohidast-Akradauthor=E.+Cetinauthor=R.+Axmannauthor=J.+Smolenauthor=G.+Schett&title=Differential+tissue+expression+and+activation+of+p38+MAPK+alpha%2C+beta%2C+gamma%2C+and+delta+isoforms+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Differential tissue expression and activation of p38 MAPK α, β, γ, and δ isoforms in rheumatoid arthritis</span></div><div class="casAuthors">Korb, Adelheid; Tohidast-Akrad, Makiyeh; Cetin, Erdal; Axmann, Roland; Smolen, Josef; Schett, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2745-2756</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. Activation of p38 MAPK is a key signaling step in chronic inflammation.  Inhibition of p38 MAPK is considered to be a promising future strategy to control inflammatory diseases, but studies of compds. to inhibit this kinase have so far been limited to investigation of their side effects.  We undertook the present study to investigate which specific mol., among 4 different isoforms of p38 MAPK (α, β, γ, and δ), is predominantly expressed and activated in inflammation.  Such knowledge could allow more specific targeting of p38 MAPK in inflammatory disease.  Methods. Studies were performed on inflamed tissue from patients with rheumatoid arthritis, as a prototype of inflammatory disease.  The expression and activation of the α, β, γ, and δ isoforms of p38 MAPK were examd. by immunoblotting, immunopptn., and immunohistochem.  Results. Immunoblot anal. revealed that α and γ were the predominantly expressed p38 MAPK isoforms, whereas the other 2 isoforms were less frequently present.  By immunohistochem., the expression of all p38 MAPK isoforms was localized to the synovial lining layer as well as to blood vessels.  Colabeling with cell-specific markers revealed that macrophages expressed the α and γ isoforms, synovial fibroblasts the β and γ isoforms, and granulocytes the δ isoform, whereas T lymphocytes were rarely pos. for any p38 MAPK isoform.  Double-labeling with isoform-specific antibody and pan-p38 antibody against the phosphorylated form of p38 MAPK showed activation of the α and γ isoforms.  Occasional activation of the β isoform was also noted in the synovial lining and the endothelium, whereas the δ isoform, although expressed in pericytes around blood vessels, was not phosphorylated.  This phosphorylation pattern was confirmed in immunopptn. studies in which activated p38 MAPK from synovial tissue exts. was identified as p38 MAPKα and -γ but not p38 MAPKβ or -δ.  Conclusion. These data show that the α and γ isoforms of p38 MAPK dominate in chronic inflammation.  Effective strategies to inhibit p38 MAPK should therefore aim to specifically target either or both of these isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcWrhAqc63DbVg90H21EOLACvtfcHk0lhicwPljWHhSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWksLjN&md5=33803193f35ab7b1ee652d4005e968a0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fart.22080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.22080%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DA.%26aulast%3DTohidast-Akrad%26aufirst%3DM.%26aulast%3DCetin%26aufirst%3DE.%26aulast%3DAxmann%26aufirst%3DR.%26aulast%3DSmolen%26aufirst%3DJ.%26aulast%3DSchett%26aufirst%3DG.%26atitle%3DDifferential%2520tissue%2520expression%2520and%2520activation%2520of%2520p38%2520MAPK%2520alpha%252C%2520beta%252C%2520gamma%252C%2520and%2520delta%2520isoforms%2520in%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2006%26volume%3D54%26spage%3D2745%26epage%3D2756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Schett, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tohidast-Akrad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smolen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitzan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redlich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, G.</span><span> </span><span class="NLM_article-title">Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2501</span><span class="NLM_x">–</span> <span class="NLM_lpage">2512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2F1529-0131%28200011%2943%3A11%3C2501%3A%3AAID-ANR18%3E3.0.CO%3B2-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=11083274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosFyntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2501-2512&author=G.+Schettauthor=M.+Tohidast-Akradauthor=J.+S.+Smolenauthor=B.+J.+Schmidauthor=C.+W.+Steinerauthor=P.+Bitzanauthor=P.+Zenzauthor=K.+Redlichauthor=Q.+Xuauthor=G.+Steiner&title=Activation%2C+differential+localization%2C+and+regulation+of+the+stress-activated+protein+kinases%2C+extracellular+signal-regulated+kinase%2C+c-JUN+N-terminal+kinase%2C+and+p38+mitogen-activated+protein+kinase%2C+in+synovial+tissue+and+cells+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis</span></div><div class="casAuthors">Schett, Georg; Tohidast-Akrad, Makiyeh; Smolen, Josef S.; Schmid, Beatrice Jahn; Steiner, Carl-Walter; Bitzan, Peter; Zenz, Peter; Redlich, Kurt; Xu, Qingbo; Steiner, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2501-2512</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">It was investigated whether stress- and mitogen-activated protein kinases (SAPK/MAPK), such as extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK, are significantly activated in rheumatoid arthritis (RA) synovial tissue compared with their activation in degenerative joint disease.  The localization of SAPK/MAPK activation in rheumatoid synovial tissue was assessed.  The factors leading to stress kinase activation in human synovial cells were studied.  Immunoblotting and immunohistol. by antibodies specific for the activated forms of SAPK/MAPK were performed on synovial tissue samples from patients with RA and osteoarthritis (OA).  In addn., untreated and cytokine-treated human synovial cells were assessed for SAPK/MAPK activation and down-stream signaling by various techniques.  ERK, JNK, and p38 MAPK activation were almost exclusively found in synovial tissue from RA, but not OA, patients.  ERK activation was localized around synovial microvessels, JNK activation was localized around and within mononuclear cell infiltrates, and p38 MAPK activation was obsd. in the synovial lining layer and in synovial endothelial cells.  Tumor necrosis factor α, interleukin-1 (IL-1), and IL-6 were the major inducers of ERK, JNK, and p38 MAPK activation in cultured human synovial cells.  Signaling through SAPK/MAPK pathways is a typical feature of chronic synovitis in RA, but not in degenerative joint disease.  SAPK/MAPK signaling is found at distinct sites in the synovial tissue, is induced by proinflammatory cytokines, and could lead to the design of highly targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow29LR5uTJLLVg90H21EOLACvtfcHk0lhicwPljWHhSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosFyntbk%253D&md5=ea27cc31ad37eaadb5391f3fc7e791b7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F1529-0131%28200011%2943%3A11%3C2501%3A%3AAID-ANR18%3E3.0.CO%3B2-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1529-0131%2528200011%252943%253A11%253C2501%253A%253AAID-ANR18%253E3.0.CO%253B2-K%26sid%3Dliteratum%253Aachs%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DTohidast-Akrad%26aufirst%3DM.%26aulast%3DSmolen%26aufirst%3DJ.%2BS.%26aulast%3DSchmid%26aufirst%3DB.%2BJ.%26aulast%3DSteiner%26aufirst%3DC.%2BW.%26aulast%3DBitzan%26aufirst%3DP.%26aulast%3DZenz%26aufirst%3DP.%26aulast%3DRedlich%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DSteiner%26aufirst%3DG.%26atitle%3DActivation%252C%2520differential%2520localization%252C%2520and%2520regulation%2520of%2520the%2520stress-activated%2520protein%2520kinases%252C%2520extracellular%2520signal-regulated%2520kinase%252C%2520c-JUN%2520N-terminal%2520kinase%252C%2520and%2520p38%2520mitogen-activated%2520protein%2520kinase%252C%2520in%2520synovial%2520tissue%2520and%2520cells%2520in%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2000%26volume%3D43%26spage%3D2501%26epage%3D2512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, T.</span><span> </span><span class="NLM_article-title">Pathway to the clinic: inhibition of P38 MAP kinase. A review of ten chemotypes selected for development</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.2174%2F1568026054985939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=16178744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1017-1029&author=D.+M.+Goldsteinauthor=T.+Gabriel&title=Pathway+to+the+clinic%3A+inhibition+of+P38+MAP+kinase.+A+review+of+ten+chemotypes+selected+for+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Pathway to the clinic: Inhibition of P38 MAP kinase. A review of ten chemotypes selected for development</span></div><div class="casAuthors">Goldstein, David M.; Gabriel, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  P38 mitogen activated protein (MAP) kinase remains the most compelling therapeutic target for oral drug intervention for a wide range of autoimmune disorders based on the central role this enzyme plays in inflammatory cell signaling.  Efforts to discover inhibitors of p38 suitable for clin. investigation have continued to escalate in part due to the incredible diversity of unique chemotypes reported to inhibit the enzyme.  Since 1993, at least seventeen p38 inhibitors have been reported to have entered into clin. trials.  Next generation inhibitors have been disclosed with improved potency for p38 and enhanced selectivity vs. other protein kinases.  Over the last three years, there have been multiple reports of cytokine suppression in humans following oral administration of p38 inhibitors.  These results, in addn. to proof of concept studies in rheumatoid patients, have established p38 inhibition as an avenue for the future management of pro-inflammatory cytokine based diseases.  This review describes the discovery at Roche of novel p38 inhibitors which have advanced into clin. trials.  The pharmacol. of the Roche compds. is then compared with eight chem. distinct p38 inhibitors known to have entered clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrve3HIFcxtSrVg90H21EOLACvtfcHk0li31__E-VYtyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK&md5=a4acd0c62b42c1f2eb4dafd8f8b60306</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1568026054985939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985939%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGabriel%26aufirst%3DT.%26atitle%3DPathway%2520to%2520the%2520clinic%253A%2520inhibition%2520of%2520P38%2520MAP%2520kinase.%2520A%2520review%2520of%2520ten%2520chemotypes%2520selected%2520for%2520development%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1017%26epage%3D1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pettus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span> </span><span class="NLM_article-title">Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006−2008</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.2174%2F156802608786264245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=18991731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWgtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1452-1467&author=L.+H.+Pettusauthor=R.+P.+Wurz&title=Small+molecule+p38+MAP+kinase+inhibitors+for+the+treatment+of+inflammatory+diseases%3A+novel+structures+and+developments+during+2006%E2%88%922008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006-2008</span></div><div class="casAuthors">Pettus, Liping H.; Wurz, Ryan P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1452-1467</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The p38 mitogen-activated protein (MAP) kinase plays a central role in inflammation.  It has been the subject of extensive efforts in both basic research and drug discovery for the treatment of inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, where aberrant cytokine signaling is the driver of the disease.  This article reviews the patent and journal publication activities during 2006-2008 describing novel small mol. p38α inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKQu_KXhrvHrVg90H21EOLACvtfcHk0li31__E-VYtyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWgtrfJ&md5=65fa3e72c52323dcd378421dd577a1b4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F156802608786264245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608786264245%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26atitle%3DSmall%2520molecule%2520p38%2520MAP%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%253A%2520novel%2520structures%2520and%2520developments%2520during%25202006%25E2%2588%25922008%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1452%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Genovese, M. C.</span><span> </span><span class="NLM_article-title">Inhibition of p38: has the fat lady sung?</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2Fart.24264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=19180514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A280%3ADC%252BD1M7isFyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=317-320&author=M.+C.+Genovese&title=Inhibition+of+p38%3A+has+the+fat+lady+sung%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38: has the fat lady sung?</span></div><div class="casAuthors">Genovese Mark C</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-20</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnT0jWinaMx0PI-fCgwosgfW6udTcc2eYHivZ1TMJzkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7isFyjtQ%253D%253D&md5=b8aaf19800021f9f8fb00f4220c8194a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fart.24264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24264%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26atitle%3DInhibition%2520of%2520p38%253A%2520has%2520the%2520fat%2520lady%2520sung%253F%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D317%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lh4LFwgk24Eaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Conway, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadepalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kull, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, J. T.</span><span> </span><span class="NLM_article-title">Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16078</span><span class="NLM_x">–</span> <span class="NLM_lpage">16083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1073%2Fpnas.0502000102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=16249345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WqsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16078-16083&author=J.+G.+Conwayauthor=B.+McDonaldauthor=J.+Parhamauthor=B.+Keithauthor=D.+W.+Rusnakauthor=E.+Shawauthor=M.+Jansenauthor=P.+Linauthor=A.+Payneauthor=R.+M.+Crosbyauthor=J.+H.+Johnsonauthor=L.+Frickauthor=M.+H.+Linauthor=S.+Depeeauthor=S.+Tadepalliauthor=B.+Vottaauthor=I.+Jamesauthor=K.+Fullerauthor=T.+J.+Chambersauthor=F.+C.+Kullauthor=S.+D.+Chamberlainauthor=J.+T.+Hutchins&title=Inhibition+of+colony-stimulating-factor-1+signaling+in+vivo+with+the+orally+bioavailable+cFMS+kinase+inhibitor+GW2580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580</span></div><div class="casAuthors">Conway, James G.; McDonald, Brad; Parham, Janet; Keith, Barry; Rusnak, David W.; Shaw, Eva; Jansen, Marilyn; Lin, Peiyuan; Payne, Alan; Crosby, Renae M.; Johnson, Jennifer H.; Frick, Lloyd; Lin, Min-Hwa Jasmine; Depee, Scott; Tadepalli, Sarva; Votta, Bart; James, Ian; Fuller, Karen; Chambers, Timothy J.; Kull, Frederick C.; Chamberlain, Stanley D.; Hutchins, Jeff T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">16078-16083</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Colony-stimulating-factor-1 (CSF-1) signaling through cFMS receptor kinase is increased in several diseases.  To help investigate the role of cFMS kinase in disease, the authors identified GW2580, an orally bioavailable inhibitor of cFMS kinase.  GW2580 completely inhibited human cFMS kinase in vitro at 0.06 μM and was inactive against 26 other kinases.  GW2580 at 1 μM completely inhibited CSF-1-induced growth of mouse M-NFS-60 myeloid cells and human monocytes and completely inhibited bone degrdn. in cultures of human osteoclasts, rat calvaria, and rat fetal long bone.  In contrast, GW2580 did not affect the growth of mouse NS0 lymphoblastoid cells, human endothelial cells, human fibroblasts, or five human tumor cell lines.  GW2580 also did not affect lipopolysaccharide (LPS)-induced TNF, IL-6, and prostaglandin E2 prodn. in freshly isolated human monocytes and mouse macrophages.  After oral administration, GW2580 blocked the ability of exogenous CSF-1 to increase LPS-induced IL-6 prodn. in mice, inhibited the growth of CSF-1-dependent M-NFS-60 tumor cells in the peritoneal cavity, and diminished the accumulation of macrophages in the peritoneal cavity after thioglycolate injection.  Unexpectedly, GW2580 inhibited LPS-induced TNF prodn. in mice, in contrast to effects on monocytes and macrophages in vitro.  In conclusion, GW2580's selective inhibition of monocyte growth and bone degrdn. is consistent with cFMS kinase inhibition.  The ability of GW2580 to chronically inhibit CSF-1 signaling through cFMS kinase in normal and tumor cells in vivo makes GW2580 a useful tool in assessing the role of cFMS kinase in normal and disease processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR5EGN2P59OrVg90H21EOLACvtfcHk0lh4LFwgk24Eaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WqsrzM&md5=6a5afc80faa9acec528fdbf766ad05bd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0502000102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0502000102%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DJ.%2BG.%26aulast%3DMcDonald%26aufirst%3DB.%26aulast%3DParham%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DShaw%26aufirst%3DE.%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DPayne%26aufirst%3DA.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DJohnson%26aufirst%3DJ.%2BH.%26aulast%3DFrick%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DM.%2BH.%26aulast%3DDepee%26aufirst%3DS.%26aulast%3DTadepalli%26aufirst%3DS.%26aulast%3DVotta%26aufirst%3DB.%26aulast%3DJames%26aufirst%3DI.%26aulast%3DFuller%26aufirst%3DK.%26aulast%3DChambers%26aufirst%3DT.%2BJ.%26aulast%3DKull%26aufirst%3DF.%2BC.%26aulast%3DChamberlain%26aufirst%3DS.%2BD.%26aulast%3DHutchins%26aufirst%3DJ.%2BT.%26atitle%3DInhibition%2520of%2520colony-stimulating-factor-1%2520signaling%2520in%2520vivo%2520with%2520the%2520orally%2520bioavailable%2520cFMS%2520kinase%2520inhibitor%2520GW2580%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D16078%26epage%3D16083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lhh62FPoK18gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, N. L.</span><span> </span><span class="NLM_article-title">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6255</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1038%2Fsj.onc.1205794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=12214266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=6255-6263&author=W.+Xiaauthor=R.+J.+Mullinauthor=B.+R.+Keithauthor=L.+H.+Liuauthor=H.+Maauthor=D.+W.+Rusnakauthor=G.+Owensauthor=K.+J.+Alligoodauthor=N.+L.+Spector&title=Anti-tumor+activity+of+GW572016%3A+a+dual+tyrosine+kinase+inhibitor+blocks+EGF+activation+of+EGFR%2FerbB2+and+downstream+Erk1%2F2+and+AKT+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways</span></div><div class="casAuthors">Xia, Wenle; Mullin, Robert J.; Keith, Barry R.; Liu, Lei-Hua; Ma, Hong; Rusnak, David W.; Owens, Gary; Alligood, Krystal J.; Spector, Neil L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6255-6263</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Dual EGFR/erbB2 inhibition is an attractive therapeutic strategy for epithelial tumors, as ligand-induced erbB2/EGFR heterodimerization triggers potent proliferative and survival signals.  Here we show that a small mol., GW572016, potently inhibits both EGFR and erbB2 tyrosine kinases leading to growth arrest and/or apoptosis in EGFR and erbB2-dependent tumor cell lines.  GW572016 markedly reduced tyrosine phosphorylation of EGFR and erbB2, and inhibited activation of Erk1/2 and AKT, downstream effectors of proliferation and cell survival, resp.  Complete inhibition of activated AKT in erbB2 overexpressing cells correlated with a 23-fold increase in apoptosis compared with vehicle controls.  EGF, often elevated in cancer patients, did not reverse the inhibitory effects of GW572016.  These observations were reproduced in vivo, where GW572016 treatment inhibited activation of EGFR, erbB2, Erk1/2 and AKT in human tumor xenografts.  Erk1/2 and AKT represent potential biomarkers to assess the clin. activity of GW572016.  Inhibition of activated AKT in EGFR or erbB2-dependent tumors by GW572016 may lead to tumor regressions when used as a monotherapy, or may enhance the anti-tumor activity of chemotherapeutics, since constitutive activation of AKT has been linked to chemo-resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYPkZ4sa88irVg90H21EOLACvtfcHk0lhh62FPoK18gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1yrs7w%253D&md5=38d6e25a7cfa1fdfe77fa2fea2c0aa0c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1205794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1205794%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DL.%2BH.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DOwens%26aufirst%3DG.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DSpector%26aufirst%3DN.%2BL.%26atitle%3DAnti-tumor%2520activity%2520of%2520GW572016%253A%2520a%2520dual%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520EGF%2520activation%2520of%2520EGFR%252FerbB2%2520and%2520downstream%2520Erk1%252F2%2520and%2520AKT%2520pathways%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D6255%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cuenda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doza, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=1995&pages=229-233&author=A.+Cuendaauthor=J.+Rouseauthor=Y.+N.+Dozaauthor=R.+Meierauthor=P.+Cohenauthor=T.+F.+Gallagherauthor=P.+R.+Youngauthor=J.+C.+Lee&title=SB+203580+is+a+specific+inhibitor+of+a+MAP+kinase+homologue+which+is+stimulated+by+cellular+stresses+and+interleukin-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuenda%26aufirst%3DA.%26aulast%3DRouse%26aufirst%3DJ.%26aulast%3DDoza%26aufirst%3DY.%2BN.%26aulast%3DMeier%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DGallagher%26aufirst%3DT.%2BF.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DSB%2520203580%2520is%2520a%2520specific%2520inhibitor%2520of%2520a%2520MAP%2520kinase%2520homologue%2520which%2520is%2520stimulated%2520by%2520cellular%2520stresses%2520and%2520interleukin-1%26jtitle%3DFEBS%2520Lett.%26date%3D1995%26volume%3D364%26spage%3D229%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=11896401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0lg4f2HYeC1bww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Hot topic: p38 kinase inhibitor</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.2174%2F1568026054985885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=919&author=K.+Leftheris&title=Hot+topic%3A+p38+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Editorial</span></div><div class="casAuthors">Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">919</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojP3_8LZLWfLVg90H21EOLACvtfcHk0lg4f2HYeC1bww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrnE&md5=162c76b306ecbf349b881bc27dc9a356</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F1568026054985885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985885%26sid%3Dliteratum%253Aachs%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DHot%2520topic%253A%2520p38%2520kinase%2520inhibitor%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Mavunkel, B. J.; Chakravarty, S.; Perumattam, J.; Dugar, S.; Lu, Q.; Liang, X.</span><span> </span><span class="NLM_article-title">Preparation of 5-[4-Benzylpiperidinyl(piperazinyl)]-indolecarboxamides as Inhibitors of p38 Kinase</span>. WO2000071535,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=B.+J.+Mavunkel&author=S.+Chakravarty&author=J.+Perumattam&author=S.+Dugar&author=Q.+Lu&author=X.+Liang&title=Preparation+of+5-%5B4-Benzylpiperidinyl%28piperazinyl%29%5D-indolecarboxamides+as+Inhibitors+of+p38+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMavunkel%26aufirst%3DB.%2BJ.%26atitle%3DPreparation%2520of%25205-%255B4-Benzylpiperidinyl%2528piperazinyl%2529%255D-indolecarboxamides%2520as%2520Inhibitors%2520of%2520p38%2520Kinase%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Oliver-Shaffer, P.-A.; Snoonian, J. R.</span><span> </span><span class="NLM_article-title">Processes for the Preparation of <i>N</i>-Heteroaryl-<i>N</i>-aryl-amines by Reacting an <i>N</i>-Aryl Carbamic Acid Ester with a Halo-Heteroaryl and Analogous Processes</span>. WO2004072038,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=P.-A.+Oliver-Shaffer&author=J.+R.+Snoonian&title=Processes+for+the+Preparation+of+N-Heteroaryl-N-aryl-amines+by+Reacting+an+N-Aryl+Carbamic+Acid+Ester+with+a+Halo-Heteroaryl+and+Analogous+Processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOliver-Shaffer%26aufirst%3DP.-A.%26atitle%3DProcesses%2520for%2520the%2520Preparation%2520of%2520N-Heteroaryl-N-aryl-amines%2520by%2520Reacting%2520an%2520N-Aryl%2520Carbamic%2520Acid%2520Ester%2520with%2520a%2520Halo-Heteroaryl%2520and%2520Analogous%2520Processes%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabbagh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phippard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suttmann, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. R.</span><span> </span><span class="NLM_article-title">Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1124%2Fjpet.108.139006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=18776065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=610-619&author=R.+J.+Hillauthor=K.+Dabbaghauthor=D.+Phippardauthor=C.+Liauthor=R.+T.+Suttmannauthor=M.+Welchauthor=E.+Pappauthor=K.+W.+Songauthor=K.+C.+Changauthor=D.+Leafferauthor=Y.+N.+Kimauthor=R.+T.+Robertsauthor=T.+S.+Zabkaauthor=D.+Audauthor=P.+J.+Dalauthor=A.+M.+Manningauthor=S.+L.+Pengauthor=D.+M.+Goldsteinauthor=B.+R.+Wong&title=Pamapimod%2C+a+novel+p38+mitogen-activated+protein+kinase+inhibitor%3A+preclinical+analysis+of+efficacy+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity</span></div><div class="casAuthors">Hill, Ronald J.; Dabbagh, Karim; Phippard, Deborah; Li, Ching; Suttmann, Rebecca T.; Welch, Mary; Papp, Eva; Song, Kyung W.; Chang, Kung-ching; Leaffer, David; Kim, Yong-Nam; Roberts, Richard T.; Zabka, Tanja S.; Aud, Dee; Dal Porto, Joseph; Manning, Anthony M.; Peng, Stanford L.; Goldstein, David M.; Wong, Brian R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">610-619</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P38α is a protein kinase that regulates the expression of inflammatory cytokines, suggesting a role in the pathogenesis of diseases such as rheumatoid arthritis (RA) or systemic lupus erythematosus.  Here, we describe the preclin. pharmacol. of pamapimod, a novel p38 mitogen-activated protein kinase inhibitor.  Pamapimod inhibited p38α and p38β enzymic activity, with IC50 values of 0.014±0.002 and 0.48±0.04 μM, resp.  There was no activity against p38δ or p38γ isoforms.  When profiled across 350 kinases, pamapimod bound only to four kinases in addn. to p38.  Cellular potency was assessed using phosphorylation of heat shock protein-27 and c-Jun as selective readouts for p38 and c-Jun NH2-terminal kinase (JNK), resp.  Pamapimod inhibited p38 (IC50, 0.06 μM), but inhibition of JNK was not detected.  Pamapimod also inhibited lipopolysaccharide (LPS)-stimulated tumor necrosis factor (TNF) α prodn. by monocytes, interleukin (IL)-1β prodn. in human whole blood, and spontaneous TNFα prodn. by synovial explants from RA patients.  LPS- and TNFα-stimulated prodn. of TNFα and IL-6 in rodents also was inhibited by pamapimod.  In murine collagen-induced arthritis, pamapimod reduced clin. signs of inflammation and bone loss at 50 mg/kg or greater.  In a rat model of hyperalgesia, pamapimod increased tolerance to pressure in a dose-dependent manner, suggesting an important role of p38 in pain assocd. with inflammation.  Finally, an analog of pamapimod that has equiv. potency and selectivity inhibited renal disease in lupus-prone MRL/lpr mice.  Our study demonstrates that pamapimod is a potent, selective inhibitor of p38α with the ability to inhibit the signs and symptoms of RA and other autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoImm011NnzW7Vg90H21EOLACvtfcHk0li2iTa18YxWcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtL3F&md5=9311aa6b1a51544ac755d1cc77cdd92f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.139006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.139006%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DDabbagh%26aufirst%3DK.%26aulast%3DPhippard%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DSuttmann%26aufirst%3DR.%2BT.%26aulast%3DWelch%26aufirst%3DM.%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DSong%26aufirst%3DK.%2BW.%26aulast%3DChang%26aufirst%3DK.%2BC.%26aulast%3DLeaffer%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DY.%2BN.%26aulast%3DRoberts%26aufirst%3DR.%2BT.%26aulast%3DZabka%26aufirst%3DT.%2BS.%26aulast%3DAud%26aufirst%3DD.%26aulast%3DDal%26aufirst%3DP.%2BJ.%26aulast%3DManning%26aufirst%3DA.%2BM.%26aulast%3DPeng%26aufirst%3DS.%2BL.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DWong%26aufirst%3DB.%2BR.%26atitle%3DPamapimod%252C%2520a%2520novel%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibitor%253A%2520preclinical%2520analysis%2520of%2520efficacy%2520and%2520selectivity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D610%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadus, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span> </span><span class="NLM_article-title">Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6402</span><span class="NLM_x">–</span> <span class="NLM_lpage">6411</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi900655f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=6402-6411&author=L.+Xingauthor=H.+S.+Shiehauthor=S.+R.+Selnessauthor=R.+V.+Devrajauthor=J.+K.+Walkerauthor=B.+Devadasauthor=H.+R.+Hopeauthor=R.+P.+Comptonauthor=J.+F.+Schindlerauthor=J.+L.+Hirschauthor=A.+G.+Bensonauthor=R.+G.+Kurumbailauthor=R.+A.+Stegemanauthor=J.+M.+Williamsauthor=R.+M.+Broadusauthor=Z.+Waldenauthor=J.+B.+Monahan&title=Structural+bioinformatics-based+prediction+of+exceptional+selectivity+of+p38+MAP+kinase+inhibitor+PH-797804"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fbi900655f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900655f%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DCompton%26aufirst%3DR.%2BP.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DBroadus%26aufirst%3DR.%2BM.%26aulast%3DWalden%26aufirst%3DZ.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DStructural%2520bioinformatics-based%2520prediction%2520of%2520exceptional%2520selectivity%2520of%2520p38%2520MAP%2520kinase%2520inhibitor%2520PH-797804%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D6402%26epage%3D6411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Murali Dhar, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todderud, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffolds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5019</span><span class="NLM_x">–</span> <span class="NLM_lpage">5024</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5019-5024&author=T.+G.+Murali+Dharauthor=S.+T.+Wrobleskiauthor=S.+Linauthor=J.+A.+Furchauthor=D.+S.+Nirschlauthor=Y.+Fanauthor=G.+Todderudauthor=S.+Pittauthor=A.+M.+Doweykoauthor=J.+S.+Sackauthor=A.+Mathurauthor=M.+McKinnonauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Synthesis+and+SAR+of+p38alpha+MAP+kinase+inhibitors+based+on+heterobicyclic+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurali%2BDhar%26aufirst%3DT.%2BG.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DFurch%26aufirst%3DJ.%2BA.%26aulast%3DNirschl%26aufirst%3DD.%2BS.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DTodderud%26aufirst%3DG.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520p38alpha%2520MAP%2520kinase%2520inhibitors%2520based%2520on%2520heterobicyclic%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5019%26epage%3D5024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canagarajah, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassisa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">abdel-Meguid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, E. J.</span><span> </span><span class="NLM_article-title">Structural basis of inhibitor selectivity in MAP kinases</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1016%2FS0969-2126%2898%2900113-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=9753691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADyaK1cXmsVKjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=1117-1128&author=Z.+Wangauthor=B.+J.+Canagarajahauthor=J.+C.+Boehmauthor=S.+Kassisaauthor=M.+H.+Cobbauthor=P.+R.+Youngauthor=S.+abdel-Meguidauthor=J.+L.+Adamsauthor=E.+J.+Goldsmith&title=Structural+basis+of+inhibitor+selectivity+in+MAP+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of inhibitor selectivity in MAP kinases</span></div><div class="casAuthors">Wang, Zhulun; Canagarajah, Bertram J.; Boehm, Jeffrey C.; Kassisa, Skouki; Cobb, Melanie H.; Young, Peter R.; Abdel-Meguid, Sherin; Adams, Jerry L.; Goldsmith, Elizabeth J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1117-1128</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">The mitogen-activated protein (MAP) kinases are important signaling mols. that participate in diverse cellular events and are potential targets for intervention in inflammation, cancer, and other diseases.  The MAP kinase p38 is responsive to environmental stresses and is involved in the prodn. of cytokines during inflammation.  In contrast, the activation of the MAP kinase ERK2 (extracellular-signal-regulated kinase 2) leads to cellular differentiation or proliferation.  The anti-inflammatory agent pyridinylimidazole and its analogs (SB [SmithKline Beecham] compds.) are highly potent and selective inhibitors of p38, but not of the closely related ERK2, or other serine/threonine kinases.  Although these compds. are known to bind to the ATP-binding site, the origin of the inhibitory specificity toward p38 is not clear.  We report the structural basis for the exceptional selectivity of these SB compds. for p38 over ERK2, as detd. by comparative crystallog.  In addn., structural data on the origin of olomoucine (a better inhibitor of ERK2) selectivity are presented.  The crystal structures of four SB compds. in complex with p38 and of one SB compd. and olomoucine in complex with ERK2 are presented here.  The SB inhibitors bind in an extended pocket in the active site and are complementary to the open domain structure of the low-activity form of p38.  The relatively closed domain structure of ERK2 is able to accommodate the smaller olomoucine.  The unique kinase-inhibitor interactions obsd. in these complexes originate from amino-acid replacements in the active site and replacements distant from the active site that affect the size of the domain interface.  This structural information should facilitate the design of better MAP-kinase inhibitors for the treatment of inflammation and other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrARvGug2CDHbVg90H21EOLACvtfcHk0lgQqXKF9893gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsVKjt7s%253D&md5=089de6c205e51ab37ba9cbce998cda5f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900113-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900113-0%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DCanagarajah%26aufirst%3DB.%2BJ.%26aulast%3DBoehm%26aufirst%3DJ.%2BC.%26aulast%3DKassisa%26aufirst%3DS.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3Dabdel-Meguid%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DGoldsmith%26aufirst%3DE.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520inhibitor%2520selectivity%2520in%2520MAP%2520kinases%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D1117%26epage%3D1128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Fitzgerald, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikounis, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span> </span><span class="NLM_article-title">Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=764-769&author=C.+E.+Fitzgeraldauthor=S.+B.+Patelauthor=J.+W.+Beckerauthor=P.+M.+Cameronauthor=D.+Zallerauthor=V.+B.+Pikounisauthor=S.+J.+O%27Keefeauthor=G.+Scapin&title=Structural+basis+for+p38alpha+MAP+kinase+quinazolinone+and+pyridol-pyrimidine+inhibitor+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DCameron%26aufirst%3DP.%2BM.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DPikounis%26aufirst%3DV.%2BB.%26aulast%3DO%2527Keefe%26aufirst%3DS.%2BJ.%26aulast%3DScapin%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520p38alpha%2520MAP%2520kinase%2520quinazolinone%2520and%2520pyridol-pyrimidine%2520inhibitor%2520specificity%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D764%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Herberich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosfeld, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span> </span><span class="NLM_article-title">Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6271</span><span class="NLM_x">–</span> <span class="NLM_lpage">6279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8005417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6271-6279&author=B.+Herberichauthor=G.+Q.+Caoauthor=P.+P.+Chakrabartiauthor=J.+R.+Falseyauthor=L.+Pettusauthor=R.+M.+Rzasaauthor=A.+B.+Reedauthor=A.+Reicheltauthor=K.+Shamauthor=M.+Thamanauthor=R.+P.+Wurzauthor=S.+Xuauthor=D.+Zhangauthor=F.+Hsiehauthor=M.+R.+Leeauthor=R.+Syedauthor=V.+Liauthor=D.+Grosfeldauthor=M.+H.+Plantauthor=B.+Henkleauthor=L.+Shermanauthor=S.+Middletonauthor=L.+M.+Wongauthor=A.+S.+Tasker&title=Discovery+of+highly+selective+and+potent+p38+inhibitors+based+on+a+phthalazine+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm8005417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8005417%26sid%3Dliteratum%253Aachs%26aulast%3DHerberich%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DG.%2BQ.%26aulast%3DChakrabarti%26aufirst%3DP.%2BP.%26aulast%3DFalsey%26aufirst%3DJ.%2BR.%26aulast%3DPettus%26aufirst%3DL.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DSham%26aufirst%3DK.%26aulast%3DThaman%26aufirst%3DM.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DSyed%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DGrosfeld%26aufirst%3DD.%26aulast%3DPlant%26aufirst%3DM.%2BH.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DSherman%26aufirst%3DL.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DL.%2BM.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26atitle%3DDiscovery%2520of%2520highly%2520selective%2520and%2520potent%2520p38%2520inhibitors%2520based%2520on%2520a%2520phthalazine%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6271%26epage%3D6279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lisnock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frantz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Laszlo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libby, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liverton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P.</span><span> </span><span class="NLM_article-title">Molecular basis for p38 protein kinase inhibitor specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">16573</span><span class="NLM_x">–</span> <span class="NLM_lpage">16581</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi981591x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=16573-16581&author=J.+Lisnockauthor=A.+Tebbenauthor=B.+Frantzauthor=E.+A.+O%27Neillauthor=G.+Croftauthor=S.+J.+O%27Keefeauthor=B.+Liauthor=C.+Hackerauthor=S.+de+Laszloauthor=A.+Smithauthor=B.+Libbyauthor=N.+Livertonauthor=J.+Hermesauthor=P.+LoGrasso&title=Molecular+basis+for+p38+protein+kinase+inhibitor+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fbi981591x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981591x%26sid%3Dliteratum%253Aachs%26aulast%3DLisnock%26aufirst%3DJ.%26aulast%3DTebben%26aufirst%3DA.%26aulast%3DFrantz%26aufirst%3DB.%26aulast%3DO%2527Neill%26aufirst%3DE.%2BA.%26aulast%3DCroft%26aufirst%3DG.%26aulast%3DO%2527Keefe%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DHacker%26aufirst%3DC.%26aulast%3Dde%2BLaszlo%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DLibby%26aufirst%3DB.%26aulast%3DLiverton%26aufirst%3DN.%26aulast%3DHermes%26aufirst%3DJ.%26aulast%3DLoGrasso%26aufirst%3DP.%26atitle%3DMolecular%2520basis%2520for%2520p38%2520protein%2520kinase%2520inhibitor%2520specificity%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D16573%26epage%3D16581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Cohen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chindalore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damjanov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delora, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimany, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulfield, J. P.</span><span> </span><span class="NLM_article-title">Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2Fart.24266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=19180516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1CgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=335-344&author=S.+B.+Cohenauthor=T.+T.+Chengauthor=V.+Chindaloreauthor=N.+Damjanovauthor=R.+Burgos-Vargasauthor=P.+Deloraauthor=K.+Zimanyauthor=H.+Traversauthor=J.+P.+Caulfield&title=Evaluation+of+the+efficacy+and+safety+of+pamapimod%2C+a+p38+MAP+kinase+inhibitor%2C+in+a+double-blind%2C+methotrexate-controlled+study+of+patients+with+active+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active Rheumatoid arthritis</span></div><div class="casAuthors">Cohen, Stanley B.; Cheng, Tien-Tsai; Chindalore, Vishala; Damjanov, Nemanja; Burgos-Vargas, Ruben; DeLora, Patricia; Zimany, Kathleen; Travers, Helen; Caulfield, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">335-344</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To det. the efficacy and safety of pamapimod (a selective inhibitor of the α-isoform of p38 MAP kinase) as monotherapy in comparison with methotrexate (MTX) treatment in adult patients with active rheumatoid arthritis (RA).  Methods: Patients were randomly assigned to 1 of 4 treatment groups and received 12 wk of double-blind treatment.  One group received MTX (7.5 mg/wk with planned escalation to 20 mg/wk), and 3 groups received pamapimod (50, 150, or 300 mg) once daily.  The primary efficacy end point was the proportion of patients meeting the American College of Rheumatol. 20% improvement criteria (achieving an ACR20 response) at 12 wk.  Secondary end points included ACR50 and ACR70 responses, change from baseline in the Disease Activity Score in 28 joints (DAS28), categorical analyses of DAS28/European League Against Rheumatism response, and change from baseline in each parameter of the ACR core set of measures.  Safety monitoring included recording of adverse events (AEs), lab. testing, immunol. assessments, administration of electrocardiograms, and assessment of vital signs.  Results: Patients assigned to receive MTX and pamapimod had similar demographics and baseline characteristics.  At week 12, fewer patients taking pamapimod had an ACR20 response (23%, 18%, and 31% in the 50-, 150-, and 300-mg groups, resp.) compared with patients taking MTX (45%).  Secondary efficacy end points showed a similar pattern.  AEs were typically characterized as mild and included infections, skin disorders, and dizziness.  Pamapimod was generally well tolerated, but the 300-mg dose appeared to be more toxic than either the 2 lower doses or MTX.  Conclusion: The present results showed that pamapimod was not as effective as MTX in the treatment of active RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp98GB6seTS2rVg90H21EOLACvtfcHk0lgrraNZLyJPUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1CgtL4%253D&md5=d76a0ea256ab02b1c16d388be13c2f3e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fart.24266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24266%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BB.%26aulast%3DCheng%26aufirst%3DT.%2BT.%26aulast%3DChindalore%26aufirst%3DV.%26aulast%3DDamjanov%26aufirst%3DN.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DDelora%26aufirst%3DP.%26aulast%3DZimany%26aufirst%3DK.%26aulast%3DTravers%26aufirst%3DH.%26aulast%3DCaulfield%26aufirst%3DJ.%2BP.%26atitle%3DEvaluation%2520of%2520the%2520efficacy%2520and%2520safety%2520of%2520pamapimod%252C%2520a%2520p38%2520MAP%2520kinase%2520inhibitor%252C%2520in%2520a%2520double-blind%252C%2520methotrexate-controlled%2520study%2520of%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D335%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Alten, R. E.; Zerbini, C.; Jeka, S.; Irazoque, F.; Khatib, F.; Emery, P.; Bertasso, A.; Rabbia, M.; Caulfield, J. P.</span><span> </span><span class="NLM_article-title">Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy</span>.  <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1136/ard.2008.104802</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1136%2Fard.2008.104802" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=R.+E.+Alten&author=C.+Zerbini&author=S.+Jeka&author=F.+Irazoque&author=F.+Khatib&author=P.+Emery&author=A.+Bertasso&author=M.+Rabbia&author=J.+P.+Caulfield&title=Efficacy+and+safety+of+pamapimod+in+patients+with+active+rheumatoid+arthritis+receiving+stable+methotrexate+therapy&doi=10.1136%2Fard.2008.104802"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1136%2Fard.2008.104802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2008.104802%26sid%3Dliteratum%253Aachs%26aulast%3DAlten%26aufirst%3DR.%2BE.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520pamapimod%2520in%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%2520receiving%2520stable%2520methotrexate%2520therapy%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2009%26doi%3D10.1136%2Fard.2008.104802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Haddad, J. J.</span><span> </span><span class="NLM_article-title">VX-745. Vertex Pharmaceuticals</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1070</span><span class="NLM_x">–</span> <span class="NLM_lpage">1076</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=1070-1076&author=J.+J.+Haddad&title=VX-745.+Vertex+Pharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaddad%26aufirst%3DJ.%2BJ.%26atitle%3DVX-745.%2520Vertex%2520Pharmaceuticals%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2001%26volume%3D2%26spage%3D1070%26epage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Weisman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merica, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Munley, S. A</span><span> </span><span class="NLM_article-title">Double-blind, placebo-controlled, trial of VX-745, an oral p38 mitogen activated protein kinase (MAPK) inhibitor, in patients with rheumatoid arthritis (RA)</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_elocation-id">FRI0018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&issue=Suppl.+1&author=M.+Weismanauthor=D.+Furstauthor=M.+Schiffauthor=R.+Kauffmanauthor=E.+Mericaauthor=S.+A+Martin-Munley&title=Double-blind%2C+placebo-controlled%2C+trial+of+VX-745%2C+an+oral+p38+mitogen+activated+protein+kinase+%28MAPK%29+inhibitor%2C+in+patients+with+rheumatoid+arthritis+%28RA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeisman%26aufirst%3DM.%26aulast%3DFurst%26aufirst%3DD.%26aulast%3DSchiff%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DR.%26aulast%3DMerica%26aufirst%3DE.%26aulast%3DMartin-Munley%26aufirst%3DS.%2BA%26atitle%3DDouble-blind%252C%2520placebo-controlled%252C%2520trial%2520of%2520VX-745%252C%2520an%2520oral%2520p38%2520mitogen%2520activated%2520protein%2520kinase%2520%2528MAPK%2529%2520inhibitor%252C%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%2520%2528RA%2529%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2002%26volume%3D61%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span>Vertex Homepage. <a href="http://www.vrtx.com/" class="extLink">http://www.vrtx.com/</a> (accessed Sep 24,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vertex+Homepage.+http%3A%2F%2Fwww.vrtx.com%2F+%28accessed+Sep+24%2C+2001%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Norman, P.</span><span> </span><span class="NLM_article-title">Advances in anti-arthritic agents. SMI's Third Annual Conference</span> <span class="citation_source-journal">IDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=530-538&author=P.+Norman&title=Advances+in+anti-arthritic+agents.+SMI%27s+Third+Annual+Conference"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DAdvances%2520in%2520anti-arthritic%2520agents.%2520SMI%2527s%2520Third%2520Annual%2520Conference%26jtitle%3DIDrugs%26date%3D2002%26volume%3D5%26spage%3D530%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ding, C.</span><span> </span><span class="NLM_article-title">Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1020</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=1020-1025&author=C.+Ding&title=Drug+evaluation%3A+VX-702%2C+a+MAP+kinase+inhibitor+for+rheumatoid+arthritis+and+acute+coronary+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26atitle%3DDrug%2520evaluation%253A%2520VX-702%252C%2520a%2520MAP%2520kinase%2520inhibitor%2520for%2520rheumatoid%2520arthritis%2520and%2520acute%2520coronary%2520syndrome%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D7%26spage%3D1020%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Damjanov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer-Green, G. T.</span><span> </span><span class="NLM_article-title">Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1232</span><span class="NLM_x">–</span> <span class="NLM_lpage">1241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1002%2Fart.24485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=19404957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A280%3ADC%252BD1MzkvFarsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=1232-1241&author=N.+Damjanovauthor=R.+S.+Kauffmanauthor=G.+T.+Spencer-Green&title=Efficacy%2C+pharmacodynamics%2C+and+safety+of+VX-702%2C+a+novel+p38+MAPK+inhibitor%2C+in+rheumatoid+arthritis%3A+results+of+two+randomized%2C+double-blind%2C+placebo-controlled+clinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies</span></div><div class="casAuthors">Damjanov Nemanja; Kauffman Robert S; Spencer-Green George T</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1232-41</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">OBJECTIVE:  To assess the efficacy and safety of VX-702, a p38 MAPK inhibitor, in patients with active, moderate-to-severe rheumatoid arthritis (RA).  METHODS:  Two 12-week, double-blind, placebo-controlled studies of VX-702 were conducted in patients with active, moderate-to-severe RA.  In the VeRA study, 313 patients received placebo or 2 daily doses of VX-702.  In Study 304, 117 patients received placebo, daily VX-702, or twice weekly VX-702 in addition to concomitant methotrexate (MTX).  Study end points included the proportion of patients meeting the American College of Rheumatology 20% improvement criteria (an ACR20 response), ACR50 and ACR70 responses, changes in the serum levels of biomarkers of inflammation, and safety assessments.  RESULTS:  The numerically superior ACR20 response rates among patients receiving VX-702 compared with those receiving placebo in both studies did not reach pairwise statistical significance at the highest doses in either study.  At week 12 in the VeRA study, ACR20 response rates were 40%, 36%, and 28% among patients receiving 10 mg of VX-702, 5 mg of VX-702, and placebo, respectively.  In Study 304, the response rates were 40%, 44%, and 22% for patients receiving 10 mg VX-702 daily plus MTX, 10 mg VX-702 twice weekly plus MTX, and placebo, respectively.  Reductions in the levels of C-reactive protein, soluble tumor necrosis factor receptor p55, and serum amyloid A were observed as early as week 1 in both studies, but these levels rapidly returned to baseline values by week 4.  The overall frequency of adverse events was similar between the VX-702 and placebo groups.  In the VeRA study, serious infections were more frequent in the VX-702 groups compared with the placebo group (2.4% versus 0%) but not in Study 304 (2.6% versus 4.9%).  CONCLUSION:  The modest clinical efficacy plus the transient suppression of biomarkers of inflammation observed in this study suggest that p38 MAPK inhibition may not provide meaningful, sustained suppression of the chronic inflammation seen in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuFLVCXOhEpYkFb3mqPUYDfW6udTcc2eaJTs6ECiDRr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzkvFarsQ%253D%253D&md5=f23f3b448939ed3cafd7d20410ff81f7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fart.24485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24485%26sid%3Dliteratum%253Aachs%26aulast%3DDamjanov%26aufirst%3DN.%26aulast%3DKauffman%26aufirst%3DR.%2BS.%26aulast%3DSpencer-Green%26aufirst%3DG.%2BT.%26atitle%3DEfficacy%252C%2520pharmacodynamics%252C%2520and%2520safety%2520of%2520VX-702%252C%2520a%2520novel%2520p38%2520MAPK%2520inhibitor%252C%2520in%2520rheumatoid%2520arthritis%253A%2520results%2520of%2520two%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520clinical%2520studies%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D1232%26epage%3D1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Nikas, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drosos, A. A.</span><span> </span><span class="NLM_article-title">SCIO-469 Scios Inc</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1205-1212&author=S.+N.+Nikasauthor=A.+A.+Drosos&title=SCIO-469+Scios+Inc"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNikas%26aufirst%3DS.%2BN.%26aulast%3DDrosos%26aufirst%3DA.%2BA.%26atitle%3DSCIO-469%2520Scios%2520Inc%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D1205%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Amakye, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beazley, W.</span><span> </span><span class="NLM_article-title">Pharmacokinetics (PK) and pharmacodynamics (PD) of SCIO-469, a p38 gamma MAP kinase inhibitor</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">P54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2004&pages=P54&author=D.+Amakyeauthor=S.+Tongauthor=C.+Wardauthor=W.+Beazley&title=Pharmacokinetics+%28PK%29+and+pharmacodynamics+%28PD%29+of+SCIO-469%2C+a+p38+gamma+MAP+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmakye%26aufirst%3DD.%26aulast%3DTong%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DC.%26aulast%3DBeazley%26aufirst%3DW.%26atitle%3DPharmacokinetics%2520%2528PK%2529%2520and%2520pharmacodynamics%2520%2528PD%2529%2520of%2520SCIO-469%252C%2520a%2520p38%2520gamma%2520MAP%2520kinase%2520inhibitor%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2004%26volume%3D75%26spage%3DP54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Schreiner, G.</span><span> </span><span class="NLM_article-title">Kinase Inhibitors: The Next Generation of Anti-Arthritic Agents. Scios: Case Study in Their p38 Kinase Inhibitor Program</span>. Presented at the Advances in Anti-Arthritic Agents SMI Conference,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=G.+Schreiner&title=Kinase+Inhibitors%3A+The+Next+Generation+of+Anti-Arthritic+Agents.+Scios%3A+Case+Study+in+Their+p38+Kinase+Inhibitor+Program"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiner%26aufirst%3DG.%26atitle%3DKinase%2520Inhibitors%253A%2520The%2520Next%2520Generation%2520of%2520Anti-Arthritic%2520Agents.%2520Scios%253A%2520Case%2520Study%2520in%2520Their%2520p38%2520Kinase%2520Inhibitor%2520Program%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Ji, R.-R.</span><span> </span><span class="NLM_article-title">Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases</span> <span class="citation_source-journal">Curr. Drug Targets: Inflammation Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.2174%2F1568010043343804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=15379598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=299-303&author=R.-R.+Ji&title=Peripheral+and+central+mechanisms+of+inflammatory+pain%2C+with+emphasis+on+MAP+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases</span></div><div class="casAuthors">Ji, Ru-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: Inflammation & Allergy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-303</span>CODEN:
                <span class="NLM_cas:coden">CDTICU</span>;
        ISSN:<span class="NLM_cas:issn">1568-010X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tissue injury is assocd. with inflammation and produces inflammatory pain.  In animal models, inflammatory pain is normally produced by injection of irritative chems. into the hindpaw or joint of animal.  Inflammatory pain manifests as an expression of neuronal plasticity, which consists of peripheral sensitization (increased sensitivity of primary sensory neurons in the peripheral nervous system, PNS) and central sensitization (increased sensitivity of spinal dorsal horn and other neurons in the central nervous system, CNS).  Activation of several protein kinases causes both forms of sensitization via posttranslational, translational, and transcriptional regulation.  In particular, mitogen-activated protein kinase (MAPK), such as ERK and p38, is activated by inflammatory mediators in primary sensory and secondary order dorsal horn neurons and participates in the generation and maintenance of inflammatory pain.  Development of specific MAPK inhibitors will open a new avenue to the pharmacol. intervention of inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLor-Z5BbQMrVg90H21EOLACvtfcHk0lhc4tCA0hKivg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVemur4%253D&md5=8fdb40d9143d70b148dfcb92d7186689</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F1568010043343804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568010043343804%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DR.-R.%26atitle%3DPeripheral%2520and%2520central%2520mechanisms%2520of%2520inflammatory%2520pain%252C%2520with%2520emphasis%2520on%2520MAP%2520kinases%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520Inflammation%2520Allergy%26date%3D2004%26volume%3D3%26spage%3D299%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. G.</span><span> </span><span class="NLM_article-title">p38 pathway kinases as anti-inflammatory drug targets</span> <span class="citation_source-journal">J. Dent. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1177%2F154405910708600902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=17720847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOqurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2007&pages=800-811&author=J.+F.+Schindlerauthor=J.+B.+Monahanauthor=W.+G.+Smith&title=p38+pathway+kinases+as+anti-inflammatory+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">p38 pathway kinases as anti-inflammatory drug targets</span></div><div class="casAuthors">Schindler, J. F.; Monahan, J. B.; Smith, W. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dental Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">800-811</span>CODEN:
                <span class="NLM_cas:coden">JDREAF</span>;
        ISSN:<span class="NLM_cas:issn">0022-0345</span>.
    
            (<span class="NLM_cas:orgname">International Association for Dental Research</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinases (MAPK) are intracellular signaling mols. involved in cytokine synthesis.  Several classes of mammalian MAPK have been identified, including extracellular signal-regulated kinase, c-jun N-terminal kinase, and p38 MAP kinase.  P38α is a key MAPK involved in tumor necrosis factor α and other cytokine prodn., as well as enzyme induction (cyclooxygenase-2, inducible nitric oxide synthase, and matrix metalloproteinases) and adhesion mol. expression.  An understanding of the broad biol. and pathophysiol. roles of p38 MAPK family members has grown significantly over the past decade, as has the complexity of the signaling network leading to their activation.  Downstream substrates of MAPK include other kinases (e.g., mitogen-activated protein-kinase-activated protein kinase 2) and factors that regulate transcription, nuclear export, and mRNA stability and translation.  The high-resoln. crystal structure of p38α has led to the design of selective inhibitors that have good pharmacol. activity.  Despite the strong rationale for MAPK inhibitors in human disease, direct proof of concept in the clinic has yet to be demonstrated, with most compds. demonstrating dose-limiting adverse effects.  The role of MAPK in inflammation makes them attractive targets for new therapies, and efforts are continuing to identify newer, more selective inhibitors for inflammatory diseases.  Abbreviations used: MAPK, mitogen-activated protein kinase; ERK, extracellular signaling kinase; JNK, c-jun N-terminal kinase; COX2, cyclo-oxygenase-2; iNOS, inducible nitric oxide synthase; MMP, matrix metalloproteinase; MAPKK, mitogen-activated protein kinase kinase; MK-2, mitogen-activated protein-kinase-activated protein kinase-2; MAPKAP, mitogen-activated protein kinase-activated protein; MAPKKK, mitogen-activated protein kinase kinase kinase; RANKL, receptor activator of NF-κB ligand; MNK, MAP kinase signal-integrating kinase; MSK, mitogen and stress-activated protein kinase; RSK, ribosomal S6 kinase; AP-1, activator protein-1; Tp1, tumor progression locus 2; IL, interleukin; ASK1, apoptosis signal-regulating kinase 1; TAO, thousand-and-one amino acids; MLK3, mixed-lineage kinase 3; TBK, transforming growth factor β activated protein kinase; TGFβ, transforming growth factor β; LPS, lipopolysaccharide; TRAF6, TNF receptor-assocd. factor 6; MKK, mitogen-activated protein kinase kinase; TAK-1, TGF-beta activated protein kinase; GRK2, G-protein coupled receptor kinase-2 MKPs, MAP kinase phosphatases; PRAK, p38 regulated/ activated protein kinase; IFNγ, interferon gamma; AREs, AU-rich elements; AUBPs, AU-rich binding proteins; TTP, tristetraprolin; hnRNP A0, heterogeneous nuclear ribonuclear protein A0; HUR, human R antigen; PGE2, prostaglandin E2; Hsp27, small heat-shock protein-27; TNF-α, tumor necrosis factor alpha.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp29bqrL8B2KrVg90H21EOLACvtfcHk0lj5udXBOnaPWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOqurfN&md5=38486f3ec8603a4bf793b111441617b4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1177%2F154405910708600902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F154405910708600902%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DSmith%26aufirst%3DW.%2BG.%26atitle%3Dp38%2520pathway%2520kinases%2520as%2520anti-inflammatory%2520drug%2520targets%26jtitle%3DJ.%2520Dent.%2520Res.%26date%3D2007%26volume%3D86%26spage%3D800%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Tong, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desjardins, P.</span><span> </span><span class="NLM_article-title">SCIO-469, a novel p38 alpha MAPK inhibitor provides efficacy in acute post-surgical dental pain</span> <span class="citation_source-journal">Am. Soc. Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">PI-1</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2004&pages=PI-1&author=S.+E.+Tongauthor=S.+E.+Danielsauthor=T.+Montanoauthor=S.+Changauthor=P.+Desjardins&title=SCIO-469%2C+a+novel+p38+alpha+MAPK+inhibitor+provides+efficacy+in+acute+post-surgical+dental+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DS.%2BE.%26aulast%3DDaniels%26aufirst%3DS.%2BE.%26aulast%3DMontano%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DDesjardins%26aufirst%3DP.%26atitle%3DSCIO-469%252C%2520a%2520novel%2520p38%2520alpha%2520MAPK%2520inhibitor%2520provides%2520efficacy%2520in%2520acute%2520post-surgical%2520dental%2520pain%26jtitle%3DAm.%2520Soc.%2520Clin.%2520Pharmacol.%2520Ther.%26date%3D2004%26volume%3D75%26spage%3DPI-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Navas, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haghnazari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Young, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoun, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mavunkel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perumattam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medicherla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protter, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiner, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, L. S.</span><span> </span><span class="NLM_article-title">Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1017-1027&author=T.+A.+Navasauthor=A.+N.+Nguyenauthor=T.+Hideshimaauthor=M.+Reddyauthor=J.+Y.+Maauthor=E.+Haghnazariauthor=M.+Hensonauthor=E.+G.+Stebbinsauthor=I.+Kerrauthor=G.+O%27Youngauthor=A.+M.+Kapounauthor=S.+Chakravartyauthor=B.+Mavunkelauthor=J.+Perumattamauthor=G.+Luedtkeauthor=S.+Dugarauthor=S.+Medicherlaauthor=A.+A.+Protterauthor=G.+F.+Schreinerauthor=K.+C.+Andersonauthor=L.+S.+Higgins&title=Inhibition+of+p38alpha+MAPK+enhances+proteasome+inhibitor-induced+apoptosis+of+myeloma+cells+by+modulating+Hsp27%2C+Bcl-X%28L%29%2C+Mcl-1+and+p53+levels+in+vitro+and+inhibits+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNavas%26aufirst%3DT.%2BA.%26aulast%3DNguyen%26aufirst%3DA.%2BN.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DReddy%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DHaghnazari%26aufirst%3DE.%26aulast%3DHenson%26aufirst%3DM.%26aulast%3DStebbins%26aufirst%3DE.%2BG.%26aulast%3DKerr%26aufirst%3DI.%26aulast%3DO%2527Young%26aufirst%3DG.%26aulast%3DKapoun%26aufirst%3DA.%2BM.%26aulast%3DChakravarty%26aufirst%3DS.%26aulast%3DMavunkel%26aufirst%3DB.%26aulast%3DPerumattam%26aufirst%3DJ.%26aulast%3DLuedtke%26aufirst%3DG.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DMedicherla%26aufirst%3DS.%26aulast%3DProtter%26aufirst%3DA.%2BA.%26aulast%3DSchreiner%26aufirst%3DG.%2BF.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DHiggins%26aufirst%3DL.%2BS.%26atitle%3DInhibition%2520of%2520p38alpha%2520MAPK%2520enhances%2520proteasome%2520inhibitor-induced%2520apoptosis%2520of%2520myeloma%2520cells%2520by%2520modulating%2520Hsp27%252C%2520Bcl-X%2528L%2529%252C%2520Mcl-1%2520and%2520p53%2520levels%2520in%2520vitro%2520and%2520inhibits%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DLeukemia%26date%3D2006%26volume%3D20%26spage%3D1017%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Siegel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohl, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lust, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensinger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziarz, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetticaden, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span> </span><span class="NLM_article-title">Phase II trial of SCIO-469 as monotherapy (M) or in combination with bortezomib (MB) in relapsed refractory multiple myeloma (MM)</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_elocation-id">3580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&author=D.+S.+Siegelauthor=A.+Krishnanauthor=S.+Lonialauthor=G.+Chattaauthor=M.+Alsinaauthor=S.+Jagannathauthor=P.+Richardsonauthor=R.+J.+Hohlauthor=J.+A.+Lustauthor=W.+Bensingerauthor=G.+Carrumauthor=J.+Morebauthor=A.+Simicauthor=B.+Barlogieauthor=R.+T.+Maziarzauthor=K.+C.+Andersonauthor=J.+Linauthor=A.+Loweauthor=S.+Vetticadenauthor=J.+Zhu&title=Phase+II+trial+of+SCIO-469+as+monotherapy+%28M%29+or+in+combination+with+bortezomib+%28MB%29+in+relapsed+refractory+multiple+myeloma+%28MM%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%2BS.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DChatta%26aufirst%3DG.%26aulast%3DAlsina%26aufirst%3DM.%26aulast%3DJagannath%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DHohl%26aufirst%3DR.%2BJ.%26aulast%3DLust%26aufirst%3DJ.%2BA.%26aulast%3DBensinger%26aufirst%3DW.%26aulast%3DCarrum%26aufirst%3DG.%26aulast%3DMoreb%26aufirst%3DJ.%26aulast%3DSimic%26aufirst%3DA.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DMaziarz%26aufirst%3DR.%2BT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLowe%26aufirst%3DA.%26aulast%3DVetticaden%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DPhase%2520II%2520trial%2520of%2520SCIO-469%2520as%2520monotherapy%2520%2528M%2529%2520or%2520in%2520combination%2520with%2520bortezomib%2520%2528MB%2529%2520in%2520relapsed%2520refractory%2520multiple%2520myeloma%2520%2528MM%2529%26jtitle%3DBlood%26date%3D2006%26volume%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Genovese, M. C.; Cohen, S. B.; Wofsy, D.; Weinblatt, M. E.; Firestein, G. S.; Brahn, E.; Strand, V.; Baker, D. G.; Tong, S. E.</span><span> </span><span class="NLM_article-title">A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of an Oral p38α MAPK Inhibitor, SCIO-469, in Patients with Active Rheumatoid Arthritis</span>. Presented at the American College of Rheumatology Scientifc Meeting, San Francisco, CA,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract 715.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+C.+Genovese&author=S.+B.+Cohen&author=D.+Wofsy&author=M.+E.+Weinblatt&author=G.+S.+Firestein&author=E.+Brahn&author=V.+Strand&author=D.+G.+Baker&author=S.+E.+Tong&title=A+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Phase+2+Study+of+an+Oral+p38%CE%B1+MAPK+Inhibitor%2C+SCIO-469%2C+in+Patients+with+Active+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26atitle%3DA%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Phase%25202%2520Study%2520of%2520an%2520Oral%2520p38%25CE%25B1%2520MAPK%2520Inhibitor%252C%2520SCIO-469%252C%2520in%2520Patients%2520with%2520Active%2520Rheumatoid%2520Arthritis%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitfelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span> </span><span class="NLM_article-title">Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2994</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020057r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2994-3008&author=J.+Reganauthor=S.+Breitfelderauthor=P.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=B.+Klausauthor=J.+Madwedauthor=M.+Moriakauthor=N.+Mossauthor=C.+Pargellisauthor=S.+Pavauthor=A.+Protoauthor=A.+Swinamerauthor=L.+Tongauthor=C.+Torcellini&title=Pyrazole+urea-based+inhibitors+of+p38+MAP+kinase%3A+from+lead+compound+to+clinical+candidate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate</span></div><div class="casAuthors">Regan, John; Breitfelder, Steffen; Cirillo, Pier; Gilmore, Thomas; Graham, Anne G.; Hickey, Eugene; Klaus, Bernhard; Madwed, Jeffrey; Moriak, Monica; Moss, Neil; Pargellis, Chris; Pav, Sue; Proto, Alfred; Swinamer, Alan; Tong, Liang; Torcellini, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2994-3008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase.  Importantly, a key binding domain that is distinct from the ATP (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.  We describe the correlation of the structure-activity relationships and crystallog. structures of these inhibitors with p38.  In addn., we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site.  This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of Compd. 45 (BIRB 796) as a clin. candidate for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotOOfLV3xRbVg90H21EOLACvtfcHk0limnYrn794tEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D&md5=e473f514179c8fe24ab3efccc292b6c6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm020057r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020057r%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DBreitfelder%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKlaus%26aufirst%3DB.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DTorcellini%26aufirst%3DC.%26atitle%3DPyrazole%2520urea-based%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%253A%2520from%2520lead%2520compound%2520to%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2994%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Haens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geboes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yurcov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golovenko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffgen, J.</span><span> </span><span class="NLM_article-title">Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Clin. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1016%2Fj.cgh.2005.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=16527696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFOqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=325-334&author=S.+Schreiberauthor=B.+Feaganauthor=G.+D%27Haensauthor=J.+F.+Colombelauthor=K.+Geboesauthor=M.+Yurcovauthor=V.+Isakovauthor=O.+Golovenkoauthor=C.+N.+Bernsteinauthor=D.+Ludwigauthor=T.+Winterauthor=U.+Meierauthor=C.+Yongauthor=J.+Steffgen&title=Oral+p38+mitogen-activated+protein+kinase+inhibition+with+BIRB+796+for+active+Crohn%27s+disease%3A+a+randomized%2C+double-blind%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double- blind, placebo- controlled trial</span></div><div class="casAuthors">Schreiber, Stefan; Feagan, Brian; D'Haens, Geert; Colombel, Jean-Frederic; Geboes, Karel; Yurcov, Mikhail; Isakov, Vasily; Golovenko, Oleg; Bernstein, Charles N.; Ludwig, Diether; Winter, Trevor; Meier, Ulrich; Yong, Chan; Steffgen, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-334</span>CODEN:
                <span class="NLM_cas:coden">CGHLAW</span>;
        ISSN:<span class="NLM_cas:issn">1542-3565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The p38 mitogen-activated protein kinase (MAPK) regulates the expression of proinflammatory cytokines, which play a crit. role in the pathophysiol. of Crohn's disease (CD).  This study investigated the efficacy and safety of BIRB 796, a highly potent inhibitor of p38 MAPK, in chronic active CD.  In a multicenter, multinational trial, 284 patients with moderate to severe CD were randomized to receive placebo, or 10, 20, 30, or 60 mg of BIRB 796 twice daily for 8 wk.  Clin. endpoints were based on std. safety assessments, CD Activity Index, C-reactive protein levels, and quality of life (Inflammatory Bowel Disease Questionnaire).  In a substudy, the Crohn's Disease Endoscopic Index of Severity and histol. results of biopsy specimens were assessed.  No clin. efficacy (primary end point, clin. remission; secondary end point, clin. response; Inflammatory Bowel Disease Questionnaire; Crohn's Disease Endoscopic Index of Severity) was seen for BIRB 796 in comparison with placebo.  A significant, dose-dependent decrease of C-reactive protein level was obsd. transiently after BIRB 796 after 1 wk with a return to baseline level over time.  The incidence of adverse events was comparable between all treatment groups, with the exception of a mild increase of transaminase levels that was seen more frequently in the BIRB 796 groups.  Geog. center effects were obsd. with Russian centers producing distinctly higher remission and response rates and lower adverse event rates than in other countries in both placebo and active treatment groups.  There was no evidence for clin. efficacy of BIRB 796 in CD.  A remarkable difference in the course of CD exists between Russia and non-Russian centers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPlk4HFJbHhrVg90H21EOLACvtfcHk0limnYrn794tEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFOqsrs%253D&md5=f99fbaeea2b16c7e5fa11069b99518f1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.cgh.2005.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cgh.2005.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DFeagan%26aufirst%3DB.%26aulast%3DD%2527Haens%26aufirst%3DG.%26aulast%3DColombel%26aufirst%3DJ.%2BF.%26aulast%3DGeboes%26aufirst%3DK.%26aulast%3DYurcov%26aufirst%3DM.%26aulast%3DIsakov%26aufirst%3DV.%26aulast%3DGolovenko%26aufirst%3DO.%26aulast%3DBernstein%26aufirst%3DC.%2BN.%26aulast%3DLudwig%26aufirst%3DD.%26aulast%3DWinter%26aufirst%3DT.%26aulast%3DMeier%26aufirst%3DU.%26aulast%3DYong%26aufirst%3DC.%26aulast%3DSteffgen%26aufirst%3DJ.%26atitle%3DOral%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibition%2520with%2520BIRB%2520796%2520for%2520active%2520Crohn%2527s%2520disease%253A%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DClin.%2520Gastroenterol.%2520Hepatol.%26date%3D2006%26volume%3D4%26spage%3D325%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Norman, P.</span><span> </span><span class="NLM_article-title">BMS-582949: crystalline form of a p38alpha inhibitor? WO2008079857</span> <span class="citation_source-journal">Expert. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">–</span> <span class="NLM_lpage">1168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1517%2F13543770902816160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=19505194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1165-1168&author=P.+Norman&title=BMS-582949%3A+crystalline+form+of+a+p38alpha+inhibitor%3F+WO2008079857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">BMS-582949: crystalline form of a p38α inhibitor? WO2008079857</span></div><div class="casAuthors">Norman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1165-1168</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The p38 kinases have long been recognized as potentially valuable targets in the development of novel anti-inflammatory therapies.  An application claiming a single cryst. form of N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)-5-methyl-1-(3-(trifluoromethyl)pyridin-2-yl)-1H-pyrazole-4-carboxamide and its therapeutic use for the treatment of inflammatory diseases including rheumatoid arthritis, psoriasis and atherosclerosis points to the claimed compd. being a development compd.  The available evidence suggests that the compd. could be BMS-582949, a compd. in Phase II studies for the treatment of rheumatoid arthritis, psoriasis and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxQkmddjt_jrVg90H21EOLACvtfcHk0limnYrn794tEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVKktL0%253D&md5=a075540dbc5f826ac8760432b901db74</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1517%2F13543770902816160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770902816160%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DP.%26atitle%3DBMS-582949%253A%2520crystalline%2520form%2520of%2520a%2520p38alpha%2520inhibitor%253F%2520WO2008079857%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D1165%26epage%3D1168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Ji, P.; Gao, L.; Galbraith, S.; Kollia, G.; Xu, X.; Barrett, Y.; Kelsey, J.; Hawthorne, D.; Weiner, R.; Wang, J.; Luroe, S.; McKinnon, M.; Schieven, G.; Latek, R.; Thienel, U.; Kaul, S.</span><span> </span><span class="NLM_article-title">Multiple-Dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Potent P38 Inhibitor BMS-582949 in Healthy Subjects</span>. Presented at the American College of Rheumatology Scientific Meeting, San Francisco, CA,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Poster 335.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Ji&author=L.+Gao&author=S.+Galbraith&author=G.+Kollia&author=X.+Xu&author=Y.+Barrett&author=J.+Kelsey&author=D.+Hawthorne&author=R.+Weiner&author=J.+Wang&author=S.+Luroe&author=M.+McKinnon&author=G.+Schieven&author=R.+Latek&author=U.+Thienel&author=S.+Kaul&title=Multiple-Dose+Safety%2C+Tolerability%2C+Pharmacokinetics%2C+and+Pharmacodynamics+of+a+Potent+P38+Inhibitor+BMS-582949+in+Healthy+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DP.%26atitle%3DMultiple-Dose%2520Safety%252C%2520Tolerability%252C%2520Pharmacokinetics%252C%2520and%2520Pharmacodynamics%2520of%2520a%2520Potent%2520P38%2520Inhibitor%2520BMS-582949%2520in%2520Healthy%2520Subjects%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Wang, J.; Kaul, S.; Campanha, H.; Pikul, D.; Leftheris, K.; Xu, X.; Schieven, G.; Latek, R.; Kollia, G.; Ji, P.; Weiner, R.; McKinnon, M.; Galbraith, S.; Thienel, U.</span><span> </span><span class="NLM_article-title">Multiple Ascending Dose Study of a Potent p38 MAPK Inhibitor BMS-582949 in Subjects with Stable RA Receiving Concomitant Methotrexate</span>. Presented at the American College of Rheumatology Scientifc Meeting, San Francisco, CA,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract 356.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Wang&author=S.+Kaul&author=H.+Campanha&author=D.+Pikul&author=K.+Leftheris&author=X.+Xu&author=G.+Schieven&author=R.+Latek&author=G.+Kollia&author=P.+Ji&author=R.+Weiner&author=M.+McKinnon&author=S.+Galbraith&author=U.+Thienel&title=Multiple+Ascending+Dose+Study+of+a+Potent+p38+MAPK+Inhibitor+BMS-582949+in+Subjects+with+Stable+RA+Receiving+Concomitant+Methotrexate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DMultiple%2520Ascending%2520Dose%2520Study%2520of%2520a%2520Potent%2520p38%2520MAPK%2520Inhibitor%2520BMS-582949%2520in%2520Subjects%2520with%2520Stable%2520RA%2520Receiving%2520Concomitant%2520Methotrexate%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span>ClinicalTrials.gov Home Page. <a href="http://clinicaltrials.gov/show/NCT00605735" class="extLink">http://clinicaltrials.gov/show/NCT00605735</a> (accessed Jun 7,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Home+Page.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT00605735+%28accessed+Jun+7%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span>BMS Homepage. <a href="http://ctr.bms.com/OneBmsCtd/InitTrialDetailAction.do?pnum=IM119-015" class="extLink">http://ctr.bms.com/OneBmsCtd/InitTrialDetailAction.do?pnum=IM119-015</a> (accessed Jul 6,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BMS+Homepage.+http%3A%2F%2Fctr.bms.com%2FOneBmsCtd%2FInitTrialDetailAction.do%3Fpnum%3DIM119-015+%28accessed+Jul+6%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span>Ligand Homepage. <a href="http://www.pharmacopeia.com/collaborations.php#Bristol" class="extLink">http://www.pharmacopeia.com/collaborations.php#Bristol</a> (accessed Jul 6,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ligand+Homepage.+http%3A%2F%2Fwww.pharmacopeia.com%2Fcollaborations.php%23Bristol+%28accessed+Jul+6%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span>ClinicalTrials.gov Home Page. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00399906?term=BMS-582949&amp;rank=2" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT00399906?term=BMS-582949&rank=2</a> (accessed Jul 6,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Home+Page.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT00399906%3Fterm%3DBMS-582949%26rank%3D2+%28accessed+Jul+6%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span>ClinicalTrials.gov Home Page. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00570752?term=BMS-582949&amp;rank=4" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT00570752?term=BMS-582949&rank=4</a> (accessed Jul 6,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov+Home+Page.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT00570752%3Fterm%3DBMS-582949%26rank%3D4+%28accessed+Jul+6%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Remmers, A.</span><span> </span><span class="NLM_article-title">p38 Inhibitors as New Therapies for Inflammatory Pain: ARRY-797</span>. Presented at the Arrowhead Pain Therapeutic Summit, New Brunswick, NJ,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=A.+Remmers&title=p38+Inhibitors+as+New+Therapies+for+Inflammatory+Pain%3A+ARRY-797"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRemmers%26aufirst%3DA.%26atitle%3Dp38%2520Inhibitors%2520as%2520New%2520Therapies%2520for%2520Inflammatory%2520Pain%253A%2520ARRY-797%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span>Array Homepage. <a href="http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&amp;p=irol-newsArticle&amp;ID=1305781&amp;highlight=" class="extLink">http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=1305781&highlight=</a> (accessed Jul 8,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Array+Homepage.+http%3A%2F%2Finvestor.arraybiopharma.com%2Fphoenix.zhtml%3Fc%3D123810%26p%3Dirol-newsArticle%26ID%3D1305781%26highlight%3D+%28accessed+Jul+8%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Remmers, A.; Yates, J.; Daniels, S.; Martinez, C.</span><span> </span><span class="NLM_article-title">A Novel p38α Inhibitor, ARRY-797, Provides Significant Analgesic Benefit following Third Molar Extraction</span>. Presented at the American Pain Society's Annual Scientific Meeting, Tampa, FL,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=A.+Remmers&author=J.+Yates&author=S.+Daniels&author=C.+Martinez&title=A+Novel+p38%CE%B1+Inhibitor%2C+ARRY-797%2C+Provides+Significant+Analgesic+Benefit+following+Third+Molar+Extraction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRemmers%26aufirst%3DA.%26atitle%3DA%2520Novel%2520p38%25CE%25B1%2520Inhibitor%252C%2520ARRY-797%252C%2520Provides%2520Significant%2520Analgesic%2520Benefit%2520following%2520Third%2520Molar%2520Extraction%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Winski, S. L.; Humphries, M. J.; Yeh, T.; Gross, S. D.; Brown, S. A.; Anderson, D.; Wright, D.; Rodriguez, M.; Lee, P.; Munson, M.; Winkler, J.</span><span> </span><span class="NLM_article-title">Activity of ARRY-614, an Inhibitor of p38 MAP Kinase and Angiogenic Targets, In Hematological Malignancies</span>. Presented at the American Association for Cancer Research Annual Meeting, Denver, CO,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+L.+Winski&author=M.+J.+Humphries&author=T.+Yeh&author=S.+D.+Gross&author=S.+A.+Brown&author=D.+Anderson&author=D.+Wright&author=M.+Rodriguez&author=P.+Lee&author=M.+Munson&author=J.+Winkler&title=Activity+of+ARRY-614%2C+an+Inhibitor+of+p38+MAP+Kinase+and+Angiogenic+Targets%2C+In+Hematological+Malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWinski%26aufirst%3DS.%2BL.%26atitle%3DActivity%2520of%2520ARRY-614%252C%2520an%2520Inhibitor%2520of%2520p38%2520MAP%2520Kinase%2520and%2520Angiogenic%2520Targets%252C%2520In%2520Hematological%2520Malignancies%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Winski, S. L.; Freeman, B. B.; Remmers, A. E.; Carter, L. L.; Wright, A. D.; Munson, M. C.; Humphries, M. J.; Murphy, V. A.; Klopfenstein, N. S.; Wallace, R. D.; Baer, B. R.; Kemp, J. F.; Nugent, C. A.; Lee, P. A.; Winhler, J. D.</span><span> </span><span class="NLM_article-title">ARRY-614, an Inhibitor of p38 MAP Kinase and Angiogenic Targets, Is Active in Preclinical Models of Hematological Malignancies and Significantly Reduces ex-Vivo Cytokine Production in Normal Human Subjects</span>. Presented at the 7th International Symposium on Targeted Anti-Cancer Therapeutics, Amsterdam, The Netherlands,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+L.+Winski&author=B.+B.+Freeman&author=A.+E.+Remmers&author=L.+L.+Carter&author=A.+D.+Wright&author=M.+C.+Munson&author=M.+J.+Humphries&author=V.+A.+Murphy&author=N.+S.+Klopfenstein&author=R.+D.+Wallace&author=B.+R.+Baer&author=J.+F.+Kemp&author=C.+A.+Nugent&author=P.+A.+Lee&author=J.+D.+Winhler&title=ARRY-614%2C+an+Inhibitor+of+p38+MAP+Kinase+and+Angiogenic+Targets%2C+Is+Active+in+Preclinical+Models+of+Hematological+Malignancies+and+Significantly+Reduces+ex-Vivo+Cytokine+Production+in+Normal+Human+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWinski%26aufirst%3DS.%2BL.%26atitle%3DARRY-614%252C%2520an%2520Inhibitor%2520of%2520p38%2520MAP%2520Kinase%2520and%2520Angiogenic%2520Targets%252C%2520Is%2520Active%2520in%2520Preclinical%2520Models%2520of%2520Hematological%2520Malignancies%2520and%2520Significantly%2520Reduces%2520ex-Vivo%2520Cytokine%2520Production%2520in%2520Normal%2520Human%2520Subjects%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Monahan, J. B.; Hope, H.; Schindler, J.; Jungbluth, G.; Burnette, B.; Guzova, J.; Hirsch, J.; Saabye, M.; Compton, R.; Zhang, J.; Keith, R.; Anderson, G.; Stillwell, L.; Mbalaviele, G.; Webb, E.; Li, X.; Bonar, S.; Sommers, C.; Venkatraman, N.; Blorn, J.; Meyer, D.; Devraj, R.; Selness, S.</span><span> </span><span class="NLM_article-title">Anti-Inflammatory Properties of a Novel <i>N</i>-Phenyl Pyridinone Inhibitor of p38 MAP Kinase: Preclinical to Clinical Translation</span>. Presented at the Annual European Congress of Rheumatology, Copenhagen, Denmark,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Abstract FRI0001.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+B.+Monahan&author=H.+Hope&author=J.+Schindler&author=G.+Jungbluth&author=B.+Burnette&author=J.+Guzova&author=J.+Hirsch&author=M.+Saabye&author=R.+Compton&author=J.+Zhang&author=R.+Keith&author=G.+Anderson&author=L.+Stillwell&author=G.+Mbalaviele&author=E.+Webb&author=X.+Li&author=S.+Bonar&author=C.+Sommers&author=N.+Venkatraman&author=J.+Blorn&author=D.+Meyer&author=R.+Devraj&author=S.+Selness&title=Anti-Inflammatory+Properties+of+a+Novel+N-Phenyl+Pyridinone+Inhibitor+of+p38+MAP+Kinase%3A+Preclinical+to+Clinical+Translation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DAnti-Inflammatory%2520Properties%2520of%2520a%2520Novel%2520N-Phenyl%2520Pyridinone%2520Inhibitor%2520of%2520p38%2520MAP%2520Kinase%253A%2520Preclinical%2520to%2520Clinical%2520Translation%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Aston, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitulli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span> </span><span class="NLM_article-title">p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6257</span><span class="NLM_x">–</span> <span class="NLM_lpage">6269</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9004779" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6257-6269&author=N.+M.+Astonauthor=P.+Bamboroughauthor=J.+B.+Bucktonauthor=C.+D.+Edwardsauthor=D.+S.+Holmesauthor=K.+L.+Jonesauthor=V.+K.+Patelauthor=P.+A.+Smeeauthor=D.+O.+Somersauthor=G.+Vitulliauthor=A.+L.+Walker&title=p38alpha+mitogen-activated+protein+kinase+inhibitors%3A+optimization+of+a+series+of+biphenylamides+to+give+a+molecule+suitable+for+clinical+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm9004779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004779%26sid%3Dliteratum%253Aachs%26aulast%3DAston%26aufirst%3DN.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3Dp38alpha%2520mitogen-activated%2520protein%2520kinase%2520inhibitors%253A%2520optimization%2520of%2520a%2520series%2520of%2520biphenylamides%2520to%2520give%2520a%2520molecule%2520suitable%2520for%2520clinical%2520progression%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6257%26epage%3D6269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Adams, J. L.; Boehm, J. C.; Hall, R. J.; Jin, Q.; Kasparec, J.; Silva, D. J.; Taggart, J. J.</span><span> </span><span class="NLM_article-title">Preparation of 2,4,8-Trisubstituted-8<i>H</i>-pyrido[2,3-<i>d</i>]pyrimidin-7-ones as CSBP/RK/p38 Kinase Inhibitors</span>. WO2002059083,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+L.+Adams&author=J.+C.+Boehm&author=R.+J.+Hall&author=Q.+Jin&author=J.+Kasparec&author=D.+J.+Silva&author=J.+J.+Taggart&title=Preparation+of+2%2C4%2C8-Trisubstituted-8H-pyrido%5B2%2C3-d%5Dpyrimidin-7-ones+as+CSBP%2FRK%2Fp38+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26atitle%3DPreparation%2520of%25202%252C4%252C8-Trisubstituted-8H-pyrido%255B2%252C3-d%255Dpyrimidin-7-ones%2520as%2520CSBP%252FRK%252Fp38%2520Kinase%2520Inhibitors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span>GlaxoSmithKline Homepage. <a href="http://www.gsk.com/investors/product_pipeline/pp.htm" class="extLink">http://www.gsk.com/investors/product_pipeline/pp.htm</a> (accessed Oct 29,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GlaxoSmithKline+Homepage.+http%3A%2F%2Fwww.gsk.com%2Finvestors%2Fproduct_pipeline%2Fpp.htm+%28accessed+Oct+29%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule−kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule%E2%88%92kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule%25E2%2588%2592kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Stelmach, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pivnichny, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmatz, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. B.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm9012906&amp;key=10.1016%2FS0960-894X%2802%2900752-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm9012906&amp;key=12482439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm9012906&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=277-280&author=J.+E.+Stelmachauthor=L.+Liuauthor=S.+B.+Patelauthor=J.+V.+Pivnichnyauthor=G.+Scapinauthor=S.+Singhauthor=C.+E.+Hopauthor=Z.+Wangauthor=J.+R.+Straussauthor=P.+M.+Cameronauthor=E.+A.+Nicholsauthor=S.+J.+O%27Keefeauthor=E.+A.+O%27Neillauthor=D.+M.+Schmatzauthor=C.+D.+Schwartzauthor=C.+M.+Thompsonauthor=D.+M.+Zallerauthor=J.+B.+Doherty&title=Design+and+synthesis+of+potent%2C+orally+bioavailable+dihydroquinazolinone+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase</span></div><div class="casAuthors">Stelmach, John E.; Liu, Luping; Patel, Sangita B.; Pivnichny, James V.; Scapin, Giovanna; Singh, Suresh; Hop, Cornelis E. C. A.; Wang, Zhen; Strauss, John R.; Cameron, Patricia M.; Nichols, Elizabeth A.; O'Keefe, Stephen J.; O'Neill, Edward A.; Schmatz, Dennis M.; Schwartz, Cheryl D.; Thompson, Chris M.; Zaller, Dennis M.; Doherty, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-280</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The development of potent, orally bioavailable (in rat) and selective dihydroquinazolinone inhibitors I (R = CO2Me, R1 = H, Br, 2-FC6H4, etc.; R = OMe, R1 = 2-Cl-4-FC6H3, 2,4-F2C6H3, 2-ClC6H4), II (R1 = 2-Cl-4-FC6H3, 2,4-F2C6H3, 2-ClC6H4, X = none, O, NH, CH2, CO, Y = CH, N) and III (R2 = Me, Et, CHMe2, etc.) of p38α MAP kinase is described.  For example, III (R2 = CMe3) was prepd. via the Still coupling of I (R = OSO2CF3, R1 = 2-Cl-4-FC6H3) with 1-tert-butyl-4-(trimethylstannyl)-1,2,3,6-tetrahydropyridine.  These analogs are hybrids of a pyridinylimidazole p38α inhibitor reported by Merck Research Labs. and VX-745.  Optimization of the C-5 Ph and the C-7 piperidinyl substituents led to the identification of III (R2 = CMe3) which gave excellent suppression of TNF-α prodn. in LPS-stimulated whole blood (IC50=10 nM) and good oral exposure in rats (F=68%, AUCn PO=0.58 μM h).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeEsr0ksZsw7Vg90H21EOLACvtfcHk0lhR_oNs7NTvjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVemu7c%253D&md5=489ab070411bc48e879737d57d98d745</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900752-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900752-7%26sid%3Dliteratum%253Aachs%26aulast%3DStelmach%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DPivnichny%26aufirst%3DJ.%2BV.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DHop%26aufirst%3DC.%2BE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DStrauss%26aufirst%3DJ.%2BR.%26aulast%3DCameron%26aufirst%3DP.%2BM.%26aulast%3DNichols%26aufirst%3DE.%2BA.%26aulast%3DO%2527Keefe%26aufirst%3DS.%2BJ.%26aulast%3DO%2527Neill%26aufirst%3DE.%2BA.%26aulast%3DSchmatz%26aufirst%3DD.%2BM.%26aulast%3DSchwartz%26aufirst%3DC.%2BD.%26aulast%3DThompson%26aufirst%3DC.%2BM.%26aulast%3DZaller%26aufirst%3DD.%2BM.%26aulast%3DDoherty%26aufirst%3DJ.%2BB.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520orally%2520bioavailable%2520dihydroquinazolinone%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D277%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QD9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QD9','PDB','2QD9'); return false;">PDB: 2QD9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M7Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1M7Q','PDB','1M7Q'); return false;">PDB: 1M7Q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FLW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FLW','PDB','3FLW'); return false;">PDB: 3FLW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HLL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HLL','PDB','3HLL'); return false;">PDB: 3HLL</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9012906&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm9012906%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9012906" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b145b7dd01995","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
